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Abstract 
A key area of uncertainty in human health risk assessment of chemical mixtures is the 
application of additivity of dose or effects, which may overestimate or underestimate the 
actual risk. In this PhD thesis, interaction effects among mixtures of benzo[a]pyrene 
(B[a]P), pyrene (Pyr), phenanthrene (Phe) and naphthalene (Nap) in the presence or 
absence of arsenic (As), cadmium (Cd), lead (Pb) is elucidated for bioaccessibility, uptake 
(surrogate bioavailability) and metabolism of PAHs in human systems using in vitro 
models. A simulated human digestion based on the use of an in vitro model (Unified 
BARGE Method) was used to quantify PAH bioaccessibility from exposure to 
contaminated soils, whereas a human liver hepatocellular (HepG2) cell line (surrogate 
liver) was used as an in vitro model to quantify uptake and metabolism of PAHs. This PhD 
focused on mixtures of B[a]P, Pyr, Phe and Nap as model compounds for PAHs.      
 
Two QuEChERS based analytical methods have been developed and validated for the 
analysis of PAHs and its mono-hydroxylated metabolites (OH-PAHs) in HepG2 cells and 
soils. The QuEChERS based methods were successfully optimised for use with triple 
quadrupole Gas Chromatography with Mass Spectrometer (GS-QqQ-MS/MS) and High 
Performance Liquid Chromatography with an Orbitrap system (Q-Orbitrap-LC/MS). Both 
methods are the first analytical reports with applications in chemical mixtures study.  
 
To investigate bioaccessibility of PAHs, seven chemically-variant top soils were collected 
from background sites in Australia and were spiked with PAHs and aged up to 90 days. 
The UBM results suggest that the most significant interactions between PAHs and soil 
components controlling its bioaccessibility was completed by the first 7 days of ageing 
condition of this study. It is noted that there was a significant lower bioaccessibility of 
B[a]P, Pyr, Phe and Nap in the gastric phase in comparison to that of gastrointestinal 
phase. 
 
Three key soil parameters, including total organic carbon (TOC), clay and aluminium oxide 
were most influential in decreasing bioaccessibility of B[a]P, Pyr, Phe and Nap in the 
spiked and aged soil samples (R2 = 0.5 – 0.86). Notably, decreasing bioaccessibility of 
PAHs in all soil types generally followed a sequence based on increasing TOC content. In 
contrast, dissolved organic carbon (R2 = 0.74 – 0.83) was found to be the key soil 
parameter in increasing the bioaccessibility of B[a]P, Pyr, Phe and Nap in spiked and aged 
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soil samples. Further, UBM results indicate that PAHs in some contaminated soils 
impacted by anthropogenic activities may not necessarily be readily available. An 
important observation in this study with one particular soil type (MTA) was that its relative 
bioaccessibility of B[a]P was 53.3 ± 10.7 % and was found not to be significantly different 
(p value = 0.21) from the relative bioavailability value of 62.7 % reported in the juvenile 
swine study (Duan, 2014).  
 
For mixture effects, the bioaccessibility of B[a]P in the presence of As, Cd or Pb 
decreased by 0.2 %, 1.8 % and 2 % (based on the adjusted 100 %), respectively. Similar 
observations were seen with Pyr, Phe and Nap in combination with As, Cd or Pb, with 
decrease in bioaccessibilities in the range of 0.1 – 1.8 %. No significant interaction effects 
of B[a]P, Pyr, Phe and Nap on their respective bioaccessibility were observed in any of the 
seven soil types.  
 
Data from pure solution study suggests that uptake of PAHs and in the presence of As, 
Cd, and Pb in HepG2 cells generally showed less than additive effects among binary, 
ternary and seven compound mixtures of B[a]P, Pyr, Phe and Nap. Notably, the % uptake 
of Phe in HepG2 cells was found to decrease significantly in the seven compound mixture 
(p < 0.05) which had As, Cd and Pb. Using UBM-extracted solutions, interaction effects on 
uptake of PAHs in HepG2 cells was found to be both additive and less than additive. 
Moreover, the % uptake data from UBM-extracted real soil samples showed a decrease in 
% uptake of B[a]P, Pyr, Phe and Nap by 0.7 %, 1.8 %, 0.4 % and 0.04 %, respectively 
when compared to their individual PAH % uptake in HepG2 cells from exposure to UBM-
extracted spiked soil samples.  
 
Results of bioaccessibility, uptake and metabolism of B[a]P, Pyr, Phe and Nap as 
individual compounds or mixtures in the presence or absence of As, Cd and Pb provide 
significant new understanding towards interaction effects of these compounds in the 
context of human health risk assessment. For assessment of soils contaminated with 
PAHs and metal/loids, it clarifies situations where additive effects can be expected rather 
than assuming additivity as a general rule in risk assessment of chemical mixtures. 
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Chapter 1 General Introduction 
 
Soil is a complex and heterogeneous matrix, containing both inorganic and organic 
components, and is often subject to intense chemical pollution (Vera et al., 2013). Soil is 
an important and limited natural resource and it is important to maintain its vitality for our 
future generations. In recognition of its importance, the United Nations declared 2015 as 
‘‘The International Year of Soil’’ (United Nations General Assembly, 2014). Such an 
initiative follows from the footsteps of the development of soil policy at the European Union 
level such as the introduction of thematic strategy for the protection of soils (EC, 2006a) 
and the proposed soil framework directive (EC, 2006b), which is envisioned to reduce 
ecosystem and human health risk from possible exposure to contaminated soil. 
Contamination of soil creates a significant risk to human health. In today’s context, soil 
contamination is mainly associated to industrial and commercial land-use, waste land-fills, 
military camps and areas with established nuclear power plants (Panagos et al., 2013). In 
a recent paper by Naidu et al. (2015a) it is estimated that on a global scale, there are over 
3 million potentially contaminated sites that may pose a threat to human health and the 
environment. 
In the developed world the cost of remediating such contaminated sites is estimated to be 
in billions of dollars. In Australia remediation of over 150,000 contaminated sites is 
estimated to cost around 5 – 8 billion dollars (Australia,1997), in the USA about 1 trillion 
dollars (Rao et al., 1996) and about 0.1 % – 1.5 % of the gross domestic product (GDP) 
per annum in Europe (Lanno et al., 2004). The high cost for remediating contaminated 
sites can be attributed to current legislations which are mainly based on the total 
contaminant concentrations in soil, sediment and ground water and that the contaminant is 
assumed to be 100 % bioavailable (Ng et al., 2013). In reality, only a fraction of the 
contaminant may be bioavailable (BA) and as such the assumption that all of the ingested 
contaminant is solubilised in the gastrointestinal tract  and is absorbed into systemic 
circulation (e.g. 100 % bioavailable) may grossly overestimate the daily chemical intake 
thereby influencing risk assessment (Ng et al., 2010).  
However, assessment of human health risk at a contaminated site is particularly difficult 
due to the fact that the soil within the vicinity may contain a mixture of contaminants, both 
organic and inorganic in nature. Simply assuming additive effect in the risk assessment 
may not reflect on the real situation for contaminated sites. This is because the cocktail of 
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contaminants present in contaminated soils may possibly interact amongst each other and 
the soil thereby affecting their bioaccessibility (BAC) and upon ingestion their interaction 
may influence solubility in the human digestive system or uptake in target organ such as 
the liver.  
1.1 Project background 
This chapter introduces my PhD study that is part of a larger health risk assessment project 
funded by the Cooperative Centre for Contamination Assessment and Remediation of the 
Environment and entitled “Assessing the risk to human health and the environment from mixed 
contamination (CRC CARE Project number 3.1.01.11-12)”. My PhD research focussed on 
investigating the bioaccessibility of PAHs in different soil types, which occur as single 
contaminant or co-contaminated with other PAHs and metal/loids and aged over a period of 
time. Subsequently, investigating PAH uptake (surrogate bioavailability) and metabolism in 
human liver cells (surrogate liver). The results from my PhD complements the bioaccessibility 
and uptake of metal/loids data (Xia, 2016 – PhD thesis) as well as toxicity of mixtures of PAHs 
and metal/loids (Muthusamy, 2016 PhD thesis), both aspects of the larger project aimed 
towards better understanding and refining risk assessment of these chemical mixtures.  
1.2 Human contaminant exposure  
Human exposure to contaminants in soil may result from a variety of pathways including 
dermal absorption, inhalation or oral ingestion. Exposure to volatile and semi-volatile 
contaminants such as PAHs may occur via inhalation of particulate matter, whereas 
dermal absorption will result mainly during physical contact of contaminated soil with the 
bare skin. Oral ingestion of PAHs mainly results from incidental ingestion of soil and 
contaminated food chain. Oral ingestion can also result following inhalation of particulates 
containing PAHs, impaction onto mucus in tracheobronchial tract, movement up the tract 
by cilia to pharynx, and swallowing. Notably, a major non-dietary exposure of PAHs is via 
the incidental ingestion of contaminated soil which is one of the key subjects of 
investigation in this PhD study.  
1.3 3R principle: Animal use for scientific purposes and in vitro assays 
Humans cannot be subjected to scientific investigations requiring intentional ingestion of 
contaminants within a toxicological framework. In the absence of human studies or the 
availability of suitable epidemiological data, the ‘‘gold’’ standard for in vivo studies is using 
animal models such as immature swine because of its similarity of anatomical 
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gastrointestinal tract to infants, the most sensitive risk receptor in human populations (Ng 
et al., 2013; Bordelon et al., 2000; Duan et al., 2015). Nevertheless, animal studies can be 
very expensive with many ethical issues relating to animal welfare in research and testing. 
It is also noteworthy that since 1986, the European Union (EU) has had in place specific 
legislation covering the use of animals for scientific purposes. On 22 September 2010, the 
EU adopted Directive 2010/63/EU which updated and replaced the 1986 Directive 
86/609/EEC on the protection of animals used for scientific purposes. The overall aim of 
the new Directive is to strengthen legislation, and improve the welfare of those animals still 
needed to be used, as well as to firmly anchor the principle of the Three Rs; to Replace, 
Reduce and Refine the use of animals in laboratory experiments, in EU legislation. The 
Directive 2010/63/EU took full effect on 1 January 2013.  
To address such issues, considerable effort has been put into the development and 
implementation of in vitro methods for regulatory use in human health risk assessment. 
This includes examples of extensive international collaborations with formation of a 
number of research initiatives, including the Solubility and Bioavailability Research 
Consortium (SBRC), the Bioavailability Research Group of Europe (BARGE) and 
Bioavailability Research Canada (BARC) working towards refining the understanding of 
the scientific validity of in vitro research. Moreover, the increase in use of in vitro bioassay 
based on human cells are supported by National Research Council (NRC) to determine 
the effects of chemicals of concern on human health risks (Bhattacharya et al., 2011).  
Immortalised cell lines and primary hepatocytes are the most widely-adopted in vitro 
models. Human liver hepatocellular carcinoma (HepG2) cell line is one of the well-
characterised immortalised cells, which can activate and detoxify xenobiotics and thus 
reflect the metabolism of xenobiotics in the human body (Mersch-Sundermann et al., 
2004; Baderna et al., 2013). The HepG2 cell line was isolated from a liver biopsy of a male 
Caucasian aged 15 years, with a well differentiated hepatocellular carcinoma. HepG2 cells 
can be useful representative of the human liver, which is the key organ in the human body 
responsible for metabolic and detoxification functions (Underhill, 1914; Chen et al., 2005).  
Further, HepG2 cells secrete a variety of major plasma proteins e.g. albumin, α2-
macroglobulin, α 1-antitrypsin, transferrin and plasminogen, which are normally lost in 
primary hepatocytes in culture. HepG2 cells have been used successfully in large scale 
cultivation systems. Importantly, Hepatitis B virus surface antigens have not been detected 
in cultures and these cells will respond to stimulation with human growth hormone. In 
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addition, HepG2 cells have an endogenous expression of metabolising enzymes (e.g. 
cytochromes or CYPs) and antioxidant defence system (Schoonen et al., 2005). However, 
HepG2 cells have been reported to have lower levels of CYPs in comparison to primary 
hepatocytes, but normal levels of phase II enzymes except UDP-glucuronosyl transferases 
(Guillouzo et al., 2007). Further, Schoonen et al (2005) reported that HepG2 cell line has a 
higher predictability of humans compared to animal cell lines. The use of animal 
alternatives by adopting in vitro assays in risk assessment process is investigated in this 
PhD.   
1.4 Chemicals of concern 
A wide variety of compounds commonly occur in soils at contaminated sites, often 
resulting from the type of human activity within the vicinity of the site. The co-occurrence of 
PAHs and metal/loids in contaminated soil is well documented in the literature and 
represents a major problem in remediation of soil from such sites. This is due to the lack of 
our understanding regarding their interaction and potential effects of chemical mixtures in 
human health risk assessment. In this thesis, four selected PAHs are studied not only 
because of their wide occurrence and levels at which they are found in contaminated soils 
but also due to their well-documented health impacts on humans (IARC, 2012). PAHs 
discussed in this thesis include; naphthalene (Nap), phenanthrene (Phe), pyrene (Pyr) and 
benzo[a]pyrene (B[a]P). A brief introduction of the four PAHs in terms of their 
physicochemical properties (Table 1.1 – Table 1.4), source, fate in the environment, 
exposure pathways, metabolism and toxicity and adverse health effects are presented 
below. 
1.4.1 Physicochemical characteristics of PAHs 
The physical and chemical characteristics of PAHs vary with increasing molecular weight. 
PAHs can be divided into two groups based on their physical, chemical, and biological 
characteristics. The lower molecular weight PAHs consist of 2 to 3 aromatic rings whereas 
the high molecular weight PAHs have 4 to 7 aromatic rings. Heavier PAHs are more 
resistant to oxidation, reduction, and volatilisation. In comparison lighter PAHs have 
greater aqueous solubility and are semi-volatile in nature, hence more susceptible to 
degradation (Mackay and Shiu, 1992). The high molecular weight PAHs are primarily 
associated with particles and less available for degradation and persistent in nature. Both 
low and high molecular weight PAHs are lipophilic in nature and bioaccumulate in living 
organisms. Thus, PAHs as a group of organic chemicals vary in their behaviour, 
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distribution in the environment and their effects on biological systems. It is also noteworthy 
that the planer structure of PAHs allows them to bind as a ligand to Aryl hydrocarbon 
receptor (AhR) and induce its own metabolism through AhR-regulated cytochrome P450 
monooxygenase (Chiaro, 2007).  The binding of PAHs to Cytochrome P450 enzyme is 
essential for their metabolism (Shimada and Fujii-Kuriyama, 2004). The structures of some 
PAHs which include “bay region” have also been linked to their toxicity (Jerina et al., 1980; 
Weis, 1998). Representative PAHs for this study include; Nap, Phe, Pyr and B[a]P which 
have 2, 3, 4 and 5 aromatic rings respectively, and corresponding diverse physico-
chemical properties.  
Structure and physicochemical properties of benzo[a]pyrene 
IUPAC name: benzo[a]pyrene  
Molecular formula: C20H12 
CAS Number: 50-32-8 
 
Figure 1.1 Structural formula of benzo[a]pyrene 
 
Number of aromatic rings: 5 
 
Table 1.1 Physicochemical properties of benzo[a]pyrene 
Properties Detail  Reference 
Colour Yellowish (Budavari, 1989) 
Solubility in water at 25 oC 3.8 μg L-1 (Mackay and Shiu, 1977) 
vapour pressure at 25 oC 7.3 x 10-700 Pa (Mackay and Shiu, 1977) 
n-Octanol: water partition coefficient (log Kow) 6.5 (Bruggeman et al.,1982) 
Henry’s law constant at 20 oC 3.4 x 10-5 (Mackay and Shiu, 1977) 
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Structure and physicochemical properties of pyrene 
IUPAC name: pyrene  
Molecular formula: C16H10 
CAS Number: 129-00-0 
 
Figure 1.2 Structural formula of pyrene 
 
Number of aromatic rings: 4 
 
Table 1.2 Physicochemical properties of pyrene 
Properties Detail Reference 
Colour Colourless  (Budavari, 1989) 
Solubility in water at 25 oC 135 μg L-1 (Mackay and Shiu, 1977) 
vapour pressure at 25 oC 6 x 10-4 Pa (Sonnefeld et al., 1983) 
n-Octanol: water partition coefficient (log Kow) 5.18 (Karickhoff et al., 1979) 
Henry’s law constant at 20 oC 1.1 x 10-3 (Mackay and Shiu, 1981) 
 
 
Structure and physicochemical properties of phenanthrene 
IUPAC name: phenanthrene  
Molecular formula: C14H10 
CAS Number: 85-01-8 
 
Figure 1.3 Structural formula of phenanthrene 
 
Number of aromatic rings: 3 
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Table 1.3 Physicochemical properties of phenanthrene 
Properties Detail Reference 
Colour Colourless  (Hawley, 1987) 
Solubility in water at 25 oC 1.29 x 103 μg L-1 (Mackay and Shiu, 1977) 
vapour pressure at 25 oC 1.6 x 10-2 Pa (Mackay and Shiu, 1977) 
n-Octanol: water partition coefficient          
(log Kow) 
4.6 (Karickhoff et al., 1979) 
Henry’s law constant at 20 oC 3.98 x 10-3 (Mackay and Shiu, 1981) 
 
Structure and physicochemical properties of naphthalene 
IUPAC name: naphthalene  
Molecular formula: C10H8 
CAS Number: 91-20-3 
 
Figure 1.4 Structural formula of naphthalene 
 
Number of aromatic rings: 2 
 
Table 1.4 Physicochemical properties of naphthalene 
Properties Detail Reference 
Colour White (Lewis, 1992) 
Solubility in water at 25 oC 3.17 x 104 μg L-1 (Mackay and Shiu, 1977) 
vapour pressure at 25 oC 10.4 Pa (Sonnefeld et el., 1983) 
n-Octanol: water partition coefficient 
(log Kow) 
3.4 (Karickhoff et al., 1979) 
Henry’s law constant at 20 oC 4.89 x 10-2 (Mackay and Shiu, 1981) 
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1.4.2 Sources of PAHs 
Polycyclic aromatic hydrocarbons are organic compounds that are formed and released 
into the environment from both natural and anthropogenic combustion sources. The type 
of PAHs released from these sources depend on combustion temperature, where high 
temperatures (e.g. coking process) create simple PAHs while low temperatures result in 
formation of complex PAHs (Harvey, 1997; Harvey,1998). Natural sources of PAHs 
include forest fires and volcanoes. Anthropogenic sources, however, are the primary 
sources of PAHs that result in atmospheric pollution which has the potential to cause 
adverse human health effects. Some of the key anthropogenic sources include 
combustion of fossil fuel by motor vehicles, coal, tar, crude oil, wood burning, cigarette 
smoking and grilled foods. The four PAHs in this study, including B[a]P, Pyr, Phe and Nap 
are often found in PAH contaminated soils from sites impacted with long term human 
activity such as former manufacturing gasworks sites that are found as obsolete 
establishments in most developed countries around the world. Most of the gasworks 
facilities are found within or close to the vicinity of urban land-use in developed countries 
and therefore is of interest from the perspective of potential health risk to human 
populations. A schematic of a gasworks facility is shown in Figure 1.5, from which it can be 
interpreted that the key source of PAHs is the tar and liquor wells that are often buried 
within the vicinity of a former manufacturing gasworks sites.  
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Figure 1.5 Schematic diagram of a typical gasworks plant (adopted; Meade, 1934) 
Sources of benzo[a]pyrene     
B[a]P is primarily produced as a by-product of incomplete combustion of organic matter. 
However, it is found naturally in petroleum-based tars. B[a]P was first identified as being 
one of the chemical agents in coal tar responsible for causing tumour in chimney sweep 
workers in the 1930s (Cook et al., 1932; Kennaway, 1955). B[a]P is found associated with 
particulate matter and has the tendency to accumulate in the environment through sorption 
to organic matter, animals and plants (Juhasz and Naidu, 2000). 
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Sources of phenanthrene, pyrene and naphthalene  
Pyr, Phe and Nap are also primarily produced from incomplete combustion of organic 
matter. All three compounds are found naturally in petroleum based-tars. It is noteworthy 
that Nap is found as the most abundant single component in tar. All three PAHs listed here 
are also constituents of gasoline, diesel and jet fuel (Clark et al., 1982; White, 1999; 
McDougal et al., 2000).  
1.4.3 Metabolism and toxicity of PAHs 
The toxicity of PAHs is dependent on both the structure of the individual PAHs and also 
the metabolism to reactive intermediates with the potential to bind to cellular proteins and 
DNA (Shimada and Fujii-Kariyama, 2004). Generally, PAHs are biologically inert and 
require metabolic activation for either their removal or for further reaction. The metabolism 
of different PAHs includes enzymatic modification to more water soluble compounds, 
which are more readily excreted by the exposed subjects (Gelboin, 1980). Metabolism of 
PAHs may be divided into phase I and phase 2 reactions. Phase 1 of PAH metabolism 
introduces a polar group in the molecule through reduction, hydrolysis or oxidation (Abdel-
Shafy and Mansour, 2016). In phase II of PAH metabolism, a more polar group is 
conjugated with the intermediate making the conjugated product more soluble in water for 
excretion (Gelbion, 1980). There are a number of pathways for PAH metabolism. The 
most widely accepted pathway of biological activation involves cytochrome-P450 (CYP) 
enzymes. Several of the major CYP enzymes, like CYP1A1, CYP1A2 and CYP1B1, are 
important for the metabolic activation of different PAHs (Shimada and Fujii-Kariyama, 
2004). The metabolism of PAHs may also lead to formation of reactive metabolites which 
have the potential to bind to DNA forming adducts thereby inducing the carcinogenic effect 
of PAHs (Alexandrov et al., 2006). Due to structural similarities the metabolism of PAHs is 
generally similar.  
Benzo[a]pyrene and its metabolites  
According to the International Agency for Research on Cancer (IARC, 2012), B[a]P is 
classified into “Group 1 carcinogens”. Under the IARC, chemicals listed under Group 1 are 
confirmed to be human carcinogens. It is known that B[a]P requires biological activation 
through oxidative metabolism to be carcinogenic. B[a]P induces its own metabolism by 
activating the AhR pathway, leading to the induction of biotransformation enzymes 
(Cosman et al., 1992; Hankinson, 1995). The metabolism of B[a]P is divided into two main 
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phases. During phase I, enzymatic reaction through cytochrome P450s such as CYP1A1 
and CYP1B1, epoxide reductases and epoxide hydrolases leads to monooxygenation of 
B[a]P (Gelboin, 1980). The oxidised metabolites of phase 1 are then further metabolised 
by phase II enzymes such as glutathione transferases, UDP-glucuronyl transferases, and 
sulfotransferases (Miller and Ramos, 2001). During phase II, the B[a]P metabolites are 
conjugated to hydrophilic molecules such as glucuronic acid or glutathione, making them 
more hydrophilic and for that reason easier to be excreted (Gelboin, 1980). The main 
groups of B[a]P metabolites are epoxides, dihydrodiols, phenols and quinones (Figure 
1.6).  
Monohydroxylated metabolites of B[a]P are mainly result from phase 1 of cellular 
metabolism while other B[a]P metabolites from phase 1 metabolism include 
benzo[a]pyrene-7,8-diol, benzo[a]pyrene-7,8-dione, benzo[a]pyrene-4,5-diol and B[a]P 
metabolites with a high carcinogenic potential such as benzo[a]pyrene-7,8-dihydrodiol-
9,10-epoxide (BPDE) (Frank et al., 1998; Dreij et al., 2005).  
 
Figure 1.6 Overview of benzo[a]pyrene metabolism and BPDE-DNA adduct 
formation 
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As DNA is nucleophilic in nature it has a tendency to bind to the electrophilic epoxide 
(Shukla et al., 1997). The highly reactive B[a]P metabolite, BPDE binds to DNA at the N²-
position of deoxyguanosine (BPDE-N²-dG) and to proteins, forming both DNA and protein 
adducts (Penning et al., 1999; Flowers et al., 1996). It is believed that the formation of 
BPDE is responsible for the production of the majority of DNA adducts in cells (Li et al., 
1995; Geacintov et al., 1997; Kozack and Loechler, 1999). BPDE-DNA adducts may lead 
to cancer by causing mutations in genes responsible for important cell functions, including 
apoptosis, proliferation and differentiation (Chi et al., 2009; Boysen and Hecht, 2003). 
Phenanthrene and its metabolites 
According to the IARC carcinogen classification (IARC, 2010), Phe is classified into Group 
3, which means evidence for carcinogenicity is inadequate in humans and inadequate or 
limited in experimental animals. Similar to B[a]P metabolism, phase I enzymatic reaction 
through cytochrome CYP-450s produces the oxidised metabolites of Phe such as the 
monohydroxilated intermediates or the diol intermediates (Figure 1.7). Some of the key 
metabolites from Phe metabolism include; 1-hydroxyphenanthrene, 2-
hydroxyphenanthrene, 3-hydroxyphenanthrene and 4-hydroxyphenanthrene. The Centre 
for Disease Control (CDC) in their National Survey of population exposure to PAHs in the 
United States of America reported that monohydroxylated Phe metabolites were the major 
metabolites of Phe present in human urine samples (US CDC, 2014). 
 
Figure 1.7 Overview of phenanthrene metabolism 
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In Phase 2, the CYP-P450 further metabolises the monohydroxilated and diol Phe 
intermediates to epoxides and tetrols, often adding hydrophilic molecules such as 
glucuronic acid or glutathione for easier excretion. 
Pyrene and its metabolites 
According to the IARC classification (IARC, 2010), Pyr is classified into Group 2B, which 
means this compound is possibly carcinogenic to humans. Pyr metabolism proceeds via 
phase I enzymatic reaction through cytochrome CYP-450s and produces the oxidized 
metabolites of Pyr such as the monohydroxylated intermediates or the diol intermediates 
(Figure 1.8). The key metabolite for Pyr is 1-hydroxypyrene. The metabolite 1-
hydroxypyrene has been used as a key indicator chemical in human biomonitoring studies 
regarding exposure to PAHs (particularly Pyr). Urinary concentrations of 1-hydroxypyrene 
in human populations can reflect changes in exposure to PAHs in their environment.  
The Centre for Disease Control (CDC) in their National Survey (US CDC, 2013) for 
population exposure to PAHs in the United States of America reported that 
monohydroxylated Pyr is the major metabolite of Pyr in human urine samples. In Phase 2, 
the CYP-P450 further metabolizes the monohydroxylated and diol Pyr intermediates to 
epoxides and tetrols, often adding hydrophilic molecules such as glucuronic acid or 
glutathione for easier excretion.  
 
Figure 1.8 Overview of pyrene metabolism 
33 
 
Naphthalene and its metabolites 
According to the IARC carcinogen classification (IARC, 2010), Nap is classified into Group 
2B, which means this compound is possibly carcinogenic to humans. Acute exposure to 
Nap has been associated to liver damage and haemolytic anaemia. The latter is 
developed in infants whose mothers “sniffed” or ingested Nap (as mothballs) during 
pregnancy. Nap metabolism proceeds via phase I enzymatic reaction through cytochrome 
CYP-450s which produces the oxidized metabolites of Nap such as the monohydroxylated 
Nap or the diol intermediates (Figure 1.9). The key metabolites for Nap in human 
biomonitoring studies are 1-hydroxynapthalene and 2-hydroxynapthalene. The Centre for 
Disease Control (CDC) in their National Survey for population exposure to PAHs in the 
United States of America reported that monohydroxylated Nap (e.g. 1-hydroxynapthalene 
and 2-hydroxynapthalene) are the major metabolites of Nap in human urine samples (US 
CDC, 2013). In Phase 1, the CYP-P450 further metabolises the monohydroxylated and 
diol intermediates to epoxides and tetrols, while in phase 2 reaction hydrophilic molecules 
such as glucuronic acid or glutathione are added as a conjugate for easier excretion of 
metabolites.   
 
 
Figure 1.9 Overview of naphthalene metabolism 
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1.4.4 Persistence of PAHs in soil   
Soil is considered as a natural sink for various environmental contaminants. If 
contaminants by nature are persistent then over time soils become contaminated and 
exposure to such soils present a risk to human health. Accumulation of PAHs in soil 
results from both natural and anthropogenic sources. Levels of PAHs in soils below 200 µg 
Kg-1 is considered as “background soil”, while soil samples with sum PAHs in a range of 
600 µg Kg-1  – 10,000 µg Kg-1 corresponds to contaminated soil and above 10,000 µg Kg-1 
corresponds to very high contaminated soil where remediation is needed (Wcislo, 1998). 
According to the Australian Environmental Health Risk Assessment (EHRA) guidelines, 
the maximum limit for the sum of PAHs in industrial soils based on Health Investigation 
Level A (HIL A) is 300 mg Kg-1 and the limit for B[a]P in residential soils is 3 mg Kg-1 
(enHealth, 2012; NEPC, 2013).    
The increasing concentrations of PAHs in soil over the past 100 - 150 years has been 
linked the growing industrial activities, notably concentrations of PAHs in industrial and 
urban soil are found 10 – 100 times higher than concentrations in remote soils (Wild and 
Jones, 1995). In a review of literature, Juhasz and Naidu (2000) reported total PAH 
concentrations of 5863 mg Kg-1 in soil at a creosote production site, 18704 mg Kg-1 in soil 
at a wood preservation site, 821 mg Kg-1 in soil at a petrochemical site and 451 mg Kg-1 in 
soil samples from a gas manufacturing plant site. This indicates industrial soil PAH 
concentrations and type varied depending on the type of industry. It is significant that high 
concentration of PAHs have been reported in soil samples from former gasworks sites 
around the world, including Australia and the concentrations are above soil based health 
investigation levels (Table 1.5). The contamination of soil from former manufacturing 
gasworks sites is a result of long term operation of gasworks and improper disposal of tar 
containing PAHs.  
PAHs are strongly sorbed to organic matter which makes them relatively unavailable for 
degradation processes (Wild and Jones, 1995). Generally, PAH sorption in soil increases 
with increasing benzene rings and therefore remains in the soil for many years (Bossert 
and Bartha, 1986; Howsam and Jones, 1998). The half-life (T1/2) of heavy molecular 
weight PAHs such as B[a]P in soil is up to 1.9 years, while for lower molecular weight 
PAHs such as Nap, the half-life in soil is up to 14 days only. Due to short half lives in soil, 
the lower molecular weight PAHs such as Nap are partly lost through volatilisation, 
leaching and degradation (Wilson and Jones, 1993; Johnston et al., 1993). However, 
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studies indicate that ageing of soil reduces degradation and extractability of PAHs, hence 
lowering the fraction of available PAH for uptake by living organisms (Hatzinger and 
Alexander, 1995; Loehr and Webster, 1996; Allard et al., 2000; Weissenfels et al., 1992).  
Table 1.5 Concentration ranges of U.S. EPA priority PAH* contaminants in soils and 
sediments from or near gasworks sites 
Country Matrix Concentration 
 (mg Kg-1) 
Reference 
Australia Soil 335 – 8,645 Thavamani et al., 2011 
United States of America Soil 0.57 - 3120 Koganti et al., 1998 
United States of America Soil 147 - 1234 Khalil et al., 2006 
United States of America Sediment 4 - 5700 Kreitinger et al., 2007 
United States of America Soil 7 - 1040 Stroo et al., 2000 
United Kingdom* Soil 2 - 68 Cave et al., 2010 
*Sum 16 U.S EPA PAHs include; acenaphthene, acenaphthylene, anthracene, benz[a]anthracene, 
benzo[b]fluoranthene, benzo[k]fluoranthene, benzo[g,h,i]perylene, benzo[a]pyrene, chrysene, 
dibenz[a,h]anthracene, fluoranthene, fluorene, indeno[1,2,3-c,d]pyrene, naphthalene, phenanthrene, pyrene.  
 
1.5 Research hypothesis 
The research hypothesis of this study is that interaction effects between select metal/loids 
and PAHs will influence the bioaccessibility and uptake (surrogate bioavailability) of PAHs 
in human liver hepatocellular carcinoma cell line (HepG2). This PhD study will address the 
following research questions: 
 Do metal/loids (As, Cd and Pb) and PAH mixtures lead to an increase or decrease 
in the bioaccessibility of naphthalene (Nap), phenanthrene (Phe), pyrene (Pyr) and 
benzo[a]pyrene (B[a]P) in a simulated human digestive system? 
 Is there an increase or decrease in uptake of Nap, Phe, Pyr and B[a]P into HepG2 
cells from PAH mixtures in the presence or absence of As, Cd and Pb? 
 Does ageing of contaminated soil and soil properties impact PAH bioaccessibility 
and uptake? 
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In order to address the above questions the following aims and objectives are selected. 
1.6 Aims and objectives 
Aim 
The aims of this PhD were to investigate: 
1. Bioaccessibility of B[a]P, Nap, Phe and Pyr individually, in combination and in 
presence or absence of As, Cd and Pb. 
2. The uptake of PAHs in the presence and absence of As, Cd and Pb in HepG2 cells. 
Objectives 
Specifically, the objectives of the research for this thesis were: 
1. To establish rapid and sensitive analytical methodologies for measuring PAHs and 
their metabolites in soil and HepG2 cells.  
2. To determine the bioaccessible concentration of PAHs in spiked and field 
contaminated soils using the Unified BARGE Methodology (UBM) 
3. To determine intracellular uptake of PAHs and its metabolism in HepG2 cells 
exposed to pure model compounds or extracts of different contaminated soils 
4. To investigate interaction effects of PAHs and metal/loid mixtures on the 
bioaccessibility of PAHs  
5. To investigate interaction effects of PAHs and metal/loid mixtures on the uptake of 
PAHs in HepG2 cells  
1.7 Thesis overview and layout of chapters 
The research reported in this thesis investigated the bioaccessibility of Nap, Phe, Pyr and 
B[a]P in contrasting soil types, in particular looking at the influence of soil physicochemical 
properties, PAH ageing in soils and interaction between PAHs and metal/loids in binary, 
ternary and seven compound mixtures. PAH bioaccessibility studies were carried out 
using in vitro assays simulating human digestive system and incidental exposure to 
contaminated soil via the oral route. Further, research on the uptake and metabolism of 
the four PAHs was conducted using in vitro bioassay (HepG2) as a surrogate of the 
human liver, the key organ in the human body responsible for metabolism and the first 
pass effect (i.e. following absorption of compounds and entering into systemic circulation). 
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Changes in PAH uptake and metabolism due to interaction among PAHs and metal/loids 
with PAHs were discussed.  
1.7.1 Layout of chapters  
This thesis is comprised of nine chapters. Figure 1.10 is an illustration of the layout of 
chapters and how each chapter is linked in the overall thesis.  
 
 
 
 
 
 
 
                                                 
  
 
 
 
 
 
 
 
Figure 1.10 The layout of chapters in this thesis 
 
CHAPTER 1 - Introduction 
CHAPTER 2 – Literature review 
CHAPTER 3 - General materials and methodology 
CHAPTER 4 – Method development (Cells) 
CHAPTER 5 – Uptake of pure compounds (Cells) 
CHAPTER 6 – Method development (Soil) 
CHAPTER 7 – Bioaccessibility (Soil) 
CHAPTER 8 – Uptake of UBM extract (Cells) 
CHAPTER 9 – General discussion, conclusions and recommendations  
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Chapter 2. Literature review 
This chapter reviewed the current state of knowledge on bioaccessibility and oral 
bioavailability of PAHs in soils, and analytical measurement methods. A detailed review 
was carried for the following information in published literature: 
a) the range of in vivo animal models for quantifying PAH bioavailability in soil 
b) the existence of guidance documents for PAH in vivo models 
c) In vitro to in vivo relationship studies on PAHs 
d) the availability of certified reference material for assessment of bioavailability or 
bioaccessibility 
e) PAH and metal or metalloid mixture effect on bioavailability or bioaccessibility 
f) analytical methods for the analyses of PAHs and monohydroxylated PAHs (OH-
PAHs)  
g) Mixtures effects of PAHs and metal/loids 
Chapter 3. General materials and methodology 
This chapter presented a summary of materials (including suppliers) and methodologies 
(including sample pre-treatment and quality assurance / quality control – QA/QC 
protocols). Analytical approaches used in Chapter 4, Chapter 6 and Chapter 7 are 
presented as schematic flowcharts which conceptualise the detailed method development 
and validation presented in respective chapters in this thesis.  
Chapter 4. Development of a modified QuEChERS method for the analysis of PAHs and 
OH-PAHs in human liver cells 
This chapter investigated the development of an extraction and clean-up analytical 
procedure based on the QuEChERS approach. Key analytical parameters investigated 
included solvent amount, inclusion of an enzyme hydrolysis step, extraction time, use of 
QuEChERS salt, and a derivatisation step for accommodating the analysis of OH-PAHs. 
The method was applied for the analysis of PAHs in treated human cells.  
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Chapter 5. Uptake of pure solution PAHs in human liver cells in the presence or 
absence of As, Cd and Pb  
In chapter 5, the uptake and metabolism of PAHs is evaluated using HepG2 cells. 
Possible interaction effects of PAHs and metal/loids on the uptake of PAHs in HepG2 was 
investigated for binary, ternary and seven compound mixture of select PAHs and 
metal/loids. The study is based on HepG2 cells treated with pure model compounds (e.g. 
PAHs and metal/loids). 
Chapter 6. Development of a modified QuEChERS method for the analysis of PAHs and 
OH-PAHs in soils 
This chapter studied the modifications to an extraction and clean-up procedure based on 
the QuEChERS approach. Changes were employed to solvent amount, extraction time, 
use of QuEChERS salt, and a derivatisation step for accommodating the analysis of OH-
PAHs. The method was applied for the analysis of PAHs and OH-PAHs in spiked and field 
contaminated soils.  
Chapter 7. Use of Unified BARGE Method (UBM) to evaluate bioaccessibility of PAHs in 
contaminated soils 
In chapter 7 the bioaccessibility of PAHs in contrasting soils was studied using an in vitro 
assay that simulate the human digestive system. Seven soil types with varying 
physicochemical properties were selected for this study. Bioaccessibility was determined 
for soils spiked with PAHs and aged up to 90 days. Soils were spiked with single PAHs or 
mixtures of PAHs and metal/loids in binary and a seven compound combination. 
Correlations between soil properties and ageing on extraction of PAHs using UBM were 
examined. Soils spiked with mixtures of PAHs and metal/loids were evaluated for 
extractability of PAHs using UBM protocol to interpret interaction effects of chemical 
mixtures.  
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Chapter 8. Uptake of UBM-extracted PAHs in human liver cells in the presence or 
absence of As, Cd and Pb  
In this chapter, the uptake and metabolism of PAHs in HepG2 were evaluated in cells 
treated with PAHs. Possible interaction effects of PAHs and metal/loids on the uptake of 
PAHs in HepG2 was investigated for binary and a seven compound mixture of PAHs and 
metal/loids. The study was based on HepG2 cells treated with UBM-extracted compounds 
(e.g. PAHs and metal/loids). 
Chapter 9. General discussion, conclusions and recommendations 
This chapter provided a general discussion and conclusion of the present study and 
suggested potential direction of future work. 
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Chapter 2 Literature review 
Abstract 
Current environmental regulations relating to risk assessment for contaminated sites are 
often set assuming that the contaminant is 100 % bioavailable. However, the reality is that 
only a portion of the contaminant on site becomes available for absorption and goes into 
the systemic circulation. The current NEPM has provided guidance on determination of 
bioavailability and bioaccessibility which can be incorporated into a higher tier risk 
assessment of site contamination. This chapter gives an overview of existing in vivo 
animal models that quantify oral bioavailability of polycyclic aromatic hydrocarbons (PAHs) 
in soil. It also provides a summary of in vitro gastrointestinal extraction methodologies and 
some of the key factors influencing absorption of PAHs in soil. It highlights that 
bioaccessibility values derived from in vitro studies still require validation from in vivo 
animal models to gain regulatory acceptance. Additionally, this review highlights the range 
of analytical methodologies, including QuEChERS approach that may be useful to 
quantifying the bioavailability, uptake and metabolism of PAHs.  
Keywords: bioaccessibility, bioavailability, in vitro, in vivo, polycyclic aromatic 
hydrocarbons, uptake, metabolism 
2.1 Introduction 
2.1.1 Bioaccessibility and bioavailability 
Since the publishing of Rachael Carson’s book “Silent Spring” in 1962, environmental 
issues have been of interest to the general public. However, it wasn’t until the 1980s and 
1990s when most of the industrialised (G5) countries had environmental protection 
guidelines enacted with a focus on total chemical concentrations in soils (Naidu et al., 
2015b). Notably, most recent environmental regulatory guidelines for site contamination 
assessment in Australia, National Environment Protection Measures (NEPM) and 
overseas are often set assuming the contaminant is 100 % bioavailable (Ng et al., 2010; 
NEPC, 2013). Such a conservative approach that in the absence of site-specific data, the 
bioavailability of a contaminant is assumed to be 100 % could lead to unnecessary or 
expensive remediation options (Ng et al., 2013). It is therefore not surprising that a number 
of studies highlight the possibility that clean-up at most of the contaminated sites using 
existing technologies may not be sufficient to achieve the standards set under current 
environmental regulatory guidelines (Doick et al., 2005; Ng et al., 2015; Swindell and Reid, 
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2006). In Australia, NEPM recommends that contaminant bioavailability and 
bioaccessibility measurements be adopted as part of tier-two risk assessment (e.g. 
quantitative) for contaminated sites. The inclusion of bioavailability values is a key 
parameter which can be utilised for minimising the uncertainty associated with exposure in 
risk assessment (Ng et al., 2013). It is therefore no surprise that in the past decade the 
concept of bioavailability and bioaccessibility is being given more attention by both the 
scientific community and legislators. Bioavailability (BA) is defined as the amount of 
contaminant that is systemically absorbed into the body following skin contact, ingestion or 
inhalation (Ng et al., 2010). On the other hand, bioaccessibility (BAC) is often specifically 
used when in vitro assessment models are used and is defined as the fraction of a 
contaminant that is soluble in the gastrointestinal tract and is therefore available for 
absorption (Ng et al., 2013; National Environment Protection Council, 2013). Two of the 
key objectives of this PhD study were to provide information on the application of 
bioaccessibility and bioavailability in human health risk assessment. A critical review of the 
‘‘bioavailability process’’ including the concept of a decision tree for the determination of 
contaminant bioavailability and bioaccessibility for health risk assessment is provided 
elsewhere (Ng et al., 2013; Oomen et al., 2006). 
Further, different contaminants have different effects on human health and the 
environment depending on their properties (Swindell and Reid, 2006). This study will 
investigate PAHs as chemicals of concern (COC) in soils from sites co-contaminated with 
metal/loids. PAHs cover a wide range of hydrophobic organic chemicals that are 
structurally similar and are formed during incomplete combustion or pyrolysis of organic 
matter resulting from natural or anthropogenic processes. PAHs are fairly persistent in the 
environment and are lipophilic with capacity to bioaccumulate in living organisms. As 
organic pollutants with known or potential carcinogenic and mutagenic properties, PAHs 
are of concern to human and environmental health. The United States Environmental 
Protection Agency (US EPA) has listed 16 un-substituted PAHs as priority contaminants 
as these are most widely found in the environment (Jahin et al., 2009) and considered 
markers of urban activities (Peng et al., 2013). PAHs are ubiquitously present in soil, 
sediments, air, water and in living organisms. Consequently, humans are exposed to 
PAHs on a daily basis from their surroundings including incidental soil ingestion, dietary 
intake and inhalation from ambient and indoor air. It is understood that PAHs only become 
a risk if they are or become available (i.e. bioavailable) in a form that can negatively affect 
the human and ecosystem health. Most often soil properties such as organic matter and 
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clay content may relate to the degree to which PAHs are retained within the soil as well its 
physicochemical properties (US EPA, 2007). 
As environmental pollutants, PAHs are found ubiquitously in soil. Significantly, elevated 
concentrations of PAHs are found in soils of many contaminated sites. Soils at 
contaminated sites often contain a cocktail of contaminants, both organic and inorganic in 
nature. A number of soil characterisation studies have reported the presence of PAHs with 
metals and metalloids. Together PAHs and metal/loids represent two of the largest group 
of environmental contaminants with well-documented environmental and toxicological 
effects. From a remediation point of view, the removal of PAHs from soils at contaminated 
sites is complex due to the presence of other organic and inorganic contaminants. Further, 
PAHs represents a wide group of organic compounds that are similar in chemistry, but 
vary slightly from each other in their physicochemical properties. Naphthalene with only 
two fused benzene rings is the simplest of the PAHs and is the most volatile and water 
soluble in comparison to any other PAH. Because of its physicochemical properties, Nap 
is known to be easily removed from PAH contaminated soil. On the other hand, more 
persistent higher molecular weight and less water soluble PAHs such as B[a]P are more 
resistant to microbial degradation and leaching with aqueous solutions. Further, ageing of 
PAHs such as B[a]P in soil may make them become less available for uptake by 
organisms and therefore have diminished toxicity. Therefore, it is important to understand 
the factors controlling the BAC and BA of PAHs in soil in order to evaluate the health risk 
from PAH contaminated sites such as former manufacturing gasworks sites.  
Varying physicochemical properties of soils can influence the BAC and BA of PAHs.  The 
sorption of PAH to soil is reported to be influenced by the soil organic matter (SOM), total 
organic carbon (TOC) and clay content (Müller et al., 2007; White et al., 1999). A decrease 
in extractability and bioavailability of PAHs was observed with increasing TOC, while soils 
with higher content of sand had comparatively higher BAC of PAHs (Meyer et al., 2015). 
Physical diffusion of PAHs into micropores of soils have been investigated and in such 
studies inaccessibility of PAHs to even the smallest microorganisms has been reported 
(Müller et al., 2007; Wu and Gschwend, 1986). Therefore, both the physicochemical 
properties of PAHs and soil properties are important in determining BAC and BA of PAHs.  
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It is also noteworthy that the use of traditional chemicals such as acetone, acetonitrile, 
dichloromethane or hexane in an exhaustive high extraction recovery of PAHs does not 
represent the BAC or BA of PAHs in soil. Neither can it be useful to determine declining 
BAC or BA of PAHs with ageing in soil. The “gold standard” in BA assessment is the use 
of a juvenile swine that is a surrogate for human subject especially young children. 
Alternatively there are a number of in vitro assays that simulate human digestive system 
for extraction of contaminants in soils. However, most of the in vitro assays for assessing 
oral bioavailability have been developed for inorganic compounds. While a considerable 
amount of bioavailability data is available for pure organic compounds, only a limited 
number of studies have been undertaken to assess the bioavailability of organic 
contaminants in soil (Ng et al., 2010). This PhD study addresses knowledge gaps in the 
scientific literature regarding the BA and BAC of PAHs in soil. A detailed account of 
current methods in use to assess BA and BAC of PAHs in soil and their applications and 
limitations is presented. Additionally, a state of science on a range of analytical methods, 
including QuEChERS approach used in the analysis of PAHs and OH-PAH is included to 
highlight its usefulness towards quantifying bioavailability, uptake and metabolism of PAHs 
via the measurement of both parent and metabolic compounds. 
2.1.2 Cellular uptake of PAHs 
Following exposure, proportions of the PAHs will eventually be bioavailable for cellular 
uptake. Plant et al. (1985) indicated that the principal mechanism of cellular uptake by 
B[a]P and other PAHs from lipoproteins into cells is spontaneous transfer through the 
aqueous phase by passive diffusion. In a recent study, Madureira et al. (2014) presented a 
cell based model that has been used to quantify chemical uptake of B[a]P and its fate in 
liver cells (e.g. rat hepatoma cell line – Hepa 1c1c7) based on high and low dosages of 50 
nM and 5 µM, respectively over a 24 h period. Bartley et al. (1982) studying uptake of 
B[a]P in human mammary and fibroblast cells reported that initial uptake of B[a]P was 
relatively fast and then was dependent on the rate of conversion to its respective 
biotransformation products. Using the human T47D mammary tumour cells and 
microspectrofluorometry technique, Sureau et al (1990) demonstrated that B[a]P uptake 
into one single cell reaches a plateau after 10 min and that this plateau is related to the 
relative amount of lipoprotein in the cell. While, Barhoumi et al (2000) studying rat liver 
cells by microscopy also reported that B[a]P was taken up within minutes.  
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2.2 Discussion 
2.2.1 Bioaccessibility of PAHs in soil 
In the case for in vitro model assessments, oral bioaccessibility is the contaminant fraction 
of intake that is soluble in the gastrointestinal tract and is therefore potentially available for 
absorption (Paustenbach, 2000). For inorganic soil contaminants a number of in vitro 
bioaccessibility models have been developed with soil arsenic bioaccessibility used 
routinely in the United Kingdom for quantitative risk assessment (Wragg and Cave, 2003; 
Nathanail and Smith, 2007). However, for PAHs the in vitro bioaccessibility models for 
quantitative risk assessment are generally lacking. A number of studies reported 
assessing PAH bioaccessibility in soil using a variety of in vitro gastrointestinal fluid 
extraction methods which simulate the processes that occur in the human gastrointestinal 
tract to understand the release of contaminants from soil matrix and its absorption into the 
circulatory system (Table 2.1). Examples such as the German Deutsches Institut fur 
Normung or DIN standard bioaccessibility test, SHIME (Simulator of the Human Intestinal 
Microbial System), Fed Organic Estimation human Simulation Test (FOREhST), 
Physiologically Based Extraction Test (PBET) and the Unified BARGE Method (UBM) 
have been reported to effectively model the human gastrointestinal system (Table 2.2) 
(Cave et al., 2010; DIN, 2000; Sips et al., 2001). 
Table 2.1 Summary of studies assessing PAH* bioaccessibility in soil using in vitro 
models 
In vitro model Dose  
(mg kg-1) 
Bioaccessibility 
(%) 
Mid-range 
(%) 
Reference 
UBM 200 18 - 70 44 Pu et al. (2004) 
UBM 400 53 - 89 71 Pu et al. (2004) 
UBM 6 – 270 2 - 16 9 GrØn et al. (2007) 
PBET 1.5 – 6.9 20 – 53 36.5 Khan et al. (2008) 
PBET 0.1 – 27.8 9 – 61 35 Tang et al. (2006) 
PBET 0.08 – 8.8 15 – 63 39 Lu et al. (2010) 
SHIME 49 17 17 Van de Wiele et al. (2005) 
FOREhST 10 – 300 10 - 60 35 Cave et al. (2010) 
FOREhST 871 <4 NA Pelfrêne et al. (2011)  
Magee et al. (1999) 
Gastro-intestinal 
model 
20 – 5,000 5 - 40 22.5 Hack and Selenka (1996) 
*Sum 16 U.S EPA PAHs include; acenaphthene, acenaphthylene, anthracene, benz[a]anthracene, 
benzo[b]fluoranthene, benzo[k]fluoranthene, benzo[g,h,i]perylene, benzo[a]pyrene, chrysene, 
dibenz[a,h]anthracene, fluoranthene, fluorene, indeno[1,2,3-c,d]pyrene, naphthalene, phenanthrene, pyrene.  
NA – Not applicable as bioaccessibility reported is < 4 %. 
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Using the UBM method, a study using PAH spiked soil determined the bioaccessibility of 
Phe was in the range of 18 % – 70 % (i.e. for 200 mg Kg−1 spike) and 53 % –89 % in a 400 
mg Kg−1 spiked soil (Pu et al., 2004), while another study that also used the UBM method 
(i.e. using industrial soil) reported bioaccessibility for B[a]P in the range of 2 % –16 % 
(GrØn et al., 2007). Notably, a number of in vitro studies have used the PBET method to 
measure the bioaccessibility of PAHs in soil (Table 2.1). Different PBET studies have 
reported PAH bioaccessibility in soil as 20 % – 53 % (Khan et al., 2008), 9 % – 69 % 
(Tang et al., 2006) and 15 % – 63 % (Lu et al., 2010). Other in vitro models such as the 
SHIME model reported PAH bioaccessibility in soil as 29%, while PAH bioaccessibility 
values in soil using the FOREhST model has been reported at 36 % (Cave et al., 2010). 
The wide range of PAH bioaccessibility values from in vitro studies can be attributed to 
varying compositions of gastrointestinal fluid, soil: extraction solution ratio, pH and 
extraction time (Table 2.2). 
In vitro methods for determining bioaccessibility of PAHs in soil 
A range of in vitro gastrointestinal extraction methods have been developed to determine 
the bioaccessibility of contaminants. In vitro assays that are developed for the assessment 
of contaminant bioaccessibility often focus on parameters that represent the physiology of 
children (Ng et al., 2013). Some of the key parameters for in vitro assays include chyme 
(i.e. gastric and intestinal phases), pH and residence time in gastric and intestinal phase, 
soil: extraction solution ratio and addition of food additives (Table 2.2). It is therefore 
noteworthy that variations in these key parameters could significantly influence the release 
of contaminant from the soil matrix. Juhasz et al. (2015) suggests that extending the 
timeframe with in vitro extraction may facilitate PAH equilibrium in gastrointestinal fluid. Ng 
et al. (2013) highlights that influence of bile on the mobilisation of organic contaminants 
has been well established. Additionally, most in vitro studies generally choose a pH value 
that represents the worst case scenario (i.e. fasted state) for exposure in young children 
(i.e. stomach pH of about 1.5) and for the same reason use soil to solution ratio of 1:100 
(Ng et al., 2013; Ruby et al., 1996). A potential limiting factor for bioaccessibility assays to 
accurately predict bioavailability may be due to the static nature of in vitro assays in 
comparison to the dynamic nature of animal based in vivo digestive system (Duan et al., 
2015; Abou-Elwafa Abdallah et al., 2012). The addition of a ‘‘sink’’ to provide a desorption 
gradient could potentially increase bioaccessibility (Collins et al., 2015).  
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Table 2.2. Summary of in vitro parameters used for assessment of PAH bioaccessibility in soil (modified from Ng et al., 2013) 
 
Method 
  
Phase 
 
In vitro parameters 
   Composition  (g L-1)   pH Soil : 
solution 
ratio 
Extraction 
time (h) 
PBET 
(Khan et al., 2008; 
Tang et al., 2006; Lu et al., 
2010) 
Gastric  1.25 g pepsin, 0.5 g sodium malate, 0.5 g sodium citrate, 
420 µL lactic acid, 500 µL acetic acid 
2.5 1:100 1 
PBET  Intestinal 1.75 g bile, 0.5 g pancreatin 7.0 1:100 4 
IVG  (EC, 2006a) Gastric  10 g pepsin, 8.77 g NaCl 1.8 1:150 1 
IVG  Intestinal 3.5 g bile, 0.35 g pancreatin 5.5 1:150 1 
SBRC (EC, 2006b) Gastric 30.03 g glycine 1.5 1:100 1 
SBRC  Intestinal 1.75 g bile, 0.5 g pancreatin 7.0 1:100 4 
DIN (Sips et al., 2001) Gastric 1 g pepsin, 3 g mucin, 2.9 g NaCl, 0.7 g KCl, 0.27 g 
KH2PO4 
2.0 1:50 2 
DIN  Intestinal 9 g bile, 9 g pancreatin, 0.3 g trypsin, 0.3 g urea, 0.3 g 
KCl, 0.5 g calcium chloride, 0.2 g MgCl2 
7.5 1:100 6 
SHIME (Van de Wiele et al., 
2005) 
Gastric 10 g KHCO3, 5.7 g NaCl, 10 mg pepsin 1.5 - 2 
SHIME  Intestinal 0.9 g pancreatin 6.3 1:15 5 
FOREhST (Cave et al., 
2010; Magee et al., 1999) 
Esophageal  0.2 g urea, 0.28 amylase, 25 mg mucin, 15 mg uric acid, 
0.896 KCl, 0.888 NaH2PO4, 0.2 KSCN, 0.57 Na2SO4, 
0.298 NaCl, 1M NaOH 
6.8 0.3 : 
2.45 
5 min 
FOREhST  Gastric 0.2752 g NaCl, 0.266 g NaH2PO4, 0.824g KCl, 0.4 g 
CaCl2, 0.306g NH4Cl, 6.5 ml 37% HCl, 0.65g glucose, 20 
mg glucuronic acid, 85 mg urea, 0.33 g 
glucosaminehydrochloride, 1g bovine serum albumin, 9 g 
mucin, 2.5 g pepsin  
1.3 - 3 
FOREhST  
 
 
 
Duodenal  7.012 g NaCl, 5.607g NaHCO3, 80 mg KH2PO4, 0.564 g 
KCl, 50 mg MgCl2, 0.2 g CaCl2,180 μl 37% HCl, 0.1 g 
urea, 1 g bovine serum albumin, 9g pancreatin, 1.5 g 
lipase  
8.1 - 2 
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FOREhST  Bile 5.259 g NaCl, 5.785 g NaHCO3, 0.376 g KCl, 0.222 g 
CaCl2, 180 μl 37% HCl, 0.25 g urea, 1.8 g bovine serum 
albumin, 30 g bile  
8.2 - 2 
UBM  
(Pu et al., 2004; Duan and 
Naidu, 2013; Wu and 
Gschwend, 1986; Duan et al., 
2014)  
Esophageal 1.79 g KCl, 0.4 g KSCN, 1.78 g NaH2PO4, 1.14 g 
Na2SO4, 0.6 g NaCl, 0.14 g NaOH, 0.4 g urea, 290 mg α-
amylase, 30 mg uric acid, 100 mg mucin 
6.5 1:15 5 
UBM  
Miller and Ullrey, 1987; 
Rodriguez et al., 1999; Wragg 
et al., 2011; Goon et al., 1991; 
Stroo et al., 2000)  
Gastric 5.5 g NaCl, 0.54 g NaH2PO4, 1.64 g KCl, 0.8 g 
CaCl2:2.H2O, 0.62 g NH4Cl, 1.3 g glucose, 0.04 g 
glucuronic acid, 0.17 g urea, 0.66 g glucoseamine 
hydrochloride, 2 g bovine serum albumin, 2 g porcine 
pepsin, 6 g mucin  
1.2 1:37.5 2 
UBM 
Magee et al., 1996; Juhasz et 
al., 2014; Weyand et al., 1996; 
Koganti et al., 1998; Pelfrêne 
et al., 2011; Magee et al., 
1999; Wragg and Cave, 2003) 
Intestinal Duodenal juice: 14.02 g NaCl, 6.78 g NaHCO3, 0.16 g 
KH2PO4, 1.13 g KCl, 0.1 g MgCl2, 0.2 g urea, 0.4 g 
CaCl2.2H2O, 2 g BSA, 6 g porcine pancreatin, 1 g lipase 
Bile solution: 10.52 g NaCl, 11.57 g NaHCO3, 0.75 g 
KCl, 0.5 g urea, 0.44 g CaCl2.2H2O, 3.6 g BSA, 12 g 
chicken bile   
>5.5 1:97.5 2 
TIM  Esophageal  Saliva solution 5.0 1:5 5 min 
TIM  Gastric Lipase, pepsin 2.0 1:25 1.5 
TIM  Intestinal Bile, pancreatin 7.2 - 6 
RIVM  Gastric Pepsin, mucin, BSA 1.1 - 2 
RIVM  Intestinal Duodenal juice, bile juice, pH chime mixture  5.5 - 2 
H&S  Gastric 83.3 g porcine pepsin, 58.3 g whole milk powder, 1.8% 
w/v NaCl solution, 2.9 g mucin 
2.0 1:120 2 
H&S  Intestinal 2.9 g porcine pancreatin, 2.9 g bovine bile, 83.3 trypsin  7.0 1:120 6 
Holman  Intestinal 8.8 g NaCl 
Mixed bile salts 
Mixed intestinal lipids: 0.7 g cholesterol monohydrate, 
5.5 g oleic acid, 1.4 g monoolein, 0.5 g diolein, 3.1 g 
lecithin  
6.5 - 7.3 1:50 4 
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Further, considering lower cost, time and no ethical issues, in vitro assays once validated 
against an animal model will be ideal in providing a surrogate measurement of in vivo 
bioavailability (Ng et al., 2013; Rodriguez et al., 1999). 
To date, nine in vitro studies that examined the bioaccessibility of PAHs in soil have 
reported the bioaccessibility for PAHs in a range of 2 % – 89 % (Table 2.1). Additionally, 
these studies also have used a range of in vitro gastrointestinal extraction methods (Table 
2.2) to estimate the release of PAHs. Further, in most of these in vitro studies (Table 2.1), 
the PAH bioaccessibility is less than 70 % (25th percentile: 9.25 % and 75th percentile: 58.3 
%). The results from these studies indicate varying degree of the release of PAHs from the 
soil matrix for absorption. Notably, PAH bioaccessibility may be influenced by the in vitro 
method used. It is significant that while round-robin studies have been conducted to 
compare the bioaccessibility methodologies for inorganic contaminants, such comparisons 
are lacking for organic contaminants (Ng et al., 2013). 
2.2.2 Bioavailability of PAHs in soil 
Soil is a primary reservoir of PAHs and ingestion of contaminated soil is considered to be 
an important exposure pathway to humans (Menzie et al., 1992; Paustenbach, 2000). For 
the purpose of human health risk assessment, the bioavailable fraction of the contaminant 
that enters the human body is important (Cave et al., 2010). Oral bioavailability of a given 
substance may be formally defined as the function of an administered dose that reaches 
the circulatory system from the gastrointestinal tract (Paustenbach, 2000; Rodriguez and 
Basta, 1999; Ruby et al., 1999). The bioavailability of different PAHs in soil is a three-way 
interaction and is affected by its physicochemical properties, soil characteristics (e.g. 
particle size, clay and organic matter) and the receptor organism (Stokes et al., 2006; 
Harmsen, 2007). Significantly, the <250 μm size fraction of soil is reported as the upper 
limit of particle size that is likely to adhere to hands of children who are often the risk 
receptor for assessing contaminated sites (Duggan et al., 1985). Studies on bioavailability 
of PAHs in soil indicate that high molecular weight PAHs, such as B[a]P are more 
recalcitrant and are less bioavailable in the environment, in comparison to the low 
molecular weight PAHs such as Nap (Cerniglia, 1992).  
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Another study highlighted that heterogeneity of soil can greatly influence PAH 
bioavailability (Eweis et al., 1998). Additionally, the increasing soil–clay composition has 
been reported to influence PAH bioaccessibility due to greater sorption of PAHs in soil 
(Hundal et al., 2001; Pu et al., 2004). Recent studies have also reported positive 
correlation between sorption of Phe and total soil organic carbon content (Duan and 
Naidu, 2013). Further, the aggregation of soil particles has been linked to a decrease in 
PAH bioavailability through the physical protection of PAHs on the interior of soil 
aggregates (Wu and Gschwend, 1986). 
A number of in vivo studies using animal models have measured bioavailability of PAH in 
soil (Table 2.3). A study using the rat model found the absolute bioavailability of Phe in soil 
in a range of 15 % – 49 % (e.g. at a dose of 400 μg Kg−1 body weight), while for a dose of 
800 μg Kg−1 body weight (bw) the absolute bioavailability was 22 % – 32 % (Pu et al., 
2004). The term absolute bioavailability is defined as the fraction of a compound from an 
administered dose that is absorbed into the body following skin contact, ingestion or 
inhalation and reaches systemic circulation.  
The word “organic” is deleted from “in vivo organic bioavailability” and is found on page 51, 
line 1351.Very few in vivo studies have used the juvenile swine model to assess the 
bioavailability of PAH in soil. One recent study that used the swine model reported a 
decrease in relative bioavailability of B[a]P in soil (range: 22.1 % – 62.7 %) after 90 days 
of ageing, with the exception of one very sandy soil in which the relative bioavailability (i.e. 
108.1 %) remained unchanged (Duan et al., 2014). For inorganic compounds, regulatory 
guidelines from the United States Environmental Protection Agency (U.S. EPA) 
recommends that the juvenile swine model be used to assess the bioavailability of arsenic 
or lead in contaminated soil (Lanno et al., 2004). However, in vivo bioavailability is poorly 
quantified for all organic compounds of concern and lacks such regulatory approval. 
In vivo methods for determining oral bioavailability of PAHs in soil 
While extensive research information is available relating to inorganic contaminant 
bioavailability in a recent review by Ng et al. (2013), there is very little scientifically 
published data on bioavailability of PAHs in soil. This includes in vivo studies investigating 
relative bioavailability of PAHs. Where the relative bioavailability of a compound is the ratio 
of the absorbed fraction from the exposure medium in risk assessment (e.g. soil) to the 
absorbed fraction from the dosing medium used in the critical toxicity study (Ng et al., 
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2010). It is noteworthy that in vivo studies investigating the relative bioavailability of PAHs 
have used a variety of animal models, including juvenile swine, rat and mouse (Table 2.3). 
As a ‘‘gold standard’’ for in vivo studies, swine is often used to model human digestion due 
to the many similarities between the gastrointestinal tract of juvenile swine and toddlers 
(Miller and Ullrey, 1987; Duan et al., 2015).  
To date, ten in vivo studies that exam the oral bioavailability of PAHs in soil have reported 
the relative bioavailability for PAHs in a range of 1 % – 100 % (Table 2.3). Additionally, 
these studies also have used a variety of biological end points (i.e. PAHs in faeces or 
urine, PAH metabolites, DNA adducts and area under dose-extinction curve in blood after 
the administration of radiolabelled PAH) to estimate the absorption of PAHs. Further, in 
most of these in vivo studies, the relative bioavailability is less than 50 %. The results from 
these studies indicate that PAHs from a soil matrix maybe less available for absorption in 
the gastrointestinal tract. However, in all these studies only small sample sizes were 
measured and mostly on specific soil type or contaminated sites. There is also limited 
information on soil properties. 
Table 2.3. Summary of studies assessing PAH bioavailability in soil using in vivo 
models 
In vivo model Contaminant Dose      
(mg Kg-1) 
Bioavailability 
(%) 
Reference 
Juvenile 
swine1 
 
B[a]P 
50 22.1 – 62.7 Duan et al. (2014) 
Rat Phe 400 15 - 49 Pu et al. (2004) 
Rat Phe 800 22 -32 Pu et al. (2004) 
Rat B[a]P 7 – 1,040 60 - 95 Goon et al. (1991) 
Rat2 PAHs 100 22 - 38 Stroo et al. (2000) 
Rat3 PAHs 3,500 35 Magee et al. (1996) 
Rat PAHs 3,500 40 Magee et al. (1996) 
Mouse4 PAHs 1 11 Juhasz et al. (2014) 
Mouse PAHs 35 36 Juhasz et al. (2014) 
Mouse PAHs 377 17 Juhasz et al. (2014) 
Mouse B[a]P 0.2 - 627 8 - 100 Weyand et al. (1996) 
Mouse B[a]P 8 – 3,120 8 - 76 Weyand et al. (1996) 
Mouse5 PAHs 66 - 388 1 - 29 Koganti et al. (1998) 
Mouse PAHs 66 - 338 7 - 36 Koganti et al. (1998) 
Minipig B[a]P 6 - 270 36 - 55 Magee et al. (1999) 
Minipig B[a]P 0.77 - 43 27 - 30 Magee et al. (1999) 
1Juvenile swine study was conducted using benzo[a]pyrene (B[a]P) only 2,3,4,5Sum 16 U.S EPA PAHs 
include; acenaphthene, acenaphthylene, anthracene, benz[a]anthracene, benzo[b]fluoranthene, 
benzo[k]fluoranthene, benzo[g,h,i]perylene, benzo[a]pyrene, chrysene, dibenz[a,h]anthracene, fluoranthene, 
fluorene, indeno[1,2,3-c,d]pyrene, naphthalene (Nap), phenanthrene (Phe) and pyrene (Pyr).  
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2.2.3 Analytical methods for PAHs and OH-PAH analyses 
A range of analytical methods play an important role in the risk assessment process by 
providing an accurate measurement of individual and total contaminants present in soils. A 
broad range of analytical methods have been developed for sensitive determination of 
PAH contaminants in soils.  
Most common extraction procedures for PAHs in soils include soxhlet extraction (Dean et 
al., 1995), supercritical fluid extraction (Hawthorne et al., 2000), ultrasonication (Peng et 
al., 2012), microwave-assisted extraction (Barnabas et al., 1995) and high-pressure 
accelerated solvent extraction (Li et al., 2003). Subsequently, the extracts are cleaned 
using adsorbents such as C18, florisil, alumina, silica in column or using Solid Phase 
Extraction (SPE) cartridges (Dabrowska et al., 2003). Most analytical methods are 
generally targeted towards the analysis of the parent PAHs whilst their metabolites which 
can be more toxic are often not measured (Baduel et al., 2015). There is a need to focus 
on the development of analytical methods for a rapid and sensitive determination of PAHs 
of a broad range of chemical classes in different matrices.  
A Quick, Easy, Cheap, Effective, Rugged and Safe (QuEChERS) approach was 
introduced in 2003 with a wide analytical scope and since its inception it has become one 
of the most widely used analytical technique with over 700 publications in scientific 
literature (González-Curbelo et al., 2015; Bruzzoniti et al., 2014). The QuEChERS 
approach was first applied in the determination of pesticide residues in fruits and 
vegetables (Anastassiades et al., 2003), however, it has been successfully applied to a 
great variety of matrices and compounds, including PAHs and OH-PAHs (Grova et al., 
2011; Campo et al., 2008; Avagyan et al., 2015).  
Over the past decade, QuEChERS has evolved into one of the most widely used 
extraction techniques for residue analysis (Schmidt and Snow, 2016). The two most widely 
used standardized versions of the QuEChERS approach include the AOAC Official 
Method 2007.01 (Lehotay, 2007) and European Committee for Standardisation (CEN) 
Standard Method EN 15662 (European Committee for Standardisation, 2008). The use of 
QuEChERS based procedure for extraction and analysis of polar and non-polar chemicals 
in soils have however been sparsely addressed.  
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The first QuEChERs procedure used for soil was developed for the analysis of pesticide 
residues (Lesueur et al., 2008). More recently, modified versions of the QuEChERS 
technique has been reported for the analysis of PAHs in soils using GC-MS 
chromatography (Cvetkovic et al., 2016). There is a need to take advantage of 
QuEChERS ability to recover a broad range of chemical compounds that can target both 
parent compounds and metabolites or transformation products. Additionally, the simplicity 
and cost effectiveness of the QuEChERS technique can be useful in screening large 
batches of samples in environmental monitoring.  
2.2.4 Mixtures effects of PAHs and metal/loids  
According to the Agency for Toxic Substances and Disease Registry (ATSDR, 2015) and 
the US Environmental Protection Agency (US EPA, 2014) both PAHs and heavy 
metal/loids including arsenic (As), cadmium (Cd) and lead (Pb) are ranked highly on the 
2015 list of the most hazardous xenobiotics in the environment. PAHs and metal/loids are 
often found together in contaminated soils such as in gasworks sites (Thavamani et al., 
2011). There is generally a lack of literature on joint effects of PAHs and metal/loids 
beyond their binary mixtures.  
A recent study investigating up to quaternary mixture toxicity of B[a]P, As, Cd and Pb in 
HepG2 cells showed that the nature of interaction varied according to the effect levels and 
the number of components in the mixtures, synergistic effects were observed with 
increase in complexity of the mixture (Muthusamy et al., 2016a). Another study using 
HepG2 treated with mixtures of PAHs and metal/loids and measuring micronucleus 
formation indicated that an additive effect may exist between PAHs and heavy metal/loids 
in a compound and concentration-dependent manner (Peng et al., 2015). Furthermore, Xia 
(2016) also tested mixtures of PAHs and metal/loids using the Unified BARGE Method, 
indicating no interaction between Cd+Pyr and Cd+B[a]P in spiked soil extracts in the 
simulated digestive system with regard to Cd BAC. However, Pyr and B[a]P both 
decreased the uptake of Cd in HepG2 cells (Xia, 2016). While, Vakharia et al (2001) using 
HepG2 cells observed that at 5 µM PAH concentration, the presence of various metals 
decreased levels of PAH-induced CYP 1A1 activity. Similarly, Iscan and Coban (1992) 
reported that the presence of CdCl2 decreased the levels of PAH-induced CYP 1A1 
activity in rats. Both studies indicate decreased uptake of PAHs by metals.  
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While Degawa et al (1993) observed that Pb decreased hepatic P450 and CYP 1A1 
mRNA in vivo in rats, Canepa et al (1985) observed the opposite effect as Pb induced 
P450s in cultured rat hepatocytes. Chiang and Tsou (2009) using human lung cells to 
study the effects of As and B[a]P found that the addition of arsenite enhanced the BPDE-
DNA adduct induced mutagenesis with no marked effect on repair of BPDE-DNA, 
indicating that As may act as a co-mutagen to promote the development of human lung 
cancer. Whereas Tran et al. (2002) reported arsenic inhibits the repair of DNA damage 
induced by B[a]P in a rat model. Similarly, Evans et al. (2004) treated mice with As and 
B[a]P to test the mixture effect of arsenic on B[a]P-DNA adduct formation in vivo and 
found that As co-treatment increased average B[a]P-DNA adduct levels in both lung and 
skin compared to B[a]P control.   
2.3 Conclusions 
Overall, there is a small range of in vivo animal models that have focused on quantifying 
oral bioavailability of PAHs in soil. Additionally, these studies are limited in testing only a 
small number of samples and limited range of soil types. Testing a range of soil properties 
may be important especially when testing contaminated soil. Further, in vivo animal 
models have used a variety of biological endpoints to measure absorption of PAHs. There 
is no consensus on the use of a particular animal model and the biological endpoint of 
choice. The US EPA has recommended the use of juvenile swine and developed guidance 
document for evaluating the bioavailability of inorganic contaminants in soil (US EPA, 
2007). However, there is an absence of such environmental guidance documents or 
standard operating procedures relating to organic compounds (including PAHs) in vivo 
animal models in the published literature.  
A number of in vitro methodologies have been developed for the determination of PAH 
bioaccessibility, however, only few of these studies have provided information relating to in 
vivo – in vitro relationship. As a result, there is limited confidence in using any of the 
current in vitro assays as a surrogate assay for predicting relative bioavailability for organic 
contaminants. Therefore, there is a need for a consistent scientific approach to correlate in 
vivo and in vitro data in contaminated soil and developing a standard soil reference 
sample to measure the efficiency of different in vitro methodologies for PAHs. It is worthy 
of notice that such a certified reference standard is also very limited for bioavailability and 
bioaccessibility of metals and metalloids in soil. Significantly, there is a lack of evaluation 
of bioavailability and bioaccessibility of organic compounds (PAHs) in the presence of 
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metals and metalloids and vice versa. This is an important research field that can improve 
the current health and environmental risk assessment methodologies. 
It is worth mentioning that the high efficiency and nonselective nature of the QuEChERS 
approach has favoured the development of modified versions which are capable of 
simultaneous determination of different classes of compounds, including pesticides, 
pharmaceuticals, PAHs, personal-care products, polychlorinated biphenyls, hormones, 
and polybrominated diphenyl ethers in both biological and environmental matrices. 
Further, the QuEChERS method can be used with both Gas Chromatography and Liquid 
Chromatography techniques. The use of a  QuEChERS based method clearly provides a 
fast effective alternative that could replace most of the traditional approaches, especially 
because of its adaptability and ability to significantly eliminate of a range of matrix 
components and obtaining high recoveries for a wide range of organic compounds. The 
ability to utilize smaller samples sizes without compromising sensitivity may prove useful in 
in risk assessment studies or clinical test specimens (DeArmond et al., 2015).   
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Chapter 3 General materials and methodology 
3.1 Introduction 
This chapter of my PhD thesis presents a summary of materials and methodology that are 
used in Chapters 4 to 8, including flow charts conceptualising the analytical approach used 
in Chapter 4, Chapter 6 and Chapter 7. Key topics in the general materials and 
methodology chapter include:  
a) Chemicals and reagents 
b) Instrumentation 
c) Chromatographic conditions 
d) Preparation of standards 
e) Preparation of soil samples 
f) Human liver hepatocellular carcinoma (HepG2) cell line 
g) Flow charts of analytical procedures  
h) Quality assurance and quality control (QAQC) 
i) Statistical analysis 
3.2 Chemicals and reagents 
Analytical standards used in Chapter 4 and Chapters 6 – 8 are listed in Table 3.1 and 
were obtained from Sigma Aldrich (Saint Louis, Missouri, USA), Novachem (Melbourne, 
Australia), TRC (Ontario, Canada), CIL (Tewksbury, Massachusetts, USA). Table 3.2 lists 
general reagents obtained from Merck (Kenilworth, New Jersey, USA), Astral Scientific 
(Sydney, Australia), Baker (Austin, Texas, USA), Sigma Aldrich (Saint Louis, Missouri, 
USA). HepG2 cell culture media, reagents, enzymes, supplements and kits are shown in 
Table 3.3 and were obtained from ATCC (Manassas, Virginia, USA), Thermo Fisher 
Scientific (Melbourne, Australia), Life Technologies (Melbourne, Australia), Life 
Technologies (Melbourne, Australia) and Agilent Technologies (Santa Clara, California, 
USA) 
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Table 3.1 List of analytical standards and pure compounds used in this PhD study 
Compound Acronym  CAS No. Supplier  
Naphthalene Nap 91-20-3 Sigma-Aldrich 
Phenanthrene Phe 85-01-8 Sigma-Aldrich 
Pyrene Pyr 29-00-0 Sigma-Aldrich 
Benzo[a]pyrene B[a]P 50-32-8 Sigma-Aldrich 
[2H8] Naphthalene [2H8] Nap 1146-65-2 Novachem 
[2H10] Phenanthrene [2H10] Phe 1517-22-2 Novachem 
[2H10] Pyrene [2H10] Pyr 1718-52-1 Novachem 
[2H12] Benzo[a]pyrene [2H12] B[a]P 63466-71-7 Novachem 
1-Hydroxynaphthalene 1-OH Nap 90-15-3 Novachem 
2-Hydroxynaphthalene 2-OH Nap 135-19-3 Novachem 
1-Hydroxyphenanthrene 1-OH Phe 2433-56-9 Novachem 
2-Hydroxyphenanthrene 2-OH Phe 605-55-0 Novachem 
3-Hydroxyphenanthrene 3-OH Phe 605-87-8 Novachem 
4-Hydroxyphenanthrene 4-OH Phe 7651-86-7 Novachem 
1-Hydroxypyrene 1-OH Pyr 5315-79-7 Novachem 
3-Hydrobenzo[a]pyrene 3-OH B[a]P 13345-21-6 TRC Canada 
[13C6] 2-Hydroxynaphthalene [13C6] 2-OH Nap 135-19-3 CIL USA 
[13C6] 2-Hydroxyphenanthrene [13C6] 2-OH Phe 605-55-0 CIL USA 
[13C6] 1-Hydroxypyrene [13C6] 1-OH Pyr 5315-79-7 CIL USA 
[2H12] 3-Hydrobenzo[a]pyrene [2H12] 3-OH B[a]P 1246819-35-1 TRC Canada 
Cadmium nitrate Cd(NO3)2·4H2O 10022-68-1   Sigma-Aldrich 
Lead nitrate Pb(NO3)2 10099-74-8 Sigma-Aldrich 
Sodium arsenate Na2HAsO4·7H2O 10048-95-0 Sigma-Aldrich 
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Table 3.2 List of general chemicals used in Chapters 4 – 8 in this PhD study 
General chemicals CAS No. Supplier  
Dimethyl sulfoxide (DMSO) 67-68-5 Sigma-Aldrich 
Phosphate buffered saline (PBS) TABs pH 7.4 09-2051 Astral Scientific 
N,O-Bis(trimethylsily)trifluroacetammide (BSTFA) 25561-30-2 Sigma-Aldrich 
n-Hexane (GC grade ≥ 99%) 110-54-3 Sigma-Aldrich 
Acetone (GC grade ≥ 99%) 67-64-1 Sigma-Aldrich 
Ultra pure RO water (18 MΩ.cm) N/A In-house 
α-amylase A-6814 Sigma-Aldrich 
Lipase L-3126 Sigma-Aldrich 
Bovine serum albumin (BSA) 9048-46-8 Sigma Aldrich 
Pepsin 107185 Merck 
Mucin 84082-64-4 Sigma-Aldrich 
D-Glucuronic acid 655612-3 Sigma Aldrich 
D-Glucosamine hydrochloride 104113 Merck 
Pancreatin 8049-47-6 Sigma Aldrich 
Bile salts B-3883 Sigma Aldrich 
Uric acid 69-93-2 Sigma Aldrich 
Urea 108487 Merck 
Potassium chloride (KCl) 104936 Merck 
Monosodium phosphate (NaH2PO4) 
Potassium thiocyanate (KSCN) 
0303 
105125 
Baker 
Merck 
Sodium sulfate (Na2SO4) 106647 Merck 
Calcium chloride (CaCl2) 102382 Merck 
Ammonium chloride (NH4Cl) 101145 Merck 
Glucose 8337 Merck 
Monopotassium phosphate (KH2PO4) 0240 Baker 
Magnesium chloride (MgCl2) 105833 Merck 
Sodium bicarbonate (NaHCO3) 106329 Merck 
Hydrogen chloride (HCl) 100317 Merck 
Magnesium sulphate (Mg2SO4) 7487889 Sigma Aldrich 
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Table 3.3 List of HepG2 cell culture media, reagents, enzymes, supplements and kits 
Item Details Supplier  
 
Human liver hepatocellular carcinoma 
(HepG2) cell line 
ATCC No. HB-8065 American type culture 
collection (ATCC®) 
Dulbecco’s Modified Eagle’s Medium 
(DMEM) 
Gibco® Thermo Fisher Scientific 
Foetal bovine serum (FBS) Gibco® Thermo Fisher Scientific 
Penicillin-streptomycin (50 units/ml).  Life Technologies 
Trypsin-EDTA (0.25 %)  Life Technologies 
75 cm2 culture flask Corning® Sigma Aldrich 
β-Glucuronidase/arylsulphatase (from Helix pomatia) Sigma Aldrich 
β-Glucuronidase (specific activity) 4.5 U/ml at +25°C Sigma Aldrich 
Arylsulphatase (specific activity) 14 U/ml at +25°C Sigma Aldrich 
Agilent Bond Elut AOAC salt Extraction salt Agilent Technologies 
Agilent Bond Elut fatty dispersive SPE d-SPE for clean-up Agilent Technologies 
 
3.3 Instrumentation 
All compounds (except 3-OH B[a]P) were analysed using a 7890A Gas Chromatography 
(Agilent Technologies, Wilmington, USA) system coupled with triple quadrupole mass 
spectrometer (QqQ) equipped with autosampler and MassHunter Workstation software for 
acquisition, qualitative and quantitative analysis. The compound 3-OH B[a]P was analysed 
with a benchtop LC/MS system (Q ExtractiveTM Quadrupole-Orbitrap Mass Spectrometer; 
Thermo Scientific, San Jose, California, USA) and using TraceFinderTM software for 
quantitation.   
3.4 Chromatographic and mass spectral conditions 
3.4.1 GC-QqQ-MS/MS conditions 
A DB-5MS column (30 m × 0.25 mm i.d.; 0.25 μm film thickness, J &W Scientific, Santa 
Clara, California USA) was used for GC separation. The oven temperature was 
programmed as follows: initial temperature was 100 °C for 1.5 min and ramped up to 240 
°C at 20 °C min−1 and held for 0 min, then to 248 °C at 2 °C min−1 and held at this 
temperature for 0 min. A final temperature of 320 °C was obtained by applying a ramp of 
40 °C min−1, the final temperature of 320 °C was held for 4 min. The total run time was 
18.3 min at constant flow rate of 1.2 mL min−1. The injector temperature was set at 280 °C. 
The volume of sample injected was 1.0 μL, in split-splitless mode. The mass spectrometer 
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was operated in electron ionization (EI) mode using the multiple reactions monitoring 
(MRM) mode with an emission current set at 20 μA for all the analytes and associated 
internal standards. The transfer line and ionization source temperatures were set at 280 
°C and 270 °C, respectively. The collision gas pressure was set at 1.5 mTorr and the cycle 
time was set to 0.4 s. MRM transitions, collision energy (CE) for each transition, and 
average retention times (Rt) are presented in Table 3.4. Analytes of interest were 
screened in five different time segments as shown.  
Table 3.4 GC-QqQ-MS/MS settings for PAHs and OH-PAHs and labelled internal 
standard 
Compound Segment Rt MRM 1 CE (V) MRM 2 CE (V) 
|2H8| Nap 1 3.85 136  108 20 136   134 20 
Nap 1 3.87 128  77 20 128   102 20 
1-OH Nap 2 6.35 216  185 20 201   185 20 
2-OH Nap 2 6.49 216  185 20 201   185 20 
|13C6| 2-OH Nap 2 6.51 222  191 20 207   191 20 
|2H10| Phe 1 8.32 188  158 20 188   160 20 
Phe 1 8.36 178  152 20 178   176 20 
4-OH Phe 4 9.38 235   220 20 266   235 20 
|2H10| Pyr 1 9.79 212   210 20 212   208 20 
3-OH Phe 4 9.81 266   235 15 235   220 15 
Pyr 1 9.82 202   200 20 202   176 20 
1-OH Phe 4 9.86 235   220 20 266   235 20 
2-OH Phe 4 10.06 266   235 20 235   220 20 
|13C6| 2-OH Phe 4 10.08 272   241 20 241   226 20 
1-OH PYR 5 12.83 290   259 20 275   259 20 
|13C6| 1-OH Pyr 5 12.84 296   265 10 281   265 10 
|2H12| B[a]P 4 14.86 264   260 20 264   262 20 
B[a]P 4 14.88 252   252 20 252   250 20 
 
3.4.2 Q-Orbitrap-LC/MS conditions 
The 3-OH metabolite of B[a]P was identified and confirmed using Q-Orbitrap-(Thermo 
ScientificTM) and ultra-high performance liquid chromatography (UPLC) interfaced with a 
positive chemical ionization (PCI) source. A Hypersil Gold C18 reversed-phase 
chromatographic column (2.1 x 100 mm, 1.9 µm - Thermo ScientificTM) operating at a 
temperature of 30 0C was used in the analysis of 3-OH B[a]P, a 1 µL injection volume was 
employed. The mass spectra was operating at a resolution of 70,000 and in the scan 
range 80 – 600 m/z. The detailed working conditions and parameters of the LC system 
used for metabolite identification are provided in Table 3.5. 
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Table 3.5. Q-Orbitrap-LC gradient setting for 3-OH-B[a]P and labelled internal 
standard 
Time (min)  % A % B Flow rate (mL min-1) 
0 70 30 0.2 
1 70 30 0.2 
2 15 85 0.2 
8 0 100 0.2 
15 0 100 0.2 
16 70 30 0.2 
20 70 30 0.2 
Elution solvent A – RO + 0.1 % formic acid + 10 mM ammonium formate  
Elution solvent B – MeOH + 0.1 % formic acid + 10 mM ammonium formate 
 
3.5 Preparation of standard solutions 
Stock solutions of the individual PAHs and OH-PAHs were prepared in n-hexane, except 
for 3-OH B[a]P and [2H12] 3-OH B[a]P which were prepared in methanol, and were stored 
in amber screw-capped glass vials in the dark at -20 oC. Working solutions used for the 
development of the method contained naphthalene (Nap), phenanthrene (Phe), pyrene 
(Pyr), benzo[a]pyrene (B[a]P) at the concentrations of 10 mg L-1 with serial diluted 
standards prepared as matrix matched at concentrations of 1, 2, 5, 10, 20, 50, 100, 200, 
500 and 1000 µg L-1 for all PAHs for the production of calibration curves. For the OH-
PAHs, including 1-hydroxynaphthalene (1-OH Nap), 2-hydroxynaphthalene (2-OH Nap), 1-
hydroxyphenanthrene (1-OH Phe), 2-hydroxyphenanthrene (2-OH Phe), 
3-hydroxyphenanthrene (3-OH Phe), 4-hydroxyphenanthrene (4-OH Phe), 1-
hydroxypyrene (1-OH Pyr) the working solution was prepared at a concentration of 1 mg L-
1. The calibration curves for these OH-PAHs were prepared as matrix matched at 
concentrations of 0.1, 1, 2, 5, 10, 20, 50, 100, and 200 µg L-1. From the pure isotopically 
labelled compounds, an internal standard solution containing [13C6] 2-hydroxynaphthalene, 
[13C6] 2-hydroxyphenanthrene, [13C6] 4-hydroxyphenanthrene and [13C6] 1-hydroxypyrene 
was prepared at the concentration of 50 µg L-1 in hexane. For PAHs, [2H8] Nap, [2H10] Phe, 
[2H10] Pyr and [2H12] B[a]P is used as an internal standard at the concentration of 200 µg L-
1 in hexane. All standards were stored at -20 oC in the dark.  
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3.6 Preparation of soil samples 
Contrasting soil types (n = 7) were sourced from unpolluted areas, with an expected low 
concentration of contaminants. The sampling sites are located in the states of Victoria and 
South Australia, Australia (Figure 3.1). These included; Dublin (DUA), Kersbrook (KBA), 
Millicent (MIA), Mount Gambier (MGA), Port Broughton (PBA), Tarrington (TAA) and 
Wallaroo (WRA) (Table 3.6). Field contaminated soils were collected from a former 
manufacturing gas plant site (n = 3) at Cootamundra, New South Wales, undisclosed 
industrial sites (n = 3) in Australia and soils (n = 2) used in a study investigating the effects 
of ageing and soil properties on oral bioavailability of B[a]P using a swine model. The 
samples represented the top layer (0 - 20 cm) of soil. Details on samples nomenclature 
and physicochemical properties of the contaminated soils are found in Chapter 7 of this 
thesis.  
 
Figure 3.1 Locations of sampling sites in states of Victoria and South Australia, 
Australia  
 
Marked on Google Maps in relation to the capital cities of Melbourne and Adelaide, 
respectively 
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Table 3.6. Soil nomenclature and chemical parameters for background sites. 
Parameter 
Soil location (and code) 
 
 MIA MGA KBA TAA WRA PBA DUA 
 
 
Millicent Mount Gambier Kersbrook Tarrington Wallaroo Port Broughton Dublin 
pH 7.12 5.68 4.45 4.92 7.66 7.73 7.31 
Clay (%) 10 16.3 20 10 17.5 6.7 7.5 
Silt (%) 6.3 21.9 37.5 17.5 23.8 10.7 12.8 
Sand (%) 83.8 61.9 42.5 72.5 58.8 82.7 79.8 
TC (%) 4.11 8.37 5.5 4.97 5.33 2.07 1.6 
TN (%) 0.00579 0.0261 0.0152 0.015 0.00598 0.00265 0.00229 
TS (%) 0.02 0.01 0 0.01 0 0 0 
TOC (%) 3.86 8.37 5.5 4.97 3.54 1.76 1.48 
DOC  
(mg Kg-1) 303 391 400 326 265 106 213 
CEC  
(cm Kg-1) 13 17.9 4.3 7.4 13.7 4.6 2.9 
Fe oxide 
(g Kg-1) 0.43 12.49 1.72 3.12 0.47 0.28 0.64 
Al oxide 
(g Kg-1)  2.27 12.6 2.13 3.01 1.38 0.5 0.74 
Mn oxide (g Kg-1) 0.0252 0.302 0.0449 0.212 0.237 0.0595 0.133 
Total Fe  
(g Kg-1) 18.21 30.95 22.65 43.9 16.8 8.55 9.87 
Total Al 
(g Kg-1) 33.07 26.99 11.13 56.64 28.31 12.01 7.98 
Total Mn  
(g Kg-1) 0.07 0.5 0.06 0.27 0.37 0.09 0.17 
USDA texture Loamy sand Sandy loam Loam Sandy loam Loamy sand Loamy sand Loamy sand     
 
TC (%) – the percentage of total carbon, TN (%) – the percentage of total nitrogen, TS (%) – the percentage of total sulphur, TOC (%) – 
the percentage of total organic carbon, DOC – dissolved organic carbon, CEC – cation exchange capacity, Fe oxide – ferrous oxide, Al 
oxide – aluminium oxide, Mn Oxide – manganese oxide, Total Fe – total iron, Total Al – total aluminium, Total Mn – total manganese  
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The soil samples were dried at room temperature and passed through a 2 mm stainless 
steel sieve. Our collaborators, at the University of Newcastle (previously at the University 
of South Australia) conducted the measurements of some soil properties (Table 3.6). In 
brief, soil textures were categorised according to the United States Department of 
Agriculture soil classification system (USDA, 1987). Electrical conductivity (EC) was 
measured according to a standard protocol (Raymond, 1992). Dissolved organic carbon 
(DOC) was determined using a total carbon analyser (1010 OI Analytical). Soil pH is 
determined potentiometrically (TPS SmartCHEM) at a 1:5 ratio of soil to 10 mM CaCl2 after 
1 h of end-to-end shaking. Elemental analyses of total carbon (TC), total nitrogen (TN), 
total sulphur (TS) were measured by TOC analyser (Leco TruMac CNS analyser, St. 
Joseph, Missouri, USA). Total organic carbon content (TOC) was determined after HCl 
addition to eliminate carbonates as recommended by the manufacturer. Cation exchange 
capacity (CEC) was measured following the compulsive exchange method (Gillman and 
Sumpter, 1986). Oxalate-extractable iron (Fe), aluminium (Al) and manganese (Mn) were 
determined using the acid oxalate method (pH = 3) (Rayment and Higginson, 1992). Sand, 
silt and clay contents were determined using the hydrometer method (Gee and Bauder, 
1986).  
3.7 Spiking of soil samples 
As the background soils were collected from relatively unpolluted areas, they were ideal 
for use in method optimisation and validation (including for use as blank samples and in 
spike recovery experiments). The concentrations of PAHs in soils were determined before 
spiking for recovery experiments.  
All seven soil types once processed (Section 3.6) and stored at room temperature were 
ready for spiking with PAHs. Minimum volume of acetone was used in dissolving each 
PAH compound (e.g. Nap, Phe, Pyr and B[a]P) before being spiked onto soils at 10 mg 
Kg-1, 50 mg Kg-1 and 250 mg Kg-1 for B[a]P and 250 mg Kg-1, 500 mg Kg-1 and 1000 mg 
Kg-1 for Nap, Phe and Pyr. Following the addition of PAHs, the soil samples were dried 
under a gentle stream of high purity nitrogen to facilitate the removal of acetone vehicle. 
For mixture study, soils that were spiked with As, Cd and Pb were mixed thoroughly by a 
mechanical mixer for over an hour before spiking with PAHs. Each background soil taken 
as control was prepared and stored in the same manner. Soils were aged for up to 90 
days at ambient temperature in a closed opaque container. Spiked concentrations of 
B[a]P, Pyr, Phe, Nap, As, Cd and Pb were based on the Australian National Environmental 
Protection Measure (NEPM) for the Assessment of Site Contamination health investigation 
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level A (HIL A) for standard residential garden/accessible soil and children's day care 
centres, kindergartens, preschools and primary schools. The HILs A for B[a]P is 3 mg Kg-1 
and 300 mg Kg-1 for total PAHs (including Nap, Phe, Pyr). The HILs for As, Cd and Pb are 
100 mg Kg-1, 15 mg Kg-1 and 300 mg Kg-1, respectively (NEPC, 2013). The 500 mg Kg-1 
and 1000 mg Kg-1 soil spikes for Nap, Phe and Pyr were chosen to reflect the high end 
concentrations found in Australian gasworks sites (Thavamani et al., 2011). This is also 
based in toxicological data suggesting no cytotoxic effects were observed on HepG2 cells 
exposed to Nap, Phe and Pyr at their maximum soluble concentration (Muthusamy, 2016 
PhD thesis). Similar concentrations up to 1000 mg Kg-1 have been used for Phe and Pyr in 
recent studies to refine estimates of human exposure to PAHs via incidental soil ingestion 
(Juhasz et al., 2016).  
3.8 Human liver hepatocellular carcinoma (HepG2) cell line 
3.8.1 Culturing of human liver cells (HepG2) 
Human hepatocellular carcinoma cell line (HepG2) was obtained from the American Type 
Culture Collection (ATCC®), USA (ATCC No. HB-8065). After thawing the cells were 
cultured in DMEM, containing 10 % (v/v) FBS, 2 mM of l-glutamine, 50 U/mL penicillin and 
50 U/mL streptomycin. Cultured cells are maintained in a humidified incubator (Heracell 
150i CO2 incubator, Thermo Scientific, Australia) at 37 oC under 5 % CO2. HepG2 are 
adherent and tend to clump together. For this reason a longer period of trypsinisation (3 – 
5 min) is required and during passaging cells need more rounds of pipetting in order to 
avoid clumping of cells. HepG2 cells were passaged at 60 – 80 % confluency. 
Cell dosage and collection 
Approximately 24 h before chemical treatment, the HepG2 cells were seeded at cell 
density of about 1 x 106 cells mL-1 in a 75 cm2 culture flask containing 10 mL of DMEM 
supplemented with 10 % FBS. For chemical treatment, stock solutions of B[a]P, Nap, Phe 
and Pyr were dissolved in DMSO whereas cadmium nitrate, lead nitrate and sodium 
arsenate stock solutions were diluted using Milli-Q water. Mixtures were prepared by 
mixing equal volumes of each solution. The individual compound or mixtures were 
exposed to HepG2 cells for 24 h. The final concentration of DMSO in the medium did not 
exceed 1% (v/v). Solvent vehicle (DMSO and Milli-Q water) was used as the negative 
control. To initiate exposure, cells were treated with testing compounds at different 
concentrations for 24 h. The selected concentrations were 0 – 5 µM for B[a]P, 0 – 30 µM 
for Nap, Phe and Pyr, 0 - 1 µM for Cd and 0 - 50 µM for Pb and As. All treatments for the 
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individual compounds, mixtures and control were carried out in triplicates. Upon 
termination of exposure, cells were harvested by first rinsing twice with PBS, then adding a 
pre-warmed trypsin-EDTA solution (0.25 %) to the cell monolayer to facilitate detachment. 
The contents were then carefully transferred to a 2 mL Eppendorf tube and centrifuged at 
10,000 x g for 2 min to separate the cell pallet from trypsin-EDTA solution. HepG2 cells 
were resuspended using 1 mL of PBS solution and cell number was determined using a 
TC20™ Automated Cell Counter from BIO-RAD. 
3.9 Conceptualised flow charts of analytical procedures 
The analytical methods developed in Chapter 4 and Chapter 6 are based on the 
QuEChERS approach. This section includes schematic flow charts that conceptualise the 
analytical method developed in this study. A modified QuEChERS procedure is developed 
for the analysis of PAHs and OH-PAHs from the <250 µM soil particles and the schematic 
flow chart is found in Figure 3.2. The procedure applies liquid extraction and use of 
commercially available QuEChERS AOAC 2007.01 extraction salt from Agilent 
Technologies, clean-up using d-SPE and analysis using a GC-QqQ-MS/MS and Q-
Orbitrap-LC/MS. Full details of the method validation is found in Chapter 6. Similarly, 
Figure 3.3 is a schematic flow chart of analytical procedure developed for the analysis of 
PAHs and OH-PAHs in biological samples (e.g. HepG2 cell line) useful in chemical risk 
assessment studies utilizing in vitro bioassays. The modified QuEChERS includes both 
PAHs and its monohydroxilated metabolites and includes additional procedures such as 
enzymatic hydrolysis, freeze-out techniques for removal of additional fat and derivatisation 
of OH-PAHs for analysis using GC-QqQ-MS/MS. Full details of the method validation is 
found in Chapter 4. Figure 3.4 is a schematic flow chart of the Unified BARGE Method 
(UBM) that is adapted from an in-house method, full details of the UBM procedure is found 
in the appendix section of this thesis. For all the methods developed in this PhD, the PAHs 
and OH-PAHs of interest were analysed using a GC-QqQ-MS/MS and Q-Orbitrap-LC/MS 
at the Department of Agriculture and Fisheries (DAF) analytical laboratory at the Coopers 
Plains Precinct in Queensland, Australia (as detailed in Section 3.4).  
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Figure 3.2. Flow chart of analytical approach for analysis of PAHs and OH-PAHs in 
soil 
 
 
Drying of soil samples 
Sieving (<250 µm) and 
homogenisation 
100 mg sieved soil sample 
Add 70 µL Milli-Q water                      
Add PAHs and OH-PAH spike  
(using vehicle acetone) 
Extract using 2 mL (x 2)                        
n-hexane: acetone (1:1, v/v) 
 
Combine extract in 10 mL centrifuge 
tube 
Add AOAC 2007.01 QuEChERS salt 
and centrifuge (3000 x g) for 10 min 
Add 980 µL extract 
(Plus deut. PAHs IS) to d-SPE 
 
Centrifuge (16,000 x g) for 5 min 
Add 980 µL extract 
(plus 13C6 OH-PAHs IS) to d-SPE 
 
Centrifuge (16,000 x g) for 5 min 
GC-QqQ-MS/MS   
 
Orbitrap-LC/MS (for 3-OH B[a]P) 
Reduce to dryness, derivatise using BSTFA 
(70 0C for 60 min) and reconstitute to 1 mL 
using n-hexane (or MeOH for 3-OH B[a]P) 
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Figure 3.3 Flow chart of analytical approach for analysis of PAHs and OH-PAHs in 
HepG2 cell lines 
 
 
 
Resuspend cell pellet using 100µL Milli-Q 
water in a 2 mL Eppendorf tube 
Cell homogenisation using mini ceramic 
homogeniser 
(Add PAHs and OH-PAHs spike using 
vehicle acetone) 
Extract using 1 mL n-hexane: acetone 
(1:1, v/v) by shaking and 
Vortex 2 min, centrifuge (16,000 x g) for 
10 min. Repeat once more.  
 
 
Combine extracts, add AOAC 2007.01 
QuEChERS salt, shake and vortex.                 
Centrifuge (1300 x g) for 2 min 
 
 
Add 980 µL extract 
(Plus deut. PAHs IS) to d-SPE 
 
Centrifuge (16,000 x g) for 10 min 
Freeze-out remaining fat at -20 0C 
(overnight). Transfer 100 µL to amber vial 
with insert   
Add 480 µL extract 
(Plus 13C6 OH-PAHs IS) to d-SPE 
Centrifuge (16,000 x g) for 10 min. Freeze-
out fat (-20 0C) overnight and transfer 100 
µL to clean amber vial with insert 
GC-QqQ-MS/MS   
 
Orbitrap-LC/MS (for 3-OH B[a]P) 
Reduce to dryness, derivertise using 
BSTFA (70 0C for 60 min) and reconstitute 
to 100 µL using n-hexane                         
(or in MeOH for 3-OH B[a]P) 
 
Add β-Glucuronidase/arylsulphatase  
 
(Incubate overnight at 37 oC) 
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Figure 3.4 Conceptual flow chart of PAHs analysis in UBM extracts 
Drying of soil samples 
Sieving (<250 µm) and 
homogenisation 
300 mg each sieved soil sample 
Add to vial labelled “stomach” and 
second vial “stomach + intestine” 
(add PAHs spike) 
 
1. Soil extraction in “stomach solution” 
with end-over-end mixing for 1 h at 370C 
 
2. Soil extraction in “stomach + intestine 
solution” with end-over-end mixing for a 
further 4 h at 370C 
Centrifuge (3000 x g) for 5 min 
0.45 µm filter and transfer to 50 mL vial 
Pass through C18 SPE + Silica SPE  
C18 + Silica SPE “stomach” elute (2x5 mL) 
using n-hexane: DCM (1:1,v/v) 
Concentrate and make to a final volume of 
1 mL with IS (deut. PAHs) in vial   
C18 + Silica SPE “stomach+intestine” elute 
(2x5 mL) using n-hexane: DCM (1:1,v/v) 
Concentrate gently using high purity 
nitrogen gas to a volume of 1 mL 
 
GC-QqQ-MS/MS   
 
GC-QqQ-MS/MS   
 
Transfer 980 µL to d-SPE tube and add 
deut. PAHs IS (20 µL at 10 µg mL-1), vortex 
30 sec and centrifuge (16,000 x g) for 10 
min. Transfer 100 µL to vial. 
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3.10 Quality assurance and quality control (QA/QC) methodology 
The main purpose of having QA/QC in this thesis is to ensure the production of reliable 
data with a minimum of errors, consistently. For implementation of QA/QC into analytical 
procedures in this thesis, the following tests were conducted using blank samples, spike 
samples and certified reference materials: 
a) Recoveries  
b) Precision 
c) Accuracy 
d) Linearity 
e) Limit of detection (LOD) 
3.10.1 Recoveries 
Analytes of interest were identified using their isopically labelled standards where possible.  
The recovery of PAHs and OH-PAHs in this study is a measure of quality assurance and is 
calculated using the following equation: 
 
Recoveries of analyte in either soil matrix or biological matrix is found in Chapters 4 – 8.  
3.10.1 Precision 
Testing how consistently reliable data is generated in this study was calculated using the 
recovery values from spike samples and soil certified reference material, the equation for 
relative standard deviation is shown below: 
    
  
σ = standard deviation  
µ = mean  
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3.10.3 Accuracy 
The performance of the analytical method to produce reliable data was measured using 
certified reference material (BCR®-524 industrial soil) from the European Commission. The 
certificate of analysis for BCR®-524 industrial soil is attached in the appendix section to 
this thesis.  
3.10.4 Linearity 
The method showed a linear response with coefficient of determination (R2) higher than 
0.995 in all cases.  
3.10.5 Limit of detection (LOD) 
The limit of detection (LOD) was defined three times the standard deviation of blank. For 
soil matrix analytical method, the LODs for the analytes were in the range of 0.2 – 10 ng g-
1 depending on the specific compound of interest. For the cell matrix analytical method, the 
LODs for the analytes were in the range of 0.1 – 2 ng g-1.  
3.11 Statistical analysis 
Data was analysed using various statistical methods. Statistical analysis was performed 
using Prism 7 (Graphpad Software Inc., La Jolla, USA). Linear regressions were 
performed to analyse the relationship between different factors. Goodness of fit (R2) of 
more than 0.5 and significance (p value) were used as indicators of the correlation 
efficiency. All data were reported as the mean (μ) ± standard deviation (σ) from replicate 
analysis. In Chapter 4 and Chapter 6, the statistical difference between μ values was 
tested using paired Student's t-test. A probability of p < 0.05 was considered as 
statistically significant. In Chapters 5, 7 and 8, data was compared for differences in 
means using one way ANOVA and Tukey test for multiple correlations. Significance 
difference was set at p < 0.05. In Chapter 7, the statistics software SPSS Statistics 24 
from IBM was used to carry out a principal component analysis (PCA) to visualise strong 
patterns in dataset and together with Hierarchical Cluster Analysis (HCA) to group more 
similar data together for interpretation of results.     
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Chapter 4 Development of a modified QuEChERS method for the analysis of 
PAHs and OH-PAHs in human liver cells  
Abstract 
A simple and rapid method based on the QuEChERS (Quick, Easy, Cheap, Effective, 
Rugged and Safe) approach and clean-up with dispersive solid phase extraction (d-SPE) 
followed by screening on gas chromatography triple quadrupole mass spectrometry (GC-
QqQ-MS/MS) and LC-Q-Orbitrap/MS has been developed and validated for the 
determination of polycyclic aromatic hydrocarbons (PAHs) and monohydroxylated 
metabolites of PAHs (OH-PAHs) in human liver cells. The optimised method is efficient 
and selective, provides reliable results with high sample throughput, has low solvent 
consumption, requires little labour and covers the target analytes with varying 
physicochemical properties and log Kow ranges from 2.7 – 6.13. The method was validated 
using human biological samples (i.e. human liver hepatocellular cell line or HepG2) 
through the evaluation of spike recovery experiments, matrix effects, linearity, precision 
and the limits of detection. Mean recoveries (n = 10) were between 70 – 120 % with 
relative standard deviation (RSD) in a range of 2 – 20 %. The LODs depending on the 
compound were in a range of 0.1 – 2 ng g-1. The chromatographic conditions used in this 
study allowed the separation of all compounds in less than 20 min. The optimised method 
was successfully applied to PAH-treated HepG2 samples, with both parent PAHs and a 
range of OH-PAH metabolites being found in these samples. Metabolite identification is 
crucial for revealing metabolic pathways and comprehensive potential toxicities of PAHs in 
the human body.  
 
Keywords: QuEChERS, polycyclic aromatic hydrocarbons, monohydroxilated PAHs, GC-
QqQ-MS/MS, Orbitrap-LC/MS, human liver cells 
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4.1 Introduction 
Gas chromatography and liquid chromatography coupled with mass spectrometry 
technologies (GC/MS and LC/MS) have become mainstream tools for identifying and 
profiling organic compounds and their metabolites or biotransformation products 
(Cvetkovic et al., 2016; Plassman et al., 2015; Baduel et al., 2015). Both chromatographic 
techniques have been widely applied in studies investigating in vitro and in vivo 
biotransformation of organic compounds. Polycyclic aromatic hydrocarbons (PAHs) are a 
group of widespread organic compounds formed mainly through the incomplete 
combustion of organic matter resulting from anthropogenic sources (i.e. incinerators, 
industrial plants, land-fills and automobile exhausts) and natural sources (i.e. forest fires 
and volcanoes). PAHs are known ubiquitous environmental pollutants and some PAHs 
such as benzo[a]pyrene have been recognized for their carcinogenic and mutagenic 
properties (Waldman et al., 1991). Due to their wide occurrence and toxicological interest, 
16 PAHs were added to the priority pollutant list of the United States Environmental 
Protection Agency in 1976 (IARC, 1983).  
 
In mammalian systems, PAHs undergo successive phase I metabolic biotransformation, 
including oxidation and hydroxylation. These processes are catalysed by cytochrome 
P450 enzymes (Madureira et al., 2014; Luan et al., 2007). Notably, certain phase I 
metabolites such as monohydroxylated PAHs (OH-PAHs) have been frequently detected 
in human urine and hair (Campo et al., 2008; Schummer et al., 2009). In studies 
investigating human exposure to PAHs, urinary OH-PAHs such as 1-hydroxypyrene (1-OH 
Pyr) and 3-hydroxybenzo[a]pyrene (3-OH B[a]P) have been used as biomarkers due to 
their comparatively higher concentrations and detectability using GC/MS and LC/MS 
(Plassman et al., 2015; Schummer et al., 2009). Such monohydroxylated PAHs (OH-
PAHs) are commonly used as biomarkers to monitor human PAHs exposure and assess 
the environmental and human health risks (Wang et al., 2017; CDC, 2013). However, OH-
PAHs may undergo further biotransformation in phase II metabolism resulting in the 
formation of glucuronide conjugates and sulfate derivatives of OH-PAHs. Hence, enzymes 
(i.e. β-glucuronidase/arylsulphatase) are needed to cleave the conjugate for analytical 
analysis. The use of GC/MS and LC/MS have been used widely in the identification and 
profiling of both parent PAHs and OH-PAH metabolites in human biomonitoring studies 
and in vivo studies using animals such as pigs and rats (Wang et al., 2017; Grova et al., 
2011). Such information is critical to explore and elucidate metabolic pathways of PAHs in 
human populations.  
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Some of the key analytical methods mainly used in the analysis of PAHs and OH-PAHs in 
biological matrices include an extraction step such as soxhlet extraction (Cvetkovic et al., 
2016), solid phase extraction (Baduel et al., 2015), and accelerated solvent extraction (Li 
et al., 2003) which is coupled to sample clean-up using a dispersive solid phase extraction 
(Baduel et al., 2015), gel permeation chromatography (Cloutier et al., 2017) or silica gel 
(Cvetkovic et al., 2016).  However, these techniques are often time consuming and mainly 
use a large volume of chlorinated solvent for extraction. In 2003, the first quick, easy, 
cheap, effective, rugged and safe (QuEChERS) method was published by Michelangelo 
Anastassiades (Chemisches und Veterinaruntersuchungsamt, Stuttgart, Germany) and 
Steven J. Lehotay (US Department of Agriculture, Philadelphia, Pennsylvania, USA) along 
with their co-workers (Anastassiades et al., 2003). The original QuEChERS method has 
since then been cited in over 700 scientific papers.  
 
The approach of the original QuEChERS method is to extract a well homogenised sample 
using acetonitrile and QuEChERS extraction salt (containing Mg2SO4 and NaCl) followed 
by clean-up of the extract using dispersive solid phase extraction (containing MgSO4, C18 
and primary secondary amines) with the aim of eliminating the possible interfering 
compounds from the biological extracts (i.e. organic acids, certain polar pigments and 
sugars) (González-Curbelo et al., 2015). The QuEChERS method has been reported to be 
very adaptable with different matrices, samples sizes and extraction solvents and provides 
high analyte recoveries (Baduel et al., 2015; Cvetkovic et al., 2016; DeArmond et al., 
2015). With such inherent advantages and its “Green Chemistry characteristics (Guardia 
and Garrigues, 2012), the QuEChERS approach has rapidly expanded to the extraction of 
different groups of compounds from environmental to bioanalytical matrices (González-
Curbelo et al., 2015). In the past 10 years a number of QuEChERS protocols have been 
developed for the analysis of the US-EPA PAHs in both environmental and biological 
matrices (Anastassiades et al., 2003; Baduel et al., 2015; Cvetkovic et al., 2016; 
DeArmond et al., 2015). However, the application of QuEChERS approach for the analysis 
of OH-PAHs is limited to a study on milk samples (Knobel et al., 2013) and rat brain tissue 
(Grova et al., 2011).   
 
The aim of the present study was to develop a sensitive method based on the QuEChERS 
analytical approach for the analysis of PAHs and OH-PAHs in human biological sample 
(i.e. HepG2 cells) using GC-QqQ-MS/MS and Q-Orbitrap-LC/MS. A total of 4 PAHs from 
the US-EPA list and 8 commercially available OH-PAHs were investigated in this study. 
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Moreover, HepG2 cells were cultivated in a Physical Containment level 2 (PC2) laboratory 
and used in validating and testing the suitability of the modified QuEChERS analytical 
method. The validated method was thereafter applied to HepG2 cells exposed over 24 h to 
PAHs at environmental and toxicologically relevant concentrations. This study is the first to 
demonstrate the use of a QuEChERS based approach in the co-analysis of parent PAHs 
and its mono-hydroxilated metabolites (i.e. OH-PAHs) in human biological sample (e.g. 
HepG2 cells). Further, its application to quantifying the bioavailability of PAHs and OH-
PAHs in human cells should provide an important new tool for in vitro and clinical studies 
in the future. 
 
4.2 Materials and methodology 
4.2.1 Chemicals and reagents 
Lists of general laboratory chemicals, pure standards and culture medium used in cell 
culture and compound extraction, sample clean-up and analysis of PAHs and OH-PAHs 
are found in Table 3.1, Table 3.2 and Table 3.3.  
 
Stock solutions and calibration standards 
Details on preparation and storage of stock solutions and calibration standards for PAHs 
and OH-PAHs are found in Chapter 3, Section 3.5.  
 
4.2.2 Materials  
Lists of general laboratory materials and kits used in experiments in Chapter 4 of this 
thesis are found in Chapter 3, Section 3.2.  
 
4.2.3 Instrumentation and chromatographic conditions 
Details on instrumentation and chromatographic conditions are found in Chapter 3 
(Sections 3.3 and 3.4). Table 3.4 lists the GC-QqQ-MS/MS settings for PAHs and OH-
PAHs and labelled internal standards and Table 3.5 lists in summary the Q-Orbitrap-
LC/MS settings for 3OH-B[a]P and corresponding labelled internal standard. The retention 
times of the target compounds are shown in Figure 4.1. 
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4.2.4 Cell culture and collection. 
The HepG2 cells were cultured using DMEM with 10 % FBS, the protocol for cell culture 
and collection is found in Chapter 3 of general materials and methodology in Section 3.8. 
 
4.2.5 Optimised sample preparation 
Optimised sample preparation is shown in Section 3.9 (Figure 3.3). To obtain cell pellets, 
the HepG2 cells were gently washed twice with PBS solution and then detached using 
trypsin. HepG2 cells (approximately 100 mg by wet weight) were extracted from 75 cm2 
cell culture flask and placed into 2 mL Eppendorf tube. The contents in the Eppendorf tube 
were centrifuged at 10,000 x g for 2 min and the supernatant was discarded. Cells were 
resuspended in clean PBS solution and vortex for 30 sec before being centrifuged again 
using the above procedure. The supernatant was discarded and the procedure repeated 
for a third time using clean PBS solution until only the cell pellet remained. This step 
ensured removal of any traces of the cell culture medium. The cell pellet was kept at a 
temperature of -80 oC until ready for analysis. Before enzyme hydrolysis of OH-PAH 
conjugates the cell pellet was taken through 2 cycles of thawing and freezing, then cells 
re-suspended in 0.1 mL Milli-Q (MQ) water. To prepare cell homogenate, a commercially 
available mini ceramic homogeniser used in QuEChERS procedure was used. Cell 
homogenate were then spiked with recovery standards (i.e. for PAHs and OH-PAHs at 50 
ng mL-1 and 200 ng mL-1 final concentration) and 0.1 mL sodium acetate buffer (1 M, pH 
5.5) and enzymes (i.e. β-glucuronidase/arylsulphatase) before incubation overnight at 37 
oC. For enzymatic hydrolysis, the minimum amount of β-glucuronidase/arylsulphatase 
needed to complete hydrolysis was tested using 10 µL and 20 µL of the enzyme (Figure 
4.2). Following overnight incubation, samples were ready for chemical extraction of PAHs 
and OH-PAHs.  
 
4.2.6 Extraction and measurement of PAHs and OH-PAHs in HepG2 
An overview of chemical extraction, clean-up and analysis of PAHs and OH-PAHs in 
HepG2 cells is presented as a schematic flow chart in Section 3.8 (Figure 3.3). The 
following describes the extraction, isolation and measurement of PAHs and OH-PAHs in 
HepG2 cellular matrix.  
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Analysis of PAHs in HepG2 using GC-QqQ-MS/MS 
A 1 mL aliquot of acetone: hexane (v/v) was added to the 2 mL Eppendorf tube containing 
the cell homogenate. The tubes were vortexed for 2 min and subsequently centrifuged at 
16,000 x g for 10 min. Extraction was repeated with another 1 mL aliquot of acetone: 
hexane (v/v). The supernatant after each extraction was added to approximately 0.2 g 
QuEChERS extraction salt (containing Mg2SO4 and sodium acetate) in a clean vial. The 
extraction vial with the combined extracts was shaken and vortexed for 2 min, then 
centrifuged at 1300 x g for 2 min. However, following the AOAC 2007.01 QuEChERS 
approach, a clean-up step was introduced by quantitatively transferring the extract to the 
QuEChERS dispersive solid phase extraction (d-SPE) tube, which contains 
Mg2SO4/PSA/C18. At this point PAH internal standard (e.g. isotopically labelled PAHs at 
200 ng mL-1 final concentration) were added and the d-SPE tube was vortexed for 30 s 
and subsequently centrifuged at 16,000 x g for 10 min. The tubes were kept overnight in a 
freezer operating at a temperature of -20 oC (e.g. to freeze out remaining fat) before a total 
of 100 µL of extract is transferred into an amber vial with an insert, the final extracts are 
analysed for PAHs by GC-QqQ-MS/MS. 
  
Analysis of OH-PAHs in HepG2 using GC-QqQ-MS/MS 
To analyse for OH-PAHs, 480 µL of the extract and labelled internal standards (e.g. 
isotopically labelled OH-PAHs at 50 ng mL-1 final concentration) were quantitatively 
transferred to a d-SPE amber vial and contents vortexed for 30 sec. Subsequently, the 
contents were centrifuged at 16,000 x g for 10 min. To freeze out remaining fat, the tubes 
were kept overnight in a freezer operating at a temperature of -20 oC. For derivatisation of 
OH-PAHs, 100 µL of clean extract was quantitatively transferred into an amber vial and 
reduced to dryness using a gentle stream of high purity nitrogen gas and temperature of 
37 oC. A 25 µL aliquot of BSTFA was added into the vial and after capping the contents 
were vortexed for 30 s (mixing the content in between by using a vortex). Notably, the 
minimum amount of derivatisation reagent and optimum conditions required for 
derivatisation of PAH metabolites are shown in Figures 4.3 – 4.5. The remaining BSTFA 
was then removed by gently drying the contents under high purity nitrogen gas and 
reconstituting the contents using 100 µL of hexane. Final extracts are analysed for OH-
PAHs (except 3-OH B[a]P) using a GC-QqQ-MS/MS (Agilent Technologies 7890A, USA).  
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Analysis of 3-OH B[a]P in HepG2 using Q-Orbitrap-LC/MS 
Prior to instrument analysis of 3-OH B[a]P, final extracts are reduced under high purity 
nitrogen gas to dryness and then reconstituted in 100 µL of MeOH (avoiding the 
derivatisation step). For determining 3-OH B[a]P, samples were analysed using an Q-
Orbitrap-LC/MS (Thermo Scientific Q-ExactiveTM, USA).  
 
4.2.7 Validation procedure 
Once the best conditions for the analyses of PAHs and OH-PAHs were optimised, the 
validation of the method was carried out according to the procedure described below. The 
calibration curves and linear ranges of the detector response for the four select PAHs and 
eight metabolites (OH-PAHs) were evaluated by analysing working standard solutions (0.1 
to 1000 ng mL−1) in triplicate. The linear working range (Table 4.1) was determined by 
spiking matrix matched samples with native and internal standards at the same 
concentrations as pure standards (representing 100 % recovery of compounds). Recovery 
of PAHs and OH-PAHs in spiked samples was determined using matrix matched 
standards. Matrix effects (ME) for each compound was determined from differences 
between slope of PAHs and OH-PAHs in solvent and matrix matched standards, which is 
determined using the equation below. 
 
 
 
The limit of detection of a given PAH or OH-PAH in this study was accepted as three times 
the standard deviation of blank. The precision in terms of repeatability was evaluated by 
carrying out the extraction and analysis of fortified samples using multiple replicates, 
injecting each extract in triplicate. Both intra-day and inter-day variability were evaluated 
for precision. Intra-day precision was assessed by analysing replicate (n = 10) samples on 
the same day, while inter-day precision was assessed over 3 days using the same number 
of samples. In both cases, precision was expressed as relative standard deviation (RSD). 
The accuracy of the analytical method was evaluated through recovery studies for all 
tested samples. 
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4.2.8 Statistical analysis 
Data was analysed using various statistical methods. The Grubb’s test was used to 
eliminate outliers in data. Data were reported as the mean (μ) ± standard deviation (σ) 
from replicate analysis. The statistical difference between μ values was tested using 
paired Student's t-test. A probability of p < 0.05 was considered as statistically significant. 
Statistical analysis were done using Prism 7 (Graphpad Software, La Jolla California, 
USA). 
4.3 Results and discussions 
4.3.1 Development and optimisation of the chromatographic conditions 
The development and optimisation of the chromatographic conditions for a GC-QqQ-
MS/MS was based on modifications to the original QuEChERS method (Anastassiades et 
al., 2003) for PAHs and the Centre for Disease Control (CDC) method for the analysis of 
OH-PAHs (US CDC, 2013) that was developed for the National Health and Nutrition 
Examination Survey (NHANES) in the United States of America (USA). The Agilent 7890A 
GC-QqQ-MS/MS was tuned before each analytical run. The abundance of mass-to-charge 
(m/z) of 69 should be >1,000,000, and the isotope ratio of m/z 70 to m/z 69 should be 
roughly 1%. These basic requirements needed to be met before each analytical run. Once 
MS is tuned, first 1 µL of pure standards of either PAHs or OH-PAHs were injected into the 
back injection port of the GC system to determine retention time, compound peak shape 
and separation conditions in order to optimise injections to maximum signal to noise ratio. 
A temperature-programmed pulsed splitless injection in a split-splitless inlet (SSL) was 
selected for PAH and OH-PAH analyses. The optimum injector and oven temperature 
programme is shown in Chapter 3 (Section 3.4). The optimisation of the MS/MS 
parameters included the acquisition of respective MS spectra in full scan mode, scans of 
precursor and product ions at different collision energies (CE) and using time segments for 
multiple reaction monitoring (MRM) mode. The optimized MS/MS conditions are found in 
Chapter 3 (Table 3.4). For EI spectra, the molecular ion [M]+. corresponding to the 
trimethylsilyl ion [Si(CH3)3OPAH]+. was obtained for all OH-PAHs in this study with an 
abundance of at least 80%. Quantitation was performed in the MRM mode and 
compounds were univocally assigned based on their retention times and m/z ratio. The 
retention time and molecular quantifying ions at m/z acquired for each PAH and OH-PAH 
and their internal standards are reported in Chapter 3. The chromatograms of the target 
compounds are shown in Figure 4.1.  
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Figure 4.1. Single ion chromatograms corresponding to PAHs and OH-PAH 
standards derivatised with BSTFA: A (Nap, 1-OH Nap and 2-OH Nap), B (Phe, 4-OH 
Phe, 3-OH Phe, 2-OH Phe and 1-OH Phe) and C (Pyr, 1-OH Pyr and B[a]P). 
Nap    
Ion m/z 128 
1-OH Nap 
Ion m/z 216 
2-OH Nap   
Ion m/z 216 
 
 
Phe   
 Ion m/z 178 
4-OH Phe    
Ion m/z 266 
2-OH Phe 
Ion m/z 266 
3-OH Phe 
Ion m/z 266 
1-OH Phe 
Ion m/z 266 
 
Pyr  
Ion m/z 202 
1-OH Pyr  
Ion m/z 290  
 
B[a]P 
Ion m/z 252 
A 
B 
C 
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In this study a Dionex UHPLC was coupled to a Q-Orbitrap and mass spectrometer 
detector to identify and quantify the compound 3-OH B[a]P, a metabolite of B[a]P. The 3-
OH B[a]P standard was injected both using a pure solvent (MeOH) and as a matrix 
matched standard into a Zorbax ODS C18 column to optimise shorter-run conditions. 
Satisfactory chromatographic separation of 3-OH B[a]P and its internal standard was 
obtained using 10mM ammonium formate in RO water plus 0.1% (v/v) formic acid as 
mobile phase A and 10mM ammonium formate in methanol plus 0.1% (v/v) formic acid as 
mobile phase B. The metabolite 3-OH B[a]P standard and the isotopically labelled internal 
standard had good peak shape and response and were separated in a 20 min gradient. 
Both electrospray ionisation (ESI) and atmospheric pressure chemical ionisation (APCI) 
modes were tested for detecting 3-OH B[a]P. The APCI mode was adopted in this study 
as it was more sensitive for 3-OH B[a]P. Full scan spectra in the range of 80 – 600 m/z 
was used under positive APCI conditions and MS resolution of 70,000. The retention time 
and m/z for 3-OH B[a]P and internal standard is found in Chapter 3.  
 
4.3.2  Extraction procedure 
The QuEChERS approach towards sample preparation is both simple and rapid and has 
been applied towards a broad range of chemicals and samples, including biologicals and 
environmental. In this study a number of parameters were investigated to optimise the 
performance of the QuEChERS based extraction protocol. These included; sample size, 
enzymatic hydrolysis, volume of the extraction solvents, use of QuEChERS extraction 
salts, compound derivatisation and extraction time.  
 
Sample preparation optimisation   
HepG2 cells were cultured using both 25 cm2 and 75 cm2 flask to obtain sufficient sample 
mass of around 100 mg, which is similar to studies using a modified QuEChERS approach 
for the extraction of PAHs, OH-PAHs and pesticide residues in clinical specimens such as 
brain and blood (DeArmond et al., 2015; Grova et al., 2011). In this study monolayer cell 
culture using a 75 cm2 flask provided approximately 100 mg of sample by mass when 
seeded at 106 cell density and extracted at 60 – 80% confluency. The cell pellet was 
isolated and homogenised as in Section 4.2.4. In the enzyme hydrolysis experiments, the 
use of 10 µL or 20 µL of the enzymes β-glucuronidase/arylsulphatase did not show any 
significant difference (p > 0.05) in the peak area response of OH-PAHs analysed using a 
GC-QqQ-MS/MS or an LC-Orbitrap/MS (Figure 4.2). However, human biomonitoring 
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studies using urine samples observed that the use of 10 µL of β-
glucuronidase/arylsulphatase produced a 67 % yield of a conjugated 1-hydroxypyrene 
glucuronide (1-OH PyrGLU), while the use of 20 µL of the solution containing the enzymes 
produced a yield of 97 % (Campo et al., 2008). Additionally, the use of an enzyme with 
both β-glucuronidase and arylsulphatase activity has been recommended for studying 
PAH metabolism as OH-PAHs are excreted as a mixture of glucuronide and sulphate 
conjugates (Li et al., 2006; Romanoff et al., 2006). In this study, 20 µL of the solution 
containing the enzymes β-glucuronidase and arylsulphatase was used in enzymatic 
hydrolysis.   
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Figure 4.2. The effects of enzyme volume on hydrolysis and detection of eight OH-
PAH standards.  
 
A = 1-OH Nap; B = 2-OH Nap; C = 1-OH Phe; D = 2-OH Phe; E = 3-OH Phe; F = 4-OH 
Phe; G = 1-OH Pyr; H = 3-OH B[a]P. p > 0.05 for volume of enzyme used. 
 
Extraction solvent and QuEChERS content 
For the extraction of both parent compound and its metabolites, the selection of an 
appropriate solvent is a crucial step in method development. Notably, the original 
QuEChERS approach used acetonitrile (ACN), however, the procedure was for the 
extraction of pesticides in fruits and vegetables (Anastassiades et al., 2003). The use of 
ACN offered co-extraction of a broad range of pesticides with little matrix interference 
(Lehotay, 2007).  Since then the use of solvents such as ethyl acetate, acetone and 
83 
 
methanol have been suggested based on the nature of organic compounds to be 
extracted and sample type (Lehotay, 2011).  
The best overall results for recovery of PAHs and OH-PAHs were achieved using a set of 
two extractions using n-hexane: acetone (1:1, v/v) and a reduced mass of QuEChERS 
extraction salt (i.e. 0.2 g for 100 mg sample size). The use of higher amount of extraction 
salts has been reported to reduce the volume of supernatant (Plassmann et al., 2015). 
Except for B[a]P, most of the PAHs were recovered in the first extraction and only low 
percentages of PAHs were recovered with the second extraction (Table 4.1).  
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Table 4.1 Validation of extraction solvent for the analysis of OH-PAHs in HepG2 cells using GC-QqQ-MS/MS and Q-Orbitrap-
LC/MS 
Analytes Recoverya     
(Low spike) 
1 min 
RSD 
(%) 
Recoverya 
(Low spike) 
4 min 
RSD 
(%) 
Recoveryb        
(High spike) 
1 min 
 
RSD 
(%) 
Recoveryb      
(High spike) 
4 min 
RSD 
(%) 
 
PAHs         
         
Naphthalene  62 14 92 8 60 15 80 16 
Phenanthrene 82 7 120 12 80 14 112 16 
Pyrene 85 4 102 8 78 8 98 10 
Benzo[a]pyrene 65 6 98 1 72 12 92 8 
         
OH-PAHs         
         
1-hydroxynaphthalene 72 12 88 12 68 14 90 20 
2-hydroxynaphthalene 74.5 10 90 8 76 20 86 17 
1-hydroxyphenanthrene 77 6 95 10 74 16 90 15 
2-hydroxyphenanthrene 70.5 8 95 11 70 11 90 9 
3-hydroxyphenanthrene  72 11 85 8 68 10 82 10 
4-hydroxyphenanthrene 78 15 98 12 75 12 92 10 
1-hydroxypyrene 78 10 90 15 75 18 84 20 
3-hydroxybenzo[a]pyrene 81 7 92 12 82 15 90 12 
aRecovery (low spike; n = 10) was evaluated with 50 ng mL-1 of cell homogenate for all PAHs and OH-PAHs. bRecovery (high spike; n = 
10) was evaluated with 200 ng mL-1 of cell homogenate for all PAHs and OH-PAHs. 1 min and 4 min indicate total time of vortexing.   
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For B[a]P and OH-PAHs, higher recoveries were obtained after two extractions using n-
hexane: acetone (1:1, v/v). The sample extracts from solvent combination of n-hexane: 
acetone (1:1, v/v) gave a clean chromatographic profile, was easily removed by 
evaporation and provided satisfactory recovery in the 70 – 120 % range for all the PAHs 
and OH-PAHs in this study.  
 
Extraction time 
The influence of the extraction time was studied for HepG2 cellular matrix using solvent n-
hexane: acetone (1:1, v/v). Lower recoveries were obtained for PAHs and OH-PAHs in the 
60 – 85 % range using an extraction time of 1 min as in the original QuEChERS method 
(Anastassiades et al., 2003). Overall recoveries of both PAHs and OH-PAHs improved up 
to 30 % when the extraction time was increased from 1 to 4 min (i.e. twice extracted with 2 
min for each extraction). In view of the results obtained in this present study, replicate 
solvent extraction using n-hexane: acetone with a slightly longer extraction time are a 
promising option that can be used with the QuEChERS based extraction procedure. 
 
Derivatisation protocol 
N,O-Bis(trimethylsily)trifluroacetammide (BSTFA) as the silylating agent was effective in 
forming the trimethyl silyl derivatives ([Si(CH3)3OPAH]+.) for all OH-PAHs in this study at 
an incubation time of 60 min at 70 0C. All experiments in the optimisation steps were 
carried in replicates (n = 3). Efficiency of derivatisation were expressed as peak area. The 
peak areas obtained for each OH-PAH in each experiment (reagent volume, derivatisation 
volume and time) are presented in Figure 4.3 – Figure 4.5. The optimum amount of 
BSFTA was found to be 25 µL. The use of BSTFA is reported to enhance selectivity and 
sensitivity in the analysis of OH-PAHs using a GC/MS system (Luan et al., 2007).  
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Figure 4.3. The effects of derivatisation reagent (BSTFA) volume on the detector 
response of seven OH-PAH standards.  
 
A = 1-OH Nap; B = 2-OH Nap; C = 1-OH Phe; D = 2-OH Phe; E = 3-OH Phe; F = 4-OH 
Phe; G = 1-OH Pyr. 
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Figure 4.4. The effects of derivatisation temperature on the detector response of 
seven OH-PAH standards.  
 
A = 1-OH Nap; B = 2-OH Nap; C = 1-OH Phe; D = 2-OH Phe; E = 3-OH Phe; F = 4-OH 
Phe; G = 1-OH Pyr 
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Figure 4.5. The effects of derivatisation time on the detector response of seven OH-
PAH standards. 
 
A = 1-OH Nap; B = 2-OH Nap; C = 1-OH Phe; D = 2-OH Phe; E = 3-OH Phe; F = 4-OH 
Phe; G = 1-OH Pyr 
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4.3.3 Method performance 
Following optimisation of the modified QuEChERS method conditions, the procedure is 
validated to measure its performance capability. The performance of this method is 
measured though quantifiable terms such as the linearity, recoveries, limit of detection, 
precision, standard deviation, repeatability and accuracy. The validation results were 
obtained from HepG2 cellular matrix from spike recovery experiment, and using reagent 
and procedural blank samples. Validation data are presented in Table 4.2.  
 
Linearity 
The analyte/IS ratio was linear from 0.1 to 1000 ng mL-1 in HepG2 matrix. Linearity was 
assessed using a least-squares regression line calculated from all standard concentrations 
and expressed by the determination coefficient (R2). In addition, the R2 value was greater 
than 0.995 for each analyte in this study. The linearity was based on the calibration of the 
PAHs and OH-PAHs supplemented in the matrix itself. Matrix blank were tested for 
background residues of PAHs and OH-PAHs, the solvent calibration standards were used 
as an alternative when high concentrations of compounds were found in the matrix.   
 
Recoveries 
For recovery experiments, the HepG2 cellular matrix was spiked at spike levels of 50 ng 
mL-1 and 200 ng mL-1 final concentration. The PAHs and OH-PAHs investigated in this 
study presented recoveries between 70 – 120% and a relative standard deviation in 1 - 20 
% range (n = 10). Based on the acceptable recoveries and precision for spike experiment, 
this method could be applied to extract a broad range of chemicals as the PAHs and OH-
PAHs analysed in this study covered log Kow values between 2.7 – 6.13 and a range of 
physicochemical properties. 
 
 Limits of detection  
Sensitivity was evaluated by the limit of detection (LOD). The LODs for the analytes were 
in the range of 0.1 - 2 ng g-1, depending on the specific compound of interest.  
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Table 4.2 Validation data obtained with GC-QqQ-MS/MS and Q-Orbitrap-LC/MS methods for analysis of PAHs and OH-PAHs in 
HepG2 cells 
Analytes Acronym  Recoverya 
(%) 
(n = 10) 
RSD  
(%) 
Range  
(ng g-1) 
Linearity  
(R2) 
LOD  
(ng g-1) 
(n = 3) 
MEb 
(%) 
Intra-dayc 
(%) 
(n = 10) 
Inter-dayc 
(%) 
(n = 10) 
PAHs          
          
Naphthalene  Nap 86 8 2 – 92 0.995 2 0.5 12 20 
Phenanthrene Phe 116 12 0.1 - 100  0.995 0.1 3 12 12 
Pyrene Pyr 100 8 1 - 100 0.998 1 5 8 10 
Benzo[a]pyrene B[a]P 95 1 0.5 - 88 0.997 0.5 4 2 4 
          
OH-PAHs          
          
1-hydroxynaphthalene 1-OH Nap 89 12 0.2 – 78 0.999 0.2 4 18 15 
2-hydroxynaphthalene 2-OH Nap 88 8 0.2 – 84 0.998 0.2 2 10 20 
1-hydroxyphenanthrene 1-OH Phe 93 10 0.2 – 86 0.995 0.2 5 10 12 
2-hydroxyphenanthrene 2-OH Phe 93 11 0.2 – 80 0.995 0.2 5 11 16 
3-hydroxyphenanthrene  3-OH Phe 84 8 0.2 – 82 0.996 0.2 2 8 12 
4-hydroxyphenanthrene 4-OH Phe 95 12 0.1 – 90 0.995 0.1 6 12 15 
1-hydroxypyrene 1-OH Pyr 87 15 0.1 – 95  0.999 0.1 4 15 20 
3-hydroxybenzo[a]pyrene 3-OH B[a]P 91 12 0.5 – 95  0.995 0.5 2 2 6 
aRecovery was evaluated with two concentrations of each analyte (50 ng mL-1 and 200 ng mL-1 of cell homogenate for all PAHs, and OH-
PAHs. bMatrix effect was determined by comparing the same samples as in footnote a. cIntraday and interday variability (RSD %) were 
determined on human liver cells (HepG2) supplemented at 50 ng mL-1 of cell homogenate for all PAHs and OH-PAHs. 
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Precision 
Precision in the chromatographic response for the modified QuEChERS method was 
determined as intra-day (n = 10) and inter-day (over 3 days). Intra-day and inter-day 
variability and accuracy were determined on HepG2 samples supplemented with PAHs 
and OH-PAHs. Variability was expressed as % of relative standard deviation (RSD) of the 
calculated concentrations. The relative standard deviations (RSD) of PAHs and OH-PAHs 
in HepG2 using GC-QqQ-MS/MS analysis are summarised in Table 4.2. The precision of 
the extraction with regards to peak areas of PAHs and OH-PAHs were generally less than 
15 % (% RSD). However, at the lowest concentrations in HepG2, the analyte response 
were varied and produced % RSD values up to 20 % for both PAHs and OH-PAHs. For 
GC-QqQ-MS/MS, the RSD for intra- and inter-day were between 1 – 18 %, and 4 – 20 %, 
respectively. For analysis of 3-OH B[a]P using an Q-Orbitrap-LC/MS, the RSDs for intra- 
and inter-day were 2 % and 4 %, respectively. The precision data demonstrate good 
reproducibility of the extraction method (Table 4.2).  
 
Matrix effect 
Matrix effects (ME) can lead to a significant enhancement or suppression of the analyte 
response in the detector due to the presence of interfering compounds which co-elute 
along with the analyte of interest in a sample compared to a pure standard solution 
(Baduel et al., 2015). An evaluation of ME was conducted in order to assess their effect on 
compound quantification in this study. One way to evaluate the ME is through the 
comparison of the slopes obtained in the calibration with matrix matched-standards with 
those obtained in calibration with standards prepared in the solvent (Romero-Gonzalez et 
al., 2011). Values of ME are presented in the validation Table 4.2. In GC-QqQ-MS/MS, the 
ME was found to be lower than 5 % for PAHs and up to 6 % for OH-PAHs in HepG2. For 
Q-Orbitrap-LC/MS, the ME for 3-OH B[a]P was less than 2 %. Overall the ME in HepG2 
was low, however, matrix-matched calibration were used to improve the accuracy of 
analyte quantification for both GC-QqQ-MS/MS and Q-Orbitrap-LC/MS analysis. 
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Quality control  
Both reagent blank and procedural blank samples were included as part of the quality 
control. All sample analysis were done in replicates. Extraction of samples was repeated 
when recoveries of spiked PAH and OH-PAH standards were out of the method validation 
range of 70 % to 120 % (RSD < 20%). Isotopically labelled internal standards were used 
for analyte identification in GC-QqQ-MS/MS and Q-Orbitrap-LC/MS analysis due to their 
similar physicochemical characteristics to the analyte. The internal standard peak area 
was acceptable when the response was within acceptable RSD of 20 %. 
 
4.3.4 Method applicability 
The developed method was applied to the analysis of human liver cells (HepG2) that were 
treated with PAHs at environmental and toxicologically relevant concentrations for a period 
of 24 h. A high exposure concentration of 5 µM and a low exposure concentration of 50 
nM were chosen for real sample analysis. The high exposure concentration of 5 µM is 
representative of an acute exposure and is frequently applied in toxicological 
investigations (Madureira et al., 2014). While the low exposure concentration of 50 nM is 
representative of long term background environmental exposure to PAHs such as from 
potable water and ambient air (Angerer et al., 1997). The monolayer of cells were cultured 
and exposed to PAHs in a controlled exposure environment. Exposure experiments were 
conducted in replicates of three. On termination of exposure, HepG2 cells were isolated 
and processed though the validated method. Both parent PAHs compounds and some of 
the OH-PAH metabolites (phase 1 metabolism) were detected and quantified in samples 
(Table 4.3). Notably, blank samples (untreated cells) in the 24 h treatment showed low 
background levels of Nap in both low and high concentration exposure. The 1-OH Nap 
and 2-OH Nap were not detected in the 24 h treated blank samples. Further, low 
background concentrations of Nap, Phe and Pyr were detected in all high concentration 24 
h treated samples. Both reagent blank and cell matrix used in preparation of matrix 
matched calibration standard did not have residues of PAHs or OH-PAHs of interest.  
 
The background contamination from PAHs is likely resulting from the cross contamination 
from treated flask kept in the same incubator over the 24 h exposure. The calculated 
concentrations in Table 4.3 are corrected by the blank samples. The results indicate that 
only a portion of the exposed PAHs become bioavailable. Further, the identification of 
phase 1 metabolites indicates metabolic activation of PAHs by CYP 450 enzymes in the 
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HepG2 cells. This study is the first to use a QuEChERS based method to simultaneously 
quantify bioavailability of PAHs and OH-PAHs in human liver cells when exposed at 
environmental and toxicologically relevant concentrations. The method is selective and 
sensitive, therefore it can be applied as a new tool in risk assessment studies that uses in 
vitro bioassays to quantify PAH uptake and metabolism.  
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Table 4.3 Concentration levels of target compounds found in 24 h treated HepG2 samples in ng g−1 wet weight 
Analytes HepG2a 
(Low) 
Blank 
(ng g-1) 
 
 
Nap  
(ng g-1) 
 
 
Phe 
 (ng g-1) 
 
 
Pyr 
(ng g-1) 
 
 
B[a]P 
(ng g-1) 
HepG2b 
(High) 
Blank 
(ng n-1) 
 
 
Nap  
(ng g-1) 
 
 
 
Phe 
(ng g-1) 
 
 
 
Pyr 
(ng g-1) 
 
 
 
B[a]P 
(ng g-1) 
 
PAHs           
           
Naphthalene  1±0.5 1.2±0.5 1±0.5 1±0.5 1±0.5 12±4 270±15 10±4 8±4 7±2 
Phenanthrene nd nd 3.6±0.5 nd nd 1.5±0.5 0.7±0.2 420±30 0.9±0.2 1±0.3 
Pyrene nd nd nd 3.2±1 nd 1±0.4 0.5±0.4 0.8±0.3 482±27 0.2±0.1 
Benzo[a]pyrene nd nd nd nd 5.1±1 nd nd nd nd 610±35 
           
OH-PAHs           
           
1-hydroxynaphthalene nd nd nd nd nd nd nd nd nd nd 
2-hydroxynaphthalene nd nd nd nd nd nd 10±4 nd nd nd 
1-hydroxyphenanthrene nd nd nd nd nd nd nd nd nd nd 
2-hydroxyphenanthrene nd nd nd nd nd nd nd nd nd nd 
3-hydroxyphenanthrene  nd nd nd nd nd nd nd nd nd nd 
4-hydroxyphenanthrene nd nd nd nd nd nd nd 36±7 nd nd 
1-hydroxypyrene nd nd nd 1.2±0.7 nd nd nd nd 60±4.4 nd 
3-hydroxybenzo[a]pyrene nd nd nd nd 1±0.4 nd nd nd nd 55±6 
aHepG2 (low; n = 3) represents cells treated with individual PAHs at a concentration of 50 nM for 24 h. bHepG2 (high; n = 3) represents 
cells treated with individual PAHs at a concentration of 5 µM for 24 h. Also nd signifies not detected.   
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4.4 Conclusions 
In this Chapter a specific and sensitive procedure based on the QuEChERS approach has 
been validated for the simultaneous analysis of PAHs and OH-PAHs in human liver cells 
(HepG2) using GC-QqQ-MS/MS and Q-Orbitrap-LC/MS. The performance characteristics 
including good selectivity, sensitivity and acceptable recovery of the analytes indicate that 
this method is accurate and can be used for the analysis of PAHs and OH-PAHs in HepG2 
or similar biological samples. To our knowledge, this is the first analytical report in which a 
modified QuEChERS approach with GC-QqQ-MS/MS and Q-Orbitrap-LC/MS is applied to 
the simultaneous determination of EPA listed PAHs and its monohydroxylated metabolites 
(OH-PAHs) in human liver cells. Furthermore, the suitability of the method for the 
determination of PAHs and OH-PAHs in HepG2 cells after exposure to PAHs was 
demonstrated. This study demonstrates for the first time that a QuEChERS based method 
can be applied as a new tool in risk assessment studies that uses in vitro bioassays to 
quantify PAH uptake and metabolism. The ability of the QuEChERS approach to 
accommodate extraction of a range of chemicals may be particularly useful in chemical 
mixtures study. 
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Chapter 5  Uptake of pure solution PAHs in HepG2 cells in the presence or 
absence of As, Cd and Pb 
  
 
Abstract 
Polycyclic aromatic hydrocarbons (PAHs) and metal/loids are common environmental 
pollutants. Most toxicological studies focus on the effect on cells from exposure to single 
environmental pollutant. There is limited data in relation to interaction effects of mixtures of 
PAHs and metal/loids on human cells. It was the goal of this study to quantify uptake and 
metabolism of B[a]P, Nap, Pyr and Phe in HepG2 cells. Effects of As, Cd and Pb on the 
uptake of PAHs in HepG2 cells was investigated in binary, ternary and seven component 
mixture. The different doses selected were 0 – 5 µM (B[a]P), 0 – 30 µM (Nap, Phe and 
Pyr) based on previous dose-response studies. Interaction effects were investigated at a 
24 h exposure period. Internal cell concentrations of PAHs and its metabolites were 
quantified in a time-resolved manner up to 24 h. Hydroxylated metabolites were formed in 
cells exposed to PAHs within 24 h. Uptake of PAHs in HepG2 cells was almost 
instantaneous indicating passive diffusion across the cell membrane as a major 
mechanism. The average % uptake of B[a]P, Pyr, Phe and Nap in HepG2 cells in the 
presence or absence of As, Cd and Pb were 2.1 %, 3.3 %, 0.97 % and 0.04 %, 
respectively. Using pure solution PAHs, interaction effects on uptake of PAHs in HepG2 
cells were generally less than additive.  
  
Keywords: Benzo[a]pyrene, mixture effects, HepG2, metabolism, risk assessment 
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5.1 Introduction 
Humans and other organisms are exposed to multi-chemical mixtures including commonly 
found carcinogens such as polycyclic aromatic hydrocarbons (PAHs) and metal/loids 
(Cheng et al., 2015). PAHs are one major group of environmental pollutants which are 
formed during incomplete combustion of organic matter. A total of 16 PAHs has been 
listed as priority pollutants by the United States Environmental Protection Agency (US 
EPA) of which B[a]P is one of the most studied due to its known carcinogenicity and 
mutagenicity (US EPA 2014). Mixed contamination of B[a]P, arsenic (As), cadmium (Cd) 
and lead (Pb) is a major environmental and human health concern (Muthusamy et al., 
2016a). B[a]P is classified as a Group 1 carcinogen by the International Agency for 
Research on Cancer (IARC) and is also known to cause teratogenicity, neurotoxicity and 
immunotoxicity (Ba et al., 2015). Naphthalene (Nap) is classified as a 2B carcinogen by 
the IARC and is associated with haemolytic anaemia, cataracts and respiratory disorders, 
whereas Pyr and Phe have been classified as Group 3 carcinogens by the IARC (Stohs et 
al., 2002; IARC, 2010). On the other hand, metal/loids which occur naturally in the earth’s 
crust are also a major group of environmental contaminants.  Arsenic (Group 1 
carcinogen) and Pb (Group 2 carcinogen) together with Cd (Group 1 carcinogen) have 
been ranked as 1, 2 and 7th prioritised pollutants in the Agency for Toxic Substances and 
Disease Registry (ATSDR) priority substances list (ATSDR, 2015).  It is known that chronic 
low level of exposure to As, Cd or Pb can cause genomic instability, endocrine disruption, 
neurotoxicity, carcinogenicity and immunotoxicity (Järup, 2003; Vakharia et al., 2001). 
Although the effects of PAHs and metal/loids as individual compounds have been well 
documented, their joint effects as a mixture is not well understood. The limited studies 
documenting combined effects of metal/loids and PAHs have reported that metal/loids 
inhibit the PAH-induced CYP1A1 and CYP1A2 at the transcriptional and post-translational 
levels (Korashy and El-Kadi, 2008; Anwar-Mohamed et al., 2009; Han et al., 2013). For 
mixtures of PAHs only, it has been proposed that competition for CYP450 among the 
individual PAHs may result in decreased level of reactive metabolites, hence less 
genotoxic effects (Vakharia et al., 2001). Further still, the interaction among PAHs and 
resulting genotoxicity is often compound dependent (Tarantini et al., 2011). It is 
noteworthy that the human health risk assessment of PAHs and metal/loids is carried out 
usually based on their individual toxicity. In published literature most studies have reported 
interaction of PAHs and metal/loids at binary combinations (Vakharia et al., 2001; 
Lewińska et al., 2007; Evans et al., 2004; Mukherjee et al., 2004). However, in some 
recent publications the effects of PAHs and metal/loids interaction at ternary, quaternary 
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and up to seven compound mixtures on micronucleus formation (Cheng et al., 2015), Nrf2-
antioxidant response pathway (Muthusamy et al., 2016b), oxidative stress (Muthusamy et 
al., 2016a) and cytotoxicity (Muthusamy et al., 2016c) have been reported. 
 
One possible route for human exposure to PAHs and metal/loids is through the incidental 
ingestion of contaminated soils, wherefrom these compounds are absorbed and 
distributed to the liver through blood circulation. The liver is the main target of many 
xenobiotics where they undergo metabolic transformation, resulting in detoxification or 
more toxic metabolites potentially harmful to liver cells. This has been demonstrated by 
the use of HepG2 cells in toxicological studies, where B[a]P and metal/loids accumulate 
following absorption and causing toxicity to liver cells (Vakharia et al., 2001; Urani et al., 
2005; Song et al., 2012; Babich et al., 1988). The HepG2 cell line has inherent metabolic 
capacity which is useful in determining toxicity of PAHs (Henkler et al., 2012), although 
their CYP expression has been reported to be lower in comparison to primary hepatocytes 
(Westerink et al., 2007; Gerets et al., 2012).Generally, HepG2 cell line qualifies as a 
suitable model for studying the effects of PAHs and metal/loids mixtures. To date there is 
very limited information in the scientific literature on interactions of PAHs and metal/loids 
mixtures and their effect on the uptake or biotransformation of PAHs in HepG2 cells. 
Therefore, this study aims to provide more insightful information about the effects of 
interaction of these compounds at binary, ternary and up to seven compound mixtures on 
the uptake and metabolic transformation of PAHs in HepG2 cells (surrogate liver). 
Addressing knowledge gaps on mixture effects can be useful to refine risk assessment of 
chemical mixtures.          
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5.2 Materials and methods  
5.2.1 Chemicals and reagents  
Please refer to Chapter 3 (see Table 3.1, Table 3.2 and Table 3.3) for the lists of general 
laboratory chemicals, pure standards and culture medium used in cell culture and 
compound extraction, sample clean-up and analysis of PAHs and OH-PAHs in Chapter 5. 
 
5.2.2 Dosing of pure compounds as solutions into human liver cells  
Please refer to Chapter 3 of general materials and methodology in Section 3.8 for protocol 
on HepG2 cell culture, dosage using pure compounds and collection of cells for analysis.   
 
5.2.3 Extraction and measurement of PAHs and OH-PAHs in the culture medium  
Upon termination of exposure, the medium is carefully removed by pipetting. The medium 
samples were vortexed thoroughly, and a 500 µL aliquot of each sample is quantitatively 
transferred to a 10 mL centrifuge tube followed by addition of 2 mL of hexane. The tube 
was vortexed and subsequently centrifuged at 1,300 x g for 5 min. The clear supernatant 
was added to a clean 10 mL centrifuge tube. Extraction was repeated with another 2 mL 
aliquot of hexane and the supernatant was added to tube containing the first extract. The 
extracts (980 µL) and internal standards (20 µL of the 10 µg mL-1) were quantitatively to a 
d-SPE tube and vortexed for 30 s before centrifuging at 16,000 x g for 10 min. The tubes 
were kept overnight in a freezer operating at a temperature of -20 oC before a total of 100 
µL of extract is transferred into an amber vial with an insert, the final extracts are analysed 
for PAHs using a GC-QqQ-MS/MS. To analyse for OH-PAHs, the above procedure is 
repeated with another 500 µL of medium, incorporating additional steps to increase the 
analytical capacity for its quantification using a GC-QqQ-MS/MS. A total of 500 µL of the 
final extract is transferred to an amber vial and contents are reduced to dryness using a 
gentle stream of high purity nitrogen gas and temperature of 37 oC. A 25 µL of BSTFA is 
added into the vial and after capping the contents were vortexed for 30 s. The BSTFA was 
added to initiate derivatisation of OH-PAHs, this done by incubating the vial at a 
temperature of 70 oC for 60 min, mixing the content in between by using a vortex. The 
remaining BSTFA was then removed by gently drying the contents under high purity 
nitrogen gas and reconstituting the contents using 500 µL of hexane. Final extracts are 
analysed for OH-PAHs (except 3-OH B[a]P) using a GC-QqQ-MS/MS (Agilent 
Technologies 7890A, USA). For determining 3-OH B[a]P an Q-Orbitrap-LC/MS (Thermo 
Scientific Q-ExactiveTM, USA) was used, prior to which final extracts were reduced under 
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high purity nitrogen gas were reconstituted in 100 µL of MeOH, avoiding the derivatisation 
step.   
 
5.2.4 Extraction and measurement of PAHs and OH-PAHs in human liver cells 
Following the isolation and determination of cell number using the protocol described in 
Chapter 3 (Section 3.8), the cell pellet was ready for extraction. First, a 100 µL aliquot of 
Milli-Q water was added to the cell pellet and cells were resuspended using vortex. The 
cells were then thoroughly homogenised using a commercially available mini ceramic 
homogeniser used in QuEChERS procedure. The cell homogenate was then spiked with 
recovery standards, sodium acetate buffer and enzymes β-glucuronidase/arylsulphatase 
and incubated overnight at 37 oC to complete enzymatic hydrolysis (see Chapter 4; 
Section 4.2.4 for details). After overnight incubation and completion of enzymatic 
hydrolysis, the cells are extracted and PAH and OH-PAH uptake (e.g. bioavailability) is 
quantified according to the procedure detailed in Chapter 4 (Section 4.2.6).  
 
 5.2.5 Extraction and measurement of PAHs and OH-PAHs in the flask plastic 
In order to estimate the mass balance in the test system, PAHs and OH-PAHs were also 
extracted from flask plastic by shaking each flask with 10 mL of hexane: acetone (1:1, v/v) 
and transferring the extracts to a 10 mL centrifuge tube. The extracts were gently reduced 
under high purity nitrogen gas to a volume of approximately 2 mL. For analysis of PAHs, 
980 µL of the extract and internal standards (20 µL of the 10 µg mL-1) were quantitatively 
to a d-SPE tube and vortexed for 30 s before centrifuging at 16,000 x g for 10 min. For 
OH-PAH analysis, the above was repeated with another 980 µL of the extract. Before 
analysis by GC-QqQ-MS/MS and Q-Orbitrap-LC/MS, the samples were further processed 
as reported in Section 5.2.3.   
 
5.2.6 Quality Control  
Background concentrations of PAHs and OH-PAHs were checked using blank samples, 
media and culturing flask. Spike recoveries and blanks were included in batch analysis. 
Isotopically labelled standards were used as internal standards to identify compounds and 
were also included in matrix matched standards. All samples were analysed with a 
minimum of three replicates.    
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5.2.7 Statistical analysis 
Statistical differences among treatments were determined by one-way ANOVA and 
Turkeys test for multiple correlation, with a significance level set at more than 95 %. All 
statistical analyses were done using Prism 7 (Graphpad Software, La Jolla California, 
USA). Results were considered to be significant if p < 0.05.  
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5.3 Results and discussion 
5.3.1 Mass balance and uptake of PAHs in the HepG2 in vitro system 
All four PAHs and their biotransformation products were measured in different 
compartments of the in vitro system (i.e. medium, HepG2 cells and plastic) as a function of 
time (Table S5.1, supplementary information). Distribution of PAHs in the different 
compartments is expressed as percentage of initial measured concentration. In this study, 
up to 96 % of the PAHs were found to be present in the culture medium and a maximum of 
5 % of some PAHs were found in HepG2 cells, whereas up to 4 % were bound to flask 
plastic. The near complete recovery of PAHs can be explained through loss of metabolism 
(i.e. metabolites not quantified) and some volatility issues (i.e. trace concentrations of Nap 
in treated samples) resulting from a 24 h incubation. Concentrations of PAHs in culture 
media and flask plastic were measured in control experiments in the absence of cells. An 
increase in the amount of PAHs (i.e. up to 10 %) was found in flask plastic in the absence 
of HepG2 cells. Experiments related to distribution and mass balance of PAHs in the 
HepG2 in vitro system were conducted in replicates (n = 5).  
 
The analysis revealed the majority of the PAHs remained in the culture medium, 
presumably due to the high affinity of PAHs to serum components in culture medium which 
has been reported to play an important role in determining the availability of B[a]P in 
mammalian cells (Madureira et al., 2014). To investigate PAH bioavailability in HepG2 
cells, the internal cell concentration were measured as a function of time. The internal 
concentrations of B[a]P and its transformation products were quantitatively measured in 
HepG2 cells. These cells were exposed to a 5 µM concentration of B[a]P over a time 
course of up to 24 h. Cell numbers determined over time were used to normalise B[a]P 
concentrations. Cellular uptake of B[a]P continued to increase over time with the highest 
concentrations found at 24 h (Figure 5.1). The uptake of B[a]P into HepG2 cells over 24 h 
was in a range of 0.5 – 2.2 % (Figure 5.2). The metabolite 3-OH-B[a]P resulting from 
biotransformation of B[a]P in HepG2 cells was also monitored over a time course of up to 
24 h. Concentrations of 3-OH-B[a]P were normalised based on cell number over the time 
course. Low concentrations of 3-OH B[a]P was found at 3 h, however, internal cell 
concentration continued to increase over the course of 24 h exposure.  
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Figure. 5.1. PAH uptake and OH-PAH metabolites measured in HepG2 cells over 24 h of exposure, Values are shown as mean ± 
SD, n = 5. 
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Even at time point 0 h (i.e.. near zero as measured as soon as possible) low 
concentrations of B[a]P were found in HepG2 cells. The rapid uptake of PAHs into 
different mammalian cells has been reported in a number of studies (Barhoumi et al., 
2002; Hockeley et al., 2006; Endo and Gross, 2011; Grova et al., 2011; Madureira et al., 
2014). In this study, the % uptake (surrogate bioavailability) of B[a]P into HepG2 cells is 
expressed as percentage of initial measured concentration and is based on the total 
internal cell concentrations of B[a]P and its metabolites. Assuming first-order kinetics in 
the uptake of B[a]P into HepG2 cells, the uptake rate was calculated to be 0.06 ± 0.01 h-1 
and the rate of biotransformation (i.e.. 3-OH B[a]P formation) was 0.09 ± 0.01 h-1. Plant et 
al (1987) investigating PAH uptake into normal human fibroblasts and P388D1 murine 
macrophage reported that cellular uptake of B[a]P followed first-order kinetics. Similarly, 
Madureira et al. (2014) using Hepa1c1c7 (i.e. mouse hepatoma cell line) reported B[a]P 
uptake and metabolism followed first-order kinetics. In this study rapid uptake of B[a]P and 
formation of 3-OH B[a]P was observed. Notably, the rate of biotransformation of B[a]P was 
found to be higher than its uptake rate in HepG2 cells. Efficient uptake followed by 
substantial bioconversion of B[a]P in fish liver is reported by Varanasi and Dennis (1981). 
While Weyand and Bevan (1986) investigating uptake of B[a]P reported that following an 
intratracheal instillation of radiolabelled B[a]P in rats, the peak concentration in the liver 
was attained in 10 min. However, Cavret and Feidt (2005) observed a much lower uptake 
of B[a]P in Caco-2 cells compared to its quick metabolism in the cells.  
 
In this study, HepG2 cells were also exposed to Nap, Phe and Pyr up to 24 h at a 
concentration of 20 µM. Cellular uptake of Pyr continued to increase over time until 
termination of exposure at 24 h. Its metabolite, 1-OH Pyr was also found to increase in 
concentration in HepG2 cells over the 24 h exposure period (Figure 5.1). Uptake of Pyr 
into HepG2 cells over 24 h were in the 0.3 – 4.9 % range (Figure 5.2). The rate of uptake 
into HepG2 cells was calculated to be 0.12 ± 0.01 h-1 and the rate of biotransformation 
was 0.13 ± 0.01 h-1. Phenanthrene cellular uptake showed similar behaviour with the 
highest intracellular concentrations found at the 24 h time point. Phe uptake into HepG2 
was in 0.2 – 1.4 % range over 24 h exposure. Further, Phe metabolite (i.e. 4-OH Phe) was 
found at low concentrations at 12 h and 24 h of exposure when compared to 1-OH Pyr, 
Pyr was dosed at the same concentration as Phe. The uptake rate of Phe was 0.07 ± 0.01 
h-1 and its biotransformation rate was 0.01 h-1. Results for Nap showed maximum uptake 
of the compound at 24 h of exposure. Based on the exposure concentration, the uptake of 
Nap into HepG2 cells was the lowest in the 0.02 – 0.04 % range. Its metabolite, 1-OH-Nap 
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was only detectable at low concentrations from 0 h time point and internal cell 
concentrations remained mostly steady until termination of exposure at 24 h. The uptake 
rate of Nap was calculated to be 0.03 ± 0.01 h-1 and its biotransformation rate was 0.07 h-
1. PAHs are common environmental pollutants and understanding the mechanism by 
which PAHs enter cells and are distributed intracellularly has considerable importance 
since many of them are potent carcinogens (Plant et al., 1987).  
 
Both Plant et al. (1985) and Shu and Nichols (1981) note that substrate transport across 
the cell membrane can follow either passive diffusion, passive facilitated diffusion or 
energy-dependent (active uptake). This work demonstrated that uptake of Phe, Pyr and 
B[a]P in HepG2 cells was rapid at time 0 h and internal concentrations continued to 
increase up to 24 h of exposure. Studies in vivo (Grubbs and Moon, 1973) and in vitro 
(Shu and Nichols, 1981) have shown that B[a]P partitions readily into plasma lipoproteins. 
Additionally, cell uptake of B[a]P has been shown to occur independently of lipoprotein 
endocytosis (Remsen and Shireman, 1981; Plant et al., 1985) and the size of the donor 
vehicle (Plant et at., 1985).  
 
It is generally believed that hydrophobicity might play a role in bioavailability of PAHs. 
Gilbert et al. (2014) reported that diffusive transport is particularly relevant for the transport 
of highly hydrophobic chemicals (log Kow > 5). In this study, Pyr uptake into HepG2 was 
higher in comparison to Phe and Nap in terms of cell internal concentration, even when 
Nap and Phe were treated at the same concentration as Pyr. Presumably hydrophobicity 
of the cell membrane and the octanol-water partition coefficient of compounds may be 
influential in limiting uptake of PAHs in HepG2 cells. This is reflected in low uptake of Nap 
in HepG2 cells, the least hydrophobic PAH with a Log Kow of 3.30.  
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Figure. 5.2. A; Percentage uptake of B[a]P (B[a]P + 3-OH B[a]P) in HepG2 cells over 24 h of exposure, Values are shown as 
mean ± SD, n = 5, B; percentage uptake of Pyr (Pyr + 1-OH Pyr) in HepG2 cells over 24 h (n = 5), C; percentage uptake of Nap 
(Nap+1-OH Nap) in HepG2 cells over 24 h   (n= 5), D; percentage uptake of Phe (Phe+4-OH Phe) in HepG2 cells over 24 h  (n =5). 
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The results in this study also demonstrated that only a fraction of PAHs exposed become 
available to cells, while major amounts remain in the culture media. The present 
investigation also found OH-PAH metabolites, indicating that PAHs were metabolised in 
HepG2 cells. Notably, Korytko et al. (2000) reported that the formation of phase 1 
metabolites such as monohydroxylated PAHs (OH-PAHs) in mammalian liver cells 
resulted following exposure to PAH compound. The presence of OH-PAH metabolites in 
HepG2 cells indicates metabolic activation of PAHs and suggests that cellular response 
can be caused by a significantly smaller fraction of PAHs than that added to the medium. 
Both 1-OH Pyr and 3-OH B[a]P were dominant metabolites in terms of intracellular 
concentration in HepG2 bioassay and maybe useful as end points in in vitro assessment 
of PAH exposure. Cell analysis showed the presence of these metabolites at almost every 
incubation time with maximum intracellular concentration at 24 h. This is also reflected in 
comparatively higher biotransformation rates for B[a]P and Pyr in HepG2 cells. This is in 
agreement with the results of previous studies that have reported a more efficient 
metabolism of larger PAHs compared with smaller compounds (Varanasi and Gmur, 
1981). Based on observations of the time trend study, the 24 h exposure period was 
chosen to investigate the PAH concentration dependent response of HepG2 cells.  
 
5.3.2 Effects of mixtures of B[a]P, Pyr, Phe and Nap on their respective uptake in 
HepG2 cells in the presence or absence of As, Cd and Pb 
 
The uptake of PAH in HepG2 cells was quantitatively examined at three different dosing 
concentrations over a period of 24 h. For B[a]P, the dosing concentrations were a low (1 
µM), medium (2.5 µM) and a high concentration of 5 µM (which had an impact on HepG2 
cell viability by about 20 % after 24 h of exposure). The concentration of 5 µM of B[a]P has 
frequently been applied in in vitro toxicological investigations (Barhoumi et al., 2002; 
Hockley et al., 2006; Endo and Gross, 2011; Madureira et al., 2014).  The concentrations 
of B[a]P used in this chapter were also consistent with a PAH-metal mixtures study using 
HepG2 cells to assess carcinogenic risks from exposure to environmental PAH-metal/loid 
mixtures (Vakharia and Kaminsky, 2001; Vakharia et al., 2000). Pyrene, Phe and Nap 
were each dosed at concentrations of 10 µM, 20 µM and 30 µM. After 24 h of exposure 
the amount of respective PAH and its metabolite were quantified and uptake was 
determined as a percentage of initial measured concentration.  
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Using a modified QuEChERS based extraction protocol and a triple quadrupole Gas 
Chromatography Mass Spectrometry (GC-QqQ-MS/MS), PAHs and their biotransformation 
products were measured in the exposure media and HepG2 cells after 24 h. The internal 
cell concentrations of B[a]P in HepG2 cells that were treated at 1, 2.5 and 5 µM were 
found at 64 ± 13, 120 ± 24, and 197 ± 12 ng/106 cells, respectively. The results 
demonstrate that increasing the concentration of individual treatment of B[a]P resulted in 
higher intracellular concentrations of B[a]P in HepG2 cells. The increasing internal cell 
concentrations were noticeably counteracted by biotransformation, that is the amount 3-
OH B[a]P formed increased as well. To quantify transfer of B[a]P into HepG2 cells, its 
uptake was calculated based on the total internal cell concentrations (i.e. B[a]P + 
metabolite) as a percentage of initial exposure concentration. Notably, most of the B[a]P 
remained in the treatment medium regardless of the external treatment concentration. The 
% uptake of B[a]P in HepG2 was calculated to be in the range of 1.7 – 2.5 % (Table 5.1). 
The % uptake of B[a]P were not significantly different from each exposure concentration (p 
value = 0.09 – 0.44) suggesting that the % uptake of B[a]P in HepG2 cells is independent 
of the different treatment concentrations.  
 
Similarly, the effects of Pyr, Phe and Nap on their respective uptake in HepG2 cells over a 
period of 24 h was quantitatively examined at three different concentrations. The uptake of 
Pyr into HepG2 cells treated at 10 and 20 µM were 804 ± 122 and 1129 ± 251 ng/106 cells, 
respectively. While at the highest concentration of 30 µM, a higher amount of Pyr was 
found at 2249 ± 132 ng/106 cells. On the basis of % uptake, it was observed that transfer 
of Pyr into HepG2 cells was in the 2.7 – 3.8 % range (Table 5.1). Similar to observations 
with B[a]P, the % uptake of Pyr in HepG2 cells resulting from three different treatment 
concentrations were not significantly different from each other (p value = 0.08 – 0.76). 
Further, the internal cell concentrations of Phe in HepG2 cells that were treated at 10, 20 
and 30 µM were found at 169 ± 23, 327 ± 81, and 548 ± 26 ng/106 cells respectively. 
While, the internal cell concentrations of Nap in HepG2 cells that were treated at 10, 20 
and 30 µM were found at 5.7 ± 1.6, 10.8 ± 0.7, and 15.5 ± 2.8 ng/106 cells respectively. 
Different exposure concentrations had no significant effect on the % uptake of Phe (p 
value = 0.59 – 0.92) and % Nap (p value = 0.48 – 0.99) in HepG2 cells (Table 5.1).  
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Table 5.1 Uptake of single PAHs in HepG2 cells at different treatment concentrations 
Compound Concentration (µM) % Uptake p value  
B[a]P 1 2.5 ± 0.5 0.09 - 0.44 
 2.5 2.1 ± 0.4  
 5 1.7 ± 0.1  
Pyr 10 3.8 ± 0.6 0.08 - 0.76 
 20 2.7 ± 0.6  
 30 3.5 ± 0.2  
Phe 10 0.95 ± 0.1 0.59 - 0.92 
 20 0.92 ± 0.2  
 30 1.03 ± 0.05  
Nap  10 0.04 ± 0.01 0.48 - 0.99 
 20 0.04 ± 0.01  
 30 0.03 ± 0.01  
    
Uptake (%) of PAHs into HepG2 cells over 24 h of exposure, values are shown as mean ± 
SD, n = 3. Turkeys multiple comparisons test was used to check significant differences 
between uptake from different exposure concentration of B[a]P, Pyr, Phe and Nap. Results 
were considered to be significant if p < 0.05.  
 
Overall, the concentration-dependent response of HepG2 cells to single PAH compounds 
indicate that their % uptake in cells was independent of the exposure concentration. B[a]P 
and Pyr % uptake in HepG2 cells were comparatively higher than Phe and Nap (Table 
5.1), this suggest that compound hydrophobicity might play a role in bioavailability of 
PAHs. The octanol-water partition coefficient (Log Kow) of B[a]P and Pyr is higher than Phe 
and Nap and therefore have a greater affinity to hydrophobic structures such as proteins, 
lipoproteins or lipids in cells (Madureira et al., 2014). Additionally, PAHs accumulated in 
the cells with an increase in the exposure concentration. The presence of PAH metabolites 
indicated biotransformation of PAHs, however, the increasing accumulation of PAHs may 
indicate lack of binding sites and capacity of CYP1A activity for higher exposure 
concentrations. Similar observations were reported for mouse hepatoma cell line treated 
with B[a]P (Madureira et al., 2014). Based on the findings of the concentration-dependent 
response of HepG2 cells to single PAH compounds, further investigations were directed at 
elucidating the effects of mixtures of PAHs and metal/loids on the uptake of PAHs into 
HepG2 cells.  
 
The effects of mixtures were evaluated to see if interaction with other PAHs and 
metal/loids can influence uptake of PAHs into HepG2 cells. A number of recent studies 
have demonstrated additive or synergistic effects of PAH and metal/loid mixtures on end 
points such micronucleus formation, oxidative stress and cytotoxicity (Peng et al., 2015, 
Muthusamy et al., 2016a; Muthusamy et al., 2016b). The U.S EPA has funded large scale 
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studies using human cells (i.e. fresh human hepatocyte cultures and HepG2 cells) and 
focused on determining the effects of mixtures of PAHs and metal/loids on induction of 
CYP1A1 and epoxide hydrolase and to produce mutations in human cells (Vakharia and 
Kaminsky, 2001; Vakharia et al., 2000). However, to date the effects of mixtures of PAHs 
and metal/loids on PAH uptake and metabolism in HepG2 cells is largely unknown.  
 
In this study effects of binary, ternary and seven-compound chemical mixtures of B[a]P, 
Pyr, Phe, Nap, As, Cd and Pb on uptake of PAHs into HepG2 cells was investigated at the 
same concentrations as exposure from individual PAH compounds. In binary mixtures 
where B[a]P was combined with another PAHs (i.e. Pyr, Phe or Nap), a decrease in % 
uptake of B[a]P in the combinations of B[a]P+Pyr and B[a]P+Nap was observed (Figure 
5.3), whereas in the B[a]P+Phe mixture an increase of 0.1 % in the % uptake of B[a]P in 
HepG2 cell was found. It is noteworthy that the interaction from Nap, Phe or Pyr causing 
an increase or decrease in % uptake of B[a]P in HepG2 cells was not statistically 
significant  (p > 0.05). Exposure to binary mixtures of B[a]P+Pb and B[a]P+As resulted in a 
decrease in % uptake of B[a]P in HepG2 cells (Figure 5.3), while an increase of 0.7 % in 
% uptake of B[a]P in HepG2 cells resulted in the B[a]P+Cd mixture (Figure 5.3). A recent 
study investigating micronucleus formation in HepG2 cells from exposure to B[a]P+Cd 
reported additivity in micronucleus counts in comparison to individual exposure from B[a]P 
or Cd (Cheng et al., 2015). Further, concentrations of 3-OH B[a]P from exposure to B[a]P 
binary combinations (i.e. B[a]P+Cd) at the 2.5 µM and 5 µM treatments were lower by up 
to 0.6 %. While 3-OH B[a]P was not detected in the 1 µM treatment in both single and 
binary compound exposure. Even though the decline in 3-OH B[a]P were not significant (p 
> 0.05), it does indicate that other PAH compounds may be competing for the same 
metabolising enzymes as well. Notably, the chemical mixtures study funded by the U.S 
EPA reported that mixtures of PAHs (including As, Cd and Pb) did not induce PAH 
bioactivation to the full potential of the individual PAH compounds (Vakharia and 
Kaminsky, 2001). The inhibition of CYP 1A1 activity by As, Cd and Pb is documented in 
literature (Vakharia et al., 2000), which may explain changes in % uptake of B[a]P and 
decrease in 3-OH B[a]P in HepG2 cells.  
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Figure 5.3 Effects of binary mixtures on uptake of PAHs in HepG2 cells over 24 h, values are shown as mean ± SD, n = 3. “*” 
indicates significance p < 0.05 among mixtures of PAHs. 
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Eighteen other binary mixture combinations of PAHs and metal/loids were investigated in 
this study (Figures 5.3). In the presence of Pyr, a significant decrease (p value = 0.02) in 
the % uptake of Phe in HepG2 cells was found in comparison to cells treated with Phe 
only. Similarly, in binary mixtures of Nap+Pyr, a significant decrease (p value = 0.04) in the 
% uptake of Nap in HepG2 cells was found when compared to % uptake of Nap exposed 
as a single compound at various concentrations (Figure 5.3). The interaction of PAHs and 
metal/loids in the remaining their binary combinations did not result in a significant decline 
or an increase in the % uptake of PAHs in HepG2 cells at 24 h incubation (Figure 5.3).  
 
A total of 12 ternary mixture combinations of B[a]P with Nap, Phe, Pyr, As, Cd or Pb were 
investigated for interaction uptake of B[a]P into HepG2 cells (Figure 5.4) No significant 
decrease in the  % uptake of B[a]P in HepG2 cells was observed in ternary mixtures (p > 
0.05). Freely available B[a]P has greater affinity to be bound to hydrophobic sites on the 
cell membrane, hence interaction effects from less hydrophobic Pyr, Phe and Nap and 
hydrophilic compounds such as, Cd and Pb may not have a significant effect on its uptake 
in HepG2 cells.  
 
Among ternary mixtures of PAHs and metal/loids, a significant decrease in the % uptake of 
Phe and Nap in HepG2 cells was observed (Figure 5.4). There was a significant decrease 
in the % uptake of Phe in HepG2 cells in the ternary combinations of Phe+B[a]P+ Pyr (p 
value = 0.002), Phe+B[a]P+Nap (p value = 0.015) and Phe+Nap+Pyr (p value = 0.011). 
Naphthalene % uptake in HepG2 cells decreased significantly in the ternary mixture 
Nap+B[a]P+Pyr (p value = 0.03). Additionally, effects of seven-compound PAH-metal/loids 
mixture on the uptake of PAH in HeG2 cells were investigated (Table 5.2). Only in the 
combination Phe+B[a]P+Pyr+Nap+As+Cd+Pb, a significant decrease in the % uptake of 
Phe was found (p value = 0.004). It is noteworthy that decrease in the uptake of less 
hydrophobic PAHs were found to be significant in higher mixtures, this may be due to 
competition for binding sites on the cell membrane and the same metabolising enzymes. 
The presence of As, Cd and Pb in mixtures of B[a]P, Pyr, Phe and Nap had no significant 
effect on their uptake. This may be due to their distinct physicochemical properties (e.g. 
As, Cd and Pb are hydrophilic), therefore not likely to interfere in the uptake of PAHs by 
competition.  
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Figure 5.4 Effects of ternary mixture on uptake of PAHs in HepG2 cell over 24 h, values are shown as mean ± SD, n = 3. “*” 
indicates significance p < 0.05, and “**” indicates significance p < 0.01 among mixtures of PAHs. 
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Table 5.2 Percentage (%) uptake (surrogate bioavailability) of PAHs in multi-compound mixture (n = 7) in HepG2 cells at 
different treatment concentrations 
Compound Concentration (µM) % Uptake p value  
B[a]P+Pyr+Phe+Nap+As+Cd+Pb 1 2.4 ± 0.4 0.06 - 0.75 
 2.5 1.8 ± 0.4  
 5 1.6 ± 0.1  
Pyr+B[a]P+Phe+Nap+As+Cd+Pb 10 3.5 ± 0.4 0.09 - 0.69 
 20 2.6 ± 0.6  
 30 3.2 ± 0.2  
Phe+B[a]P+Pyr+Nap+As+Cd+Pb 10 0.63 ± 0.5 0.9 - 0.99 
 20 0.67 ± 0.6  
 30 0.69 ± 0.6  
Nap+B[a]P+Phe+Pyr+As+Cd+Pb 10 0.04 ± 0.01 0.48 - 0.99 
 20 0.05 ± 0.01  
 30 0.04 ± 0.01  
    
Uptake (%) of PAHs (including hydroxylated metabolites) into HepG2 cells over 24 h of exposure, values are shown as mean ± SD, n = 
3. Turkeys multiple comparisons test was used to check significant difference between % uptake from different exposure concentration 
for B[a]P, Pyr, Phe and Nap. Results were considered to be significant if p < 0.05.  
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Overall the data from pure solution study suggests that uptake of PAHs in HepG2 cells 
showed either additive or mainly less than additive effects among binary, ternary and 
seven compound mixtures of B[a]P, Pyr, Phe and Nap. It is noteworthy that only 7 
chemical mixtures showed a significant effect on % uptake of PAHs in HepG2 cells with 
ternary mixture combinations having most effect on decreasing % uptake of PAHs 
followed by binary mixtures.  
 
5.4 Conclusion 
This chapter provides the first results in relation to PAH uptake and metabolism in HepG2 
cell line when exposed to individual PAHs and their mixtures with As, Cd and Pb. The 
time-trend exposure of HepG2 cells to single PAH compounds showed increased PAH 
accumulation and metabolite formation in cells up to 24 h of exposure. The findings also 
indicated that metabolic activation of HepG2 cells was caused by a much smaller amount 
of PAHs compared to the exposure concentration. Based on the concentration-dependent 
response of HepG2 cells to single PAH compounds, it was found that transfer of PAHs into 
cells was independent of the external exposure concentration and indicated passive 
diffusion as a major route of uptake in HepG2 cells. The quantitative data on mixture 
effects of PAHs and metal/loids (As, Cd and Pb) on uptake of PAHs in HepG2 cells 
suggests additive or mainly less than additive effects among binary, ternary and seven 
compound mixtures of B[a]P, Pyr, Phe and Nap. Hence, the results from this chapter adds 
new knowledge towards understanding chemical risk assessment of mixture effects.  
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Chapter 6 Development of a modified QuEChERS method for the simultaneous 
analysis of PAHs and OH-PAHs in soil  
Abstract 
An efficient and selective method based on the QuEChERS (Quick, Easy, Cheap, 
Effective, Rugged and Safe) approach for the quantitative determination of polycyclic 
aromatic hydrocarbons (PAHs) and their monohydroxylated metabolites (OH-PAHs) in 
soils by concurrent use of gas chromatography triple quadrupole mass spectrometry (GC-
QqQ-MS/MS) and Q-Orbitrap-LC/MS has been developed and validated. The optimised 
method provides reliable results with high sample throughput, has low solvent 
consumption, requires little labour and covers the target analytes with varying 
physicochemical properties and log Kow ranges from 2.7 – 6.13. The method was validated 
using certified reference material (i.e. industrial soil, BCR® 524) and through the evaluation 
of spike recovery experiments (i.e. using seven contrasting soil types), matrix effects, 
linearity, precision and the limits of detection. Mean recoveries of spiked samples (n = 10) 
were between 76 – 120 % with relative standard deviation (RSD) in a range of 1 – 18 %. 
The LODs depending on the analyte were in a range of 0.2 – 10 ng g-1. The 
chromatographic conditions used in this study allowed the separation of all analytes in less 
than 20 min. The optimised method was successfully applied on field contaminated 
samples from former manufactured gasworks sites and undisclosed industrial sites, with a 
range of PAHs found in these soil samples. The elevated concentration of benzo[a]pyrene 
found in field contaminated soil was above the acceptable Health Investigation Level A 
(HIL A), a guideline value set by the Australian National Environment Protection Measure 
(NEPM) for the assessment of contaminated sites. 
 
Keywords: QuEChERS, polycyclic aromatic hydrocarbons, monohydroxilated PAHs, GC-
QqQ-MSMS, Soil, Health Investigation Levels  
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6.1 Introduction 
Polycyclic aromatic hydrocarbons (PAHs) are a group of several hundred chemically 
related compounds that are formed during the incomplete combustion of organic matter 
which may be originating from natural (e.g. forest fires or volcanic eruptions) or 
anthropogenic (i.e. burning of coal, oil, wood and vehicle exhaust) sources (Cvetkovic et 
al., 2016; Abdel-Shafy and Mansour, 2016; Kaushik and Haritash, 2006). PAHs are 
comprised of two or more benzene rings bonded in linear, cluster, or angular 
arrangements (Di Toro et al., 2000). In general, PAHs with two to three rings are classified 
as low molecular weight PAHs and are frequently in the gaseous phase, whereas high 
molecular weight PAHs with five rings or more are largely bound to particles (Re-Poppi 
and Santiago-Silva, 2005). The intermediate molecular weight PAHs (i.e. four rings) are 
partitioned between the gaseous and particulate phases, depending on the atmospheric 
temperature (Ohura et al., 2004).  
 
As organic pollutants, PAHs are ubiquitous and are found at both trace and elevated 
concentrations in soil, water, air and living organisms (Lal et al., 2009; Douabul et al., 
1997). The United States Environmental Protection Agency (US EPA) has listed 16 PAHs 
as priority pollutants for monitoring in the environment and biota due to their wide 
occurrence, toxicity, mutagenic and carcinogenic characteristics (Jahin et al., 2009). 
Human exposure to PAHs can be through a number of different pathways such as dermal 
contact, inhalation and through consumption of food or incidental ingestion of 
contaminated soil and dust (Lal et al., 2015). Soil plays a significant role in controlling the 
potential bioavailability of contaminants in the environment (Wijayawardena et al., 2015). 
One of the most significant sources of PAHs for humans is soil, wherefrom they can reach 
air, water and food (Cvetkovic et al., 2016).  
 
Most often soil properties such as organic matter and clay content may relate to the 
degree to which PAHs are retained within the soil as well its physico-chemical properties 
(US EPA, 2007). Similarly, the octanol–water partitioning coefficient of PAHs is important 
in determining the sorption of PAHs to soils (Abdel-Shafy and Mansour, 2016). As organic 
compounds, PAHs have an affinity to bind to soil and over time degrade from natural 
attenuation or microbial metabolism (Al-Turki, 2009). However, in some soils 
microorganisms are unable to completely degrade PAHs and over a period of time 
concentrations of polar hydroxylated metabolites (OH-PAHs) may accumulate in soil 
(Avagyan et al., 2015). Human exposure to hydroxylated metabolites of PAHs is of 
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concern because some OH-PAHs have been shown to be more toxic and carcinogenic 
than PAHs (Motorykin et al., 2015). It is noteworthy that there is little information in 
published literature on OH-PAH levels in soil in comparison to PAHs and the oxy- and 
nitro-substituted PAHs (Avagyan et al., 2015). Significantly, soil-pica behaviour or 
incidental exposure to PAH contaminated soils especially in children due to their hand-to-
mouth contact presents a risk to human health (Van de Wiele et al., 2005). The US EPA 
has regulatory limit of 85 – 135 mg/day for ingestion of soil and indoor dust for children in 
the age group 6 months – 6 years (US EPA, 2011). In Australia restrictive legislations such 
as the National Environment Protection Measure (NEPM) is in place to regulate the 
presence of contaminants including PAHs in soils at various land-use which may pose a 
risk to human health (Juhasz et al., 2015). The use of analytical methods to quantify 
individual or total PAH concentrations in soils is useful in tier 2 risk assessment. In 
published literature, there is a wide range of analytical methods for sensitive determination 
of PAHs in soils. Soxhlet extraction is widely used as a standard analytical procedure for 
analysis of PAHs in soils. It is useful with a range of extraction solvents and reflux cycles 
with PAH recoveries from 84 – 100 % (Lau et al., 2010). However, it requires large 
volumes of solvents and is time consuming in achieving considerable extraction 
efficiencies. Ultrasonic extraction provides comparable recoveries for PAHs with more 
than 4 rings, but relatively low recoveries (44 – 76 %) for low molecular weight PAHs, 
including Nap and Phe (Lau et al., 2010). Accelerated solvent extraction (ASE) is mainly 
used in commercial applications and its advantages include low solvent use, high PAH 
recoveries with standard deviations of less than 10 % (Liguori et al., 2006). Microwave 
assisted extraction (MAE) is another highly instrumental extraction technique used in the 
extraction of PAHs in soils with PAH recoveries being comparable to soxhlet extraction 
(Zhang et al., 2000).  
 
Notably, most of these analytical techniques focus on PAHs as the target compounds 
whilst their metabolites which are often more toxic are not measured. In 2003, a 
QuEChERS (Quick, Easy, Cheap, Effective, Rugged and Safe) approach was introduced 
and over the past decade it has become one of the most widely used analytical techniques 
in research and commercial applications. The QuEChERS procedure was first applied in 
the analysis of pesticide residues in fruits and vegetables (Anastassiades et al., 2003). Its 
first application in soil matrix was also in the analysis of pesticide residues (Lesueur et al., 
2008). A modified version of QuEChERS procedure was applied in the analysis of PAHs in 
soil with recoveries of 80 - 110 % (Cvetkovic et al., 2016). The ability of QuEChERS 
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approach to accommodate extraction of a broad range of chemical compounds can be 
useful in analysis of both parent compounds and transformation products. It can also be 
used in screening large batches of samples as it is cost effective.  
 
This study demonstrates for the first time the use of a QuEChERS based approach in the 
co-analysis of parent PAHs and its mono-hydroxilated metabolites (OH-PAHs) in soil using 
a combination of a GC-QqQ-MS/MS and a Q-Orbitrap LC/MS. A total of 4 PAHs from the 
US-EPA list and 8 commercially available OH-PAHs were investigated in this study. The 
validated method is applied to analysis of field contaminated soil samples from former 
manufactured gasworks sites and it has been proved suitable for further use.  
 
6.2 Materials and methodology 
6.2.1 Chemicals and reagents 
For reference, the list of general laboratory chemicals and pure standards used in soil 
extraction, sample clean-up and analysis of PAHs and OH-PAHs are found in Chapter 3 
(see Table 3.1, Table 3.2 and Table 3.3).  
 
6.2.2  Stock solutions and calibration standards 
For reference, details on preparation and storage of stock solutions and calibration 
standards for PAHs and OH-PAHs are found in Chapter 3 (see Section 3.5).  
 
6.2.3 Materials  
For reference, the lists of general laboratory materials and kits used in experiments in 
Chapter 6 of this thesis are found in Chapter 3 (see Section 3.2).  
 
6.2.4 Instrumentation and chromatographic conditions 
Please refer to the details on instrumentation and chromatographic conditions in Chapter 3 
(see Sections 3.3 and 3.4).  
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6.2.5 Soil sampling 
Seven soil types varying in their physicochemical properties were sourced from unpolluted 
areas from sampling sites located in states of South Australia and Victoria, Australia (see 
Figure 3.1; Chapter 3).  These samples were used for blank and spike sample preparation. 
Protocols for sample collection and pre-treatment (i.e. drying and sieving) are found in 
Chapter 3 of general materials and methodology in Section 3.6. Physicochemical 
parameters for the seven soil types are listed in Table 3.6.  
 
6.2.6 Optimised sample preparation 
Optimised sample preparation is shown in Figure 3.2 of Chapter 3. Weighed soil samples 
(100 mg) were spiked with 70 µL of Milli-Q water plus PAHs and OH-PAHs recovery 
standards before extraction using n-hexane: acetone (1:1, v/v). Two different extraction 
schemes were tested as part of optimised sample preparation. The procedures were 
evaluated through the recovery of compounds. Recovery studies for optimisation of 
sample preparation were conducted at one spike level only (i.e. PAHs at 100 ng and OH-
PAHs at 50ng). Samples were analysed in replicates (n = 5). In preliminary experiments 
different extraction volumes and extraction times were tested using seven different soil 
types and a reduced mass of the QuEChERS extraction salt (i.e. AOAC 2007.01 from 
Agilent Technologies). In the first preliminary test (Experiment 1) spiked soil samples were 
processed using 4 mL of extraction solvent n-hexane: acetone (1:1, v/v) and an extraction 
time of 1 min. In the second experiment (Experiment 2), spiked soil samples were 
processed by a set of two extractions using the same solvent combination and final 
volume, but with a total extraction time of 4 min. Two mini-ceramic homogenisers were 
added to each tube before extraction. The sample optimisation experiments were 
performed in triplicate.  
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6.2.7 Extraction and measurement of PAHs and OH-PAHs in soil 
An overview of chemical extraction, clean-up and analysis of PAHs and OH-PAHs in soil is 
presented as a schematic flow chart in Section 3.9 (see Figure 3.2). The following 
describes the extraction, isolation and measurement of PAHs and OH-PAHs in soil.  
 
Analysis of PAHs in soil using GC-QqQ-MS/MS 
A 2 mL aliquot of acetone: hexane (v/v) was added to the 10 mL centrifuge tube containing 
the soil sample (100 mg) and two mini-ceramic homogenisers. The tubes were vortexed 
for 2 min and subsequently centrifuged at 3,000 x g for 10 min. The supernatant of the first 
extract was quantitatively transferred to a clean 10 mL centrifuge tube containing 
approximately 0.2 g QuEChERS extraction salt (containing Mg2SO4 and sodium acetate). 
Extraction was repeated with another 2 mL aliquot of acetone: hexane (v/v) and the 
supernatant was quantitatively transferred to the extraction tube containing the first 
extract. The combined extracts was shaken and vortexed for 2 min, then centrifuged at 
3,000 x g for 10 min. However, following the AOAC 2007.01 QuEChERS approach, a 
clean-up step was introduced by quantitatively transferring the extract to the QuEChERS 
dispersive solid phase extraction (d-SPE) tube, which contains Mg2SO4/PSA/C18. At this 
point PAH internal standard (i.e. isotopically labelled PAHs at 200 ng mL-1 final 
concentration) were added and the d-SPE tube was vortexed for 30 s and subsequently 
centrifuged at 16,000 x g for 5 min. The tubes were kept overnight at -20 oC to freeze out 
remaining fat, before a total of 100 µL of extract is transferred into an amber vial with an 
insert. The final extracts are analysed for PAHs by GC-QqQ-MS/MS. 
  
Analysis of OH-PAHs in soil using GC-QqQ-MS/MS 
To analyse for OH-PAHs, 980 µL of the extract and 20 µL labelled internal standards (e.g. 
isotopically labelled OH-PAHs at 50 ng mL-1 final concentration) were quantitatively 
transferred to a d-SPE amber vial and contents vortexed for 30 s. Subsequently, the 
contents were centrifuged at 16,000 x g for 5 min. To freeze out remaining fat, the tubes 
were kept overnight at -20 oC. For derivatisation of OH-PAHs, 100 µL of clean extract was 
quantitatively transferred into an amber vial and reduced to dryness using a gentle stream 
of high purity nitrogen gas and temperature of 37 oC. A 25 µL aliquot of BSTFA was added 
into the vial and after capping the contents were vortexed for 30 s. The vial was incubated 
at a temperature of 70 oC for 60 min, mixing the content in between by using a vortex. 
Notably, the minimum amount of derivatisation reagent and optimum conditions required 
for derivatisation of PAH metabolites are shown in Figure 4.2 – Figure 4.4 of Chapter 4. 
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The remaining BSTFA was then removed by gently drying the contents under high purity 
nitrogen gas and reconstituting the contents using 100 µL of hexane. Final extracts were 
analysed for OH-PAHs (except 3-OH B[a]P) using a GC-QqQ-MS/MS (Agilent 
Technologies 7890A, USA).  
 
Analysis of 3-OH B[a]P in soil using Q-Orbitrap-LC-MS 
Prior to instrument analysis of 3-OH B[a]P, final extracts were reduced under high purity 
nitrogen gas to dryness and then reconstituted in 100 µL of MeOH (avoiding the 
derivatization step). For determining 3-OH B[a]P, samples were analysed using an Q-
Orbitrap-LC/MS (Thermo Scientific Q-ExactiveTM, USA).  
 
6.2.8 Validation procedure 
The optimised method was validated for recovery, linearity, limit of detection and precision 
as outlined in Section 4.2.6 of Chapter 4. The accuracy of the analytical method was 
evaluated through recovery studies using a certified reference material (i.e. industrial soil, 
BCR® 524).  
 
6.2.9 Statistical analysis 
Data was analysed using various statistical methods. The Grubb’s test was used to 
eliminate outliers in data. Data were reported as the mean (μ) ± standard deviation (σ) 
from replicate analysis. The statistical difference between μ values was tested using 
paired Student's t-test. Linear regressions were performed to analyse the relationship 
between analyte recovery and soil physico-chemical properties. Goodness of fit (R2) of 
more than 0.5 and significance (p value) were used as indicators of the correlation 
efficiency between different soil properties and analyte recovery. Data was compared for 
differences in means using one way ANOVA and Tukey test for multiple correlations. A 
probability of p < 0.05 was considered as statistically significant. Statistical analysis were 
done using Prism 7 (Graphpad Software, La Jolla California, USA). 
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6.3 Results and discussions 
6.3.1 Development and optimisation of the chromatographic conditions 
Details for the optimisation of the chromatographic conditions for a GC-QqQ-MS/MS and a 
Q-Orbitrap-LC/MS are found in Section 4.3.1 of Chapter 4.  
 
6.3.2  Extraction procedure 
A QuEChERS based method was applied to sample preparation in this study. The 
QuEChERS approach has several advantages over most of the traditional extraction 
techniques such as high recoveries for organic compounds with varying polarity and 
volatility, low solvent usage and high sample throughput (Lehotay et al., 2010). In this 
study a number of parameters were investigated to optimise the performance of the 
QuEChERS based extraction procedure. These included; sample size, volume of the 
extraction solvents, use of QuEChERS extraction salts, addition of mini-ceramic 
homogenizers, compound derivatisation and extraction time.  
 
Sample preparation optimisation   
Soils samples were sieved to achieve < 250 µm particle size. The mass of soil used is 
similar to studies testing organic contaminants in soil or dust particles (He et al., 2017) and 
is within the US EPA regulatory limit for ingestion of soil or household dust by children (US 
EPA, 2013). The particle size of < 250 µm is similar to recent studies on PAHs in soil using 
a QuEChERS procedure (Cvetkovic et al., 2016). The soils in the current study were 
spiked and homogenised according to the spiking procedure in Section 3.6 of Chapter 3. 
All spiked soil samples were processed by two different extraction schemes as part of 
optimised sample preparation. In preliminary Experiment 1 soil samples were extracted 
using 4 mL of n-hexane: acetone (1:1, v/v) for 1 min. While in Experiment 2 soil samples 
were extracted twice, each time with 2 mL of n-hexane: acetone (1:1, v/v) and an 
extraction time of 2 min. In both extraction scheme two mini-ceramic homogenisers were 
added to each tube for extractions to be evaluated with homogenisers. The addition of the 
mini-ceramic homogenisers did not have a significant effect on analyte recovery (p > 0.05), 
however, a better degree of homogenisation by preventing the agglomeration of soil was 
observed (supplementary material, Table S6.1). After addition and vigorous shaking with 
QuEChERS extraction salt, the contents were vortexed then centrifuged at 3000 x g for 10 
min. In each case sample extracts were quantitatively transferred to a d-SPE tube for 
clean-up. Following further processing (as shown in Figure 3.2 of Chapter 3), PAH and 
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OH-PAHs recoveries were calculated based on analysis by GC-QqQ-MS/MS or Q-
Orbitrap-LC/MS. Based on the measured recovery of PAHs and OH-PAHs, the second 
extraction scheme (Experiment 2) was acceptable for this study (Table 6.1).  
 
Extraction solvent and QuEChERS content  
For the extraction of both parent compound and its metabolites, the selection of an 
appropriate solvent is a crucial step in method development. Notably, acetonitrile is used 
in the original QuEChERS approach for the extraction of pesticides in fruits and 
vegetables (Anastassiades et al., 2003), however the use of dichloromethane – hexane 
(1:1, v/v), hexane: acetone (1:1, v/v), methanol and dichloromethane has been reported 
for the extraction of PAHs and OH-PAHs from soil (Avagyan et al., 2015; Pena et al., 
2007). At low solvent volumes, the use of n-hexane: acetone (1:1, v/v) as an extraction 
solvent was found to be the most effective in removal of PAHs from soil (Pena et al., 
2007).  Similarly n-hexane: acetone (1:1, v/v) mixture showed to be an efficient solvent 
system for the extraction of different pollutants from environmental samples (EPA, 
2000).The use of solvents such as ethyl acetate, acetone and methanol have also been 
suggested for use with the QuEChERS technique based on the nature of organic 
compounds to be extracted and sample type (Lehotay, 2011).  
 
In preliminary studies of the present work, acceptable recoveries of PAHs and OH-PAHs 
were achieved using a set of two extractions with n-hexane: acetone (1:1, v/v) and a 
reduced mass of QuEChERS extraction salt (i.e. 0.2 g for 100 mg sample size). The use 
of a higher amount of extraction salts has been reported to reduce the volume of 
supernatant (Plassmann et al., 2015). As can be seen in Table 6.1, the best recoveries for 
B[a]P and OH-PAHs in the current study were obtained after two extractions using 2 mL of 
n-hexane: acetone (1:1, v/v). By comparison, B[a]P and OH-PAHs had lower recoveries 
when extracted only once with 4 mL of n-hexane: acetone. Further, the sample extracts 
from the solvent combination of n-hexane: acetone (1:1, v/v) gave a clean 
chromatographic profile, were easily removed by evaporation and provided satisfactory 
recovery in the 76 – 120 % range for all the PAHs and OH-PAHs in this study.  
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Table 6.1 Recovery data obtained with GC-QqQ-MS/MS and Q-Orbitrap-LC/MS methods for analysis of PAHs and OH-PAHs 
spiked in variant soils 
 
Compounda 
 
 
PBA 
Rec {%} 
 
 
 
RSD {%} 
 
 
DUA 
Rec {%} 
 
 
 
RSD {%} 
 
 
WRA 
Rec {%} 
 
 
 
RSD {%} 
Soil type 
 
MIA 
Rec {%} 
 
 
 
RSD {%} 
 
 
TAA 
Rec {%} 
 
 
 
RSD {%} 
 
 
KBA 
Rec {%} 
 
 
 
RSD {%} 
 
 
MGA 
Rec {%} 
 
 
 
RSD {%} 
PAHs               
               
Nap 82 (78) 6 (2) 88 (67) 7 (4) 76 (57) 4 (1) 77 (70) 5 (4) 76 (70) 6 (2) 75 (66) 9 (4) 75 (56) 5 (2) 
Phe 101 (85) 8 (5) 120 (86) 6 (2) 77 (58) 7 (2) 80 (68) 7 (5) 78 (58) 4 (2) 75 (57) 12 (7) 75 (57) 8 (5) 
Pyr 92 (83) 4 (1) 94 (75) 11 (7) 82 (77) 7 (2) 86 (66) 8 (2) 85 (66) 9 (5) 80 (72) 10 (6) 77 (65) 6 (5) 
B[a]P 90 (77) 5 (4) 97 (80) 2 (2) 80 (67) 6 (5) 90 (84) 5 (2) 85 (70) 5 (6) 80 (77) 7 (4) 78 (58) 7 (4) 
               
OH-PAHs               
               
1-OH Nap 77 (60) 10 (7) 82 (64) 5 (2) 82 (70) 18 (8) 80 (62) 10 (7) 80 (66) 6 (4) 77 (62) 12 (7) 77 (60) 12 (7) 
2-OH Nap 78 (62) 7 (5) 88 (69) 5 (2) 75 (57) 6 (2) 77 (59) 6 (5) 76 (58) 5 (4) 75 (58) 16 (10) 75 (60) 16 (10) 
1-OH Phe 75 (55) 12 (8) 79 (66) 8 (5) 80 (62) 9 (4) 83 (70) 9 (5) 82 (66) 8 (3) 77 (59) 6 (2) 75 (55) 9 (5) 
2-OH Phe 79 (60) 8 (3) 80 (72) 9 (5) 77 (58) 10 (4) 77 (70) 9 (5) 75 (67) 10 (7) 75 (60) 11 (4) 76 (58) 9 (5) 
3-OH Phe 82 (66) 12 (7) 78 (57) 11 (7) 77 (65) 10 (5) 80 (75) 11 (2) 79 (67) 6 (5) 77 (60) 7 (2) 76 (59) 11 (6) 
4-OH Phe 88 (72) 15 (7) 90 (82) 7 (4) 80 (67) 7 (2) 80 (67) 9 (3) 80 (77) 7 (5) 80 (75) 8 (5) 80 (60) 11 (8) 
1-OH Pyr 75 (57) 12 (6) 80 (69) 4 (2) 76 (66) 7 (3) 82 (66) 7 (5) 78 (72) 7 (4) 77 (70) 11 (6) 76 (60) 4 (2) 
3-OH B[a]P 80 (69) 10 (4) 80 (72) 2 (2) 75 (70) 6 (3) 75 (66) 6 (5) 75 (58) 6 (5) 75 (58) 10 (4) 77 (57) 10 (6) 
               
a Nap, Naphthalene; Phe, Phenanthrene; Pyr, Pyrene; B[a]P, Benzo[a]pyrene; 1-OH Nap, 1-hydroxynaphthalene; 2-OH Nap, 2-
hydroxynaphthalene; 1-OH Phe, 1-hydroxyphenanthrene; 2-OH Phe, 2-hydroxyphenanthrene; 3-OH Phe, 3-hydroxyphenanthrene; 4-OH 
Phe, 4-hydroxyphenanthrene; 1-OH Pyr; 1-hydroxypyrene; 3-OH B[a]P, 3-hydroxybenzo[a]pyrene. The recovery {%} and relative 
standard deviation {% RSD} is based on replicate analysis (n = 3). Values in ( ) represent 1 min extraction scheme in preliminary sample 
optimisation experiments.  
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Extraction time 
The influence of the extraction time was studied for soil matrix using solvent n-hexane: 
acetone (1:1, v/v). Lower recoveries were obtained for PAHs and OH-PAHs in the 55 – 86 
% range using an extraction time of 1 min as in the original QuEChERS method 
(Anastassiades et al., 2003). Recoveries improved for both PAHs and OH-PAHs up to 20 
% when the extraction time was increased from 1 to 4 min (e.g. twice extracted with 2 min 
for each extraction). Based on the results obtained in this present study, replicate solvent 
extraction using n-hexane: acetone (1:1, v/v) with a slightly longer extraction time are a 
promising option that can be adopted for a QuEChERS based extraction procedure. 
 
Derivatisation protocol 
N,O-Bis(trimethylsily)trifluroacetammide (BSTFA) as the silylating agent was effective in 
forming the trimethyl silyl derivatives ([Si(CH3)3OPAH]+.) for all OH-PAHs in this study at 
an incubation time of 60 min at 70 0C. Details of all experiments in the optimisation of the 
derivatisation protocol is found in Section 4.3.2 of Chapter 4.  
 
Application to different soils 
The modified QuEChERS procedure was applied to seven soils with different 
physicochemical properties (Table 3.6; Chapter 3). Tests were performed using the 
optimised procedure and the highest recoveries of PAHs and OH-PAHs were between 88 
– 120 %. As seen in Table 6.2, soil properties influencing recoveries of PAHs were found 
to be in the order; sand > silt > CEC > TOC > clay. Low PAH recoveries were correlated to 
high TOC (%) and clay (%) content in soils (Table 6.2), hence the difficulty to extract such 
analytes could be due to their interactions with soil organic matter. For OH-PAHs, soil 
properties influencing their recoveries were found to be in the order; sand > clay > silt > 
TOC > DOC. Overall, acceptable recoveries were good for PAHs, but less so for OH-
PAHs in all seven soil types using the optimised procedure shown in Figure 3.2 of Chapter 
3.  
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Table 6.2 Relationships (goodness of fit, R2) between % recoveries of PAHs and OH-PAHs and selected soil physico-chemical 
properties 
 
Compounda 
Soil properties 
TOC 
R2 
 
p  
Clay  
R2 
 
p  
Silt 
R2 
 
p 
Sand 
R2 
 
p  
TC 
R2 
 
p 
TN 
R2 
 
p  
CEC 
R2 
 
p  
DOC 
R2 
 
p  
PAHs                 
                 
Nap 0.61 0.04 0.60 0.06 0.87 0.01 0.94 0.001 0.54 0.06 0.50 0.07 0.67 0.02 0.30 0.02 
Phe 0.55 0.06 0.64 0.05 0.80 0.01 0.99 0.0001 0.49 0.08 0.44 0.10 0.68 0.02 0.26 0.02 
Pyr 0.57 0.05 0.50 0.10 0.88 0.01 0.90 0.003 0.59 0.04 0.39 0.13 0.81 0.01 0.34 0.01 
B[a]P 0.61 0.04 0.65 0.05 0.84 0.01 0.99 0.0001 0.60 0.04 0.51 0.07 0.74 0.01 0.31 0.01 
                 
OH-PAHs                 
                 
1-OH Nap 0.72 0.02 0.01 0.75 0.01 0.74 0.01 0.789 0.75 0.01 0.73 0.01 0.13 0.43 0.65 0.43 
2-OH Nap 0.66 0.03 0.55 0.07 0.95 0.00 0.81 0.013 0.60 0.04 0.63 0.03 0.62 0.04 0.26 0.04 
1-OH Phe 0.19 0.34 0.22 0.29 0.16 0.35 0.16 0.351 0.29 0.21 0.21 0.30 0.03 0.69 0.16 0.69 
2-OH Phe 0.58 0.05 0.64 0.05 0.95 0.00 0.91 0.003 0.42 0.12 0.49 0.08 0.37 0.15 0.48 0.15 
3-OH Phe 0.04 0.66 0.95 0.00 0.43 0.13 0.59 0.063 0.07 0.58 0.00 0.92 0.29 0.21 0.07 0.21 
4-OH Phe 0.38 0.14 0.80 0.01 0.60 0.06 0.79 0.015 0.32 0.18 0.27 0.24 0.61 0.04 0.18 0.04 
1-OH Pyr 0.25 0.25 0.87 0.01 0.77 0.02 0.80 0.014 0.25 0.25 0.36 0.16 0.09 0.52 0.07 0.52 
3-OH B[a]P 0.16 0.37 0.90 0.003 0.39 0.15 0.53 0.082 0.11 0.46 0.10 0.49 0.39 0.13 0.10 0.13 
                 
a Nap, Naphthalene; Phe, Phenanthrene; Pyr, Pyrene; B[a]P, Benzo[a]pyrene; 1-OH Nap, 1-hydroxynaphthalene; 2-OH Nap, 2-
hydroxynaphthalene; 1-OH Phe, 1-hydroxyphenanthrene; 2-OH Phe, 2-hydroxyphenanthrene; 3-OH Phe, 3-hydroxyphenanthrene; 4-OH 
Phe, 4-hydroxyphenanthrene; 1-OH Pyr; 1-hydroxypyrene; 3-OH B[a]P, 3-hydroxybenzo[a]pyrene. The R2 and p values obtained are 
based on replicate analysis of samples (n = 3).  
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6.3.3 Method performance 
Please refer to method performance parameters in Chapter 4. The validation results were 
obtained from several different soils from spike recovery experiments, certified reference 
material and using reagent and procedural blank samples. Validation data are presented 
in Table 6.3 and Table 6.4.  
 
Linearity 
The analyte/IS response ratio was linear from 0.1 to 1000 ng mL-1 in soil matrix. Linearity 
was assessed using a least-squares regression line calculated from all standard 
concentrations and expressed by the determination coefficient (R2). In addition, the R2 
value was greater than 0.995 for each analyte in this study. The linearity was based on the 
calibration of the PAHs and OH-PAHs supplemented in the matrix itself. Matrix blank were 
tested for background residues of PAHs and OH-PAHs, the solvent calibration standards 
were used as an alternative when high concentrations of compounds were found in the 
matrix.   
 
Recoveries 
For recovery experiments, soil matrix were spiked at spike level of 100 ng for PAHs and 
50 ng for OH-PAHs. The PAHs and OH-PAHs investigated in this study presented 
recoveries between 76 – 120 % and a relative standard deviation in 1 - 18 % range (n = 5). 
The optimised methodology was applied to the analysis of certified reference material 
BCR® 524 (contaminated industrial soil), with excellent results for recovery of PAHs (Table 
6.4). Based on the acceptable recoveries and precision for spike experiment, this method 
could be applied to extract a broad range of chemicals as the PAHs and OH-PAHs 
analysed in this study covered log Kow values between 2.7 – 6.13 and a range of physico-
chemical properties. 
  
Limits of detection  
Sensitivity was evaluated by the limit of detection (LOD). The LODs for the analytes were 
in the range of 0.2 - 10 ng g-1, depending on the specific compound of interest.  
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Precision 
Intra-day precision was assessed by analysing replicate samples (n = 5) on the same day, 
while the inter-day precision was assessed over 3 days. The RSD for intra- and inter-day 
were between 1 – 12 %, and 4 – 18 %, respectively (shown in Table 6.3). There was an 
overall good agreement between spiked and measured concentration where all data were 
within ± 20% of the certified values of the soil certified reference material (BCR® 524). 
These values demonstrated good accuracy and reproducibility of the method. 
 
Matrix effect 
Matrix effects (ME) in variant soil types can lead to a significant enhancement or 
suppression of the analyte response in the detector due to the presence of interfering 
matrix components which could co-elute with the analyte of interest. According to Baduel 
et al. (2015), matrix co-extractives in GC-MS/MS mainly cause signal enhancement, 
whereas signal suppression is typically observed in LC/MS applications. An evaluation of 
ME was conducted in order to assess their effect on compound quantification in this study. 
One way to evaluate the ME is through the comparison of the slopes obtained in the 
calibration with matrix matched-standards with those obtained in calibration with standards 
prepared in the solvent (Romero-Gonzalez et al., 2011). Values of ME are presented in 
the validation Table 6.3. In GC-QqQ-MS/MS, the ME was found to be up to 5 % for PAHs 
and lower than 10 % for OH-PAHs in soil. For Q-Orbitrap-LC/MS, the ME for 3-OH B[a]P 
was less than 2 %. Overall, no significant ME was observed for PAHs and OH-PAHs 
analysed by GC-QqQ-MS/MS or Q-Orbitrap-LC/MS. In this study, matrix-matched 
calibration were used to improve the accuracy of analyte quantification for both GC-QqQ-
MS/MS and Q-Orbitrap-LC/MS analysis. 
 
Quality control  
Both reagent blank and procedural blank samples were included as part of the method 
quality control. All sample analysis were done in replicates. Extraction of samples was 
repeated when recoveries of spiked PAH and OH-PAH standards were out of the method 
validation range of 76 % to 120 % (RSD < 18 %). Isotopically labelled internal standards 
were used for analyte identification in GC-QqQ-MS/MS and Q-Orbitrap-LC/MS analysis 
due to their similar physicochemical characteristics to the analyte. The internal standard 
peak area was acceptable when the response was within acceptable RSD of 20 %. A 
certified reference material (i.e. industrial soil – BCR® 524) was used in the quality control 
and assessment of method performance.  
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Table 6.3 Validation data obtained with GC-QqQ-MS/MS and Q-Orbitrap-LC-MS methods for analysis of PAHs and OH-PAHs in 
spiked soil 
Compounda Recovery# 
(%) 
 
RSD  
(%) 
 
Range  
(ng g-1) 
Linearity  
(R2) 
LOD  
(ng g-1) 
MEd  
(%) 
Intra-dayb  
(%) 
 
Inter-dayc 
(%) 
 
PAHs         
         
Nap 89 5 2 – 890 0.995 2 1 10 12 
Phe 120 7 10 - 1050  0.997 10 5 8 12 
Pyr 98 10 2 - 950 0.999 2 4 6 8 
B[a]P 96 5 5 - 960 0.999 5 2 6 7 
         
OH-PAHs         
         
1-OH Nap 86 10 0.2 – 420 0.995 0.2 8 7 11 
2-OH Nap 84 4 0.2 – 420 0.995 0.2 4 12 15 
1-OH Phe 79 6 0.5 – 390 0.995 0.5 5 10 12 
2-OH Phe 75 15 0.5 – 390 0.996 0.5 5 9 15 
3-OH Phe 82 11 0.5 – 420 0.996 0.5 10 8 15 
4-OH Phe 80 12 0.2 – 435 0.999 0.2 6 10 9 
1-OH Pyr 86 15 0.2 – 450 0.999 0.2 2 10 18 
3-OH B[a]P 84 15 0.5 – 445 0.995 0.5 1 1 4 
a Nap, Naphthalene; Phe, Phenanthrene; Pyr, Pyrene; B[a]P, Benzo[a]pyrene; 1-OH Nap, 1-hydroxynaphthalene; 2-OH Nap, 2-
hydroxynaphthalene; 1-OH Phe, 1-hydroxyphenanthrene; 2-OH Phe, 2-hydroxyphenanthrene; 3-OH Phe, 3-hydroxyphenanthrene; 4-OH 
Phe, 4-hydroxyphenanthrene; 1-OH Pyr; 1-hydroxypyrene; 3-OH B[a]P, 3-hydroxybenzo[a]pyrene. bIntra-day (n = 5)  and cinter-day (n = 
5) variability (RSD %) were determined on samples supplemented at 100 ng per 100 mg of soil for all PAHs and 50 ng per 100 mg of soil 
for all OH-PAHs. #Recovery (n = 10) was evaluated by supplemented soil samples at concentrations (PAHs; 100 ng per 100 mg of soil 
and OH-PAHs; 50 ng per 100 mg of soil) and certified reference material (soil); dMatrix effect (ME) was determined by comparing the 
same samples as in footnote # supplemented with PAHs and OH-PAHs with the same concentrations of PAH or OH-PAH in standard 
solutions. 
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Table 6.4 Validation data obtained with GC-QqQ-MS/MS method for analysis of PAHs in certified reference material (BCR® 524) 
Compounda Certified value 
(mg Kg-1) 
 
Uncertainty  
(mg Kg-1) 
Range 
(mg Kg-1) 
 
 
Recovery 
(%) 
n = 10 
RSD  
(%) 
n = 10 
Intra-day  
(%) 
n = 5 
Inter-day  
(%) 
n = 5 
 
Phe 
 
980 
 
NA 940 – 982 90 1.5 1.5 2 
Pyr 173 11 165 – 181 95 2 2 3 
B[a]P 8.6 0.5 8.1 – 8.6  98 1.5 2.5 2 
aPhe, Phenanthrene; Pyr, Pyrene; B[a]P, Benzo[a]pyrene. 
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6.3.4 Method applicability 
The developed method was applied to the analysis of industrial soil samples that were 
obtained from within the vicinity of former manufacturing gasworks sites at Cootamundra, 
New South Wales (NSW) and undisclosed industrial sites. Real soil samples were 
characterised for their physicochemical properties before being processed though the 
validated method. A number of 16 EPA PAH compounds were detected and quantified in 
samples (Table 6.5). The concentrations of PAHs were found in a range of 0.5 – 103 mg 
Kg-1. Benzo[a]pyrene concentrations were found in the 3 – 103 mg Kg-1 range. Based on 
Australian HIL A, the minimum recommended level for B[a]P in soils for residential use 
(including children’s day care centres) is 3 mg Kg-1. Therefore, based on this guideline 
value the soils from former manufacturing gasworks sites and undisclosed sites in this 
study would require remediation if it is to be developed for residential use. The second 
most dominant PAH in terms of soil concentration was Pyr and was found in the 8.9 – 112 
mg Kg-1 range.  Concentrations of Phe in soil was in a range of 2.3 – 54.4 mg Kg-1, while 
Nap was found in lowest concentrations in a range of 0.5 – 3 mg Kg-1. Higher molecular 
weight PAHs such as B[a]P are less volatile and are mainly found associated to 
particulates (Re-Poppi and Santiago-Silva, 2005). Naphthalene is a very volatile PAH and 
is mainly associated to gaseous phase (Ohura et al., 2004). The results for high 
concentrations of B[a]P in Cootamundra site could relate to its association with soil 
particles and ageing of the PAHs in soil (i.e. considering gasworks sites were former 
industrial establishments).  The OH-PAHs could not be detected above the LOD in soils. 
Further investigations are required to understand the occurrence of OH-PAHs in soil. 
Avagyan et al (2015) highlighted that there is a lack of certified reference material for OH-
PAHs in soils and that the development of certified methods could significantly improve 
research in this area.  
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Table 6.5. Total concentrations of PAHs in soil samples from former gasworks site at Cootamundra and undisclosed industrial 
sites 
Compounda Gasworks sites 
 
Site 1  
(mg Kg-1) 
n = 3 
 
 
Site 2 
(mg Kg-1) 
n = 3 
 
 
Site 3 
(mg Kg-1) 
n = 3 
Undisclosed sites 
 
PB8 
(mg Kg-1) 
n = 3  
 
 
PB18 
(mg Kg-1) 
n = 3 
 
 
PB24 
(mg Kg-1) 
n = 3 
 
B[a]P 60±4.8 59±12 3±0.6 25.5±6.2 54.8±8.7 103±15.6 
Nap 3±0.6 2±0.6 1±0.4 0.5±0.1 0.88±0.2 0.45±0.1 
Phe 54.4±8.2 22.7±4.5 6.8±2.7 2.3±0.4 3.5±1.1 6.8±1.2 
Pyr 112.4±13.5 23.5±3.6 8.9±1.2 13.3±1.5 13±1.8 75.3±12 
a Nap, Naphthalene; Phe, Phenanthrene; Pyr, Pyrene; B[a]P, Benzo[a]pyrene. Sites 1,2 and 3 represent soil samples taken from within 
the vicinity of the former manufacturing gasworks site at Cootamundra, New South Wales in Australia. PB8, PB18 and PB24 represent 
soil samples from undisclosed industrial sites. 
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6.4 Conclusions 
This chapter reports the first analytical protocol in which a QuEChERS based method is 
used in the simultaneous determination of PAHs and their monohydroxylated metabolites 
(OH-PAHs) in soil. The different parameters that affect the analytical procedure such as 
the extraction, clean-up, separation, and derivatisation were studied. The modified 
QuEChERS method has been validated and allows a reliable determination of PAHs and 
OH-PAHs in soils by use of GC-QqQ-MS/MS and Q-Orbitrap-LC/MS. The additional 
derivatisation protocol significantly enhanced the selectivity and sensitivity of the GC-QqQ-
MS/MS to detect and quantify OH-PAH metabolites. Recoveries for all compounds of 
interest were in the range 76 % to 120 %. The method was then applied to a soil certified 
reference material, where a good agreement with certified and experimental results was 
found. Replicate analysis of the soil CRM indicated good accuracy and repeatability of this 
method. The suitability of the method for the determination of PAHs and OH-PAHs was 
demonstrated through the analysis of real samples. The analysis of the six real samples 
found a number of 16 EPA PAHs present in soils from a former manufacturing gasworks 
site and from undisclosed industrial sites. Notably, elevated concentration of B[a]P was 
found in all field contaminated soils at or above the acceptable health investigation levels 
for residential use. The results of this chapter show that the QuEChERS based method is 
versatile and can be used to study a range of organic compounds. The results also 
demonstrated that the method could be applied to different kinds of soils, and therefore it 
can be applied as a useful new tool in risk assessment studies investigating chemical 
bioavailability of PAHs and their metabolites. 
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Chapter 7  Use of Unified BARGE Method (UBM) to evaluate bioaccessibility of 
PAHs in contaminated soils 
 
Abstract 
 
The bioaccessibilities of naphthalene (Nap), phenanthrene (Phe), pyrene (Pyr) and 
benzo[a]pyrene (B[a]P) were studied using the Unified BARGE Method (UBM) in seven 
contrasting spiked-soils which were aged at ambient temperature for 7 days, 30 days and 
90 days, respectively. The effects of soil properties and ageing on the bioaccessibility of 
these contaminants were investigated. Interaction effects between the four PAHs and 
arsenic (As), cadmium (Cd) and lead (Pb) in binary and seven-compound mixtures on the 
amount of individual PAHs that solubilised from contaminated soil into the gastric and 
intestinal fluids were examined. The bioaccessibility of Nap, Phe, Pyr and B[a]P decreased 
over the ageing period and some soil properties were found to have a significant influence 
on the PAH bioaccessibility. Total organic carbon, clay and aluminium oxide were key 
parameters that decreased the bioaccessibilities of PAHs. Bioaccessibility of PAHs was 
higher in the gastrointestinal phase in comparison to the gastric phase. Phenanthrene 
bioaccessibility was the highest in all spiked soils. Bioaccessibility of Phe ranged from 0.2 
± 0.1 % to 15 ± 0.6 %. Benzo[a]pyrene bioaccessibility ranged from 0.2 ± 0.1 % to 5.1 ± 
1.8 %. No significant interaction effects was observed for Nap, Phe, Pyr and B[a]P while 
being solubilised during bioaccessibility measurement. Low range of bioaccessible B[a]P 
was found in soil from a former manufacturing gas plant sites (i.e. Site 1), undisclosed 
industrial sites (i.e. PB 8, PB 18 and PB 24) and soils used in a juvenile swine study (e.g. 
MTA and N). 
 
Key words: Bioaccessibility, benzo[a]pyrene, soil properties, ageing effect, mixed 
contamination, risk assessment 
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7.1 Introduction 
There is a growing concern over the types of pollutants present in our environment and 
their potential negative health effects on humans. Most of these pollutants eventually settle 
on soils, which can act as a reservoir for these contaminants. Land is a limited commodity 
and with an increasing human population and urban migration, the issues regarding the 
redevelopment of contaminated land and estimation of human health risks to 
contaminated soil is driving research on contaminant bioavailability through ingestion 
pathway. Ingestion of soil is considered a significant exposure route and hence represents 
a potential health risk, particularly if the soil is contaminated with a range of contaminants 
(Intawongese and Dean, 2006; Dean and Ma, 2007). Ingestion of soil can either be 
intentional (pica behaviour) or unintentional (consumption of contaminated food and water 
and hand-to-mouth exposure), in the latter exposure can occur via adherence of soil 
particles < 250µm fraction to hands (Ruby and Lowney, 2012). Children are particularly 
vulnerable due to their higher incidental ingestion rate via hand-to-mouth activities 
compared to that by adults (US EPA, 2011; Mielke et al., 1999). 
 
In the absence of site specific data, human health risk assessment is based on the 
assumption that 100 % of the total concentration of a contaminant in soil is absorbed 
through the gastrointestinal tract (i.e. 100 % bioavailability). Such a conservative approach 
may overestimate risks and increase the cost for clean-up of contaminated sites (Ng et al., 
2013). The gold standard is the use of in vivo models such as juvenile swine; a recent 
review describes a range of in vivo models that are available to assess contaminant 
bioavailability (Ng et al., 2015). However, in vivo testing on humans or animal surrogates 
can be expensive, time consuming and have stringent ethical requirements for approval. It 
is therefore not surprising that there have been considerable research efforts into 
development of in vitro testing protocols. A number of in vitro methods simulate 
physiological conditions of the human gastrointestinal tract, are comparatively cheaper 
and less time consuming than in vivo approaches and promote replacement, reduction 
and refinement of animal experiments under the so-called “3 R” animal ethics principles. 
These approaches quantify the portion of the contaminant that can be solubilised in a 
simulated human digestive system and becomes available for further absorption. This is 
referred to as bioaccessibility.  
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Bioaccessibility tests for inorganic compounds such as, Cd and Pb have been developed 
and validated against animal models to indicate their effectiveness in predicting in vivo 
bioavailability (Denys et al., 2012; Drexler and Brattin, 2007). To date, bioaccessibility 
measurements of organic contaminants are lacking validation through in vivo testing. In 
general, a number of bioaccessibility tests for PAHs have been reported. Both batch 
(Tilston et al., 2011; Cave et al., 2010; Tao et al., 2010; Gron et al., 2007; DIN, 2000) and 
dynamic model (Van de Wiele et al., 2004) have been used, but most studies simulate the 
human stomach and upper intestine (Cave et al., 2010; Gron et al., 2007; DIN, 2000) and 
the colon compartment (Tilston et al., 2011; Van de Wiele et al., 2004) in bioaccessibility 
assessment. Notably, some bioaccessibility tests include a food component (Cave et al., 
2010; DIN, 2000; Gron et al., 2007) such as lipids due to their effect on the extraction of 
PAHs (Harris et al., 2013). The use or absence of food component is referred to as the 
“fed” or the “fasted” state. Bioaccessibility of a PAHs can also be influenced by a number 
of soil properties such as total organic carbon (Hack and Selenka, 1996; Vasiluk et al., 
2007), silt and clay (Meyer et al., 2015; Duan et al., 2014) and black carbon (Meyer et al., 
2015). Further, the effect of ageing and weathering of soils is also reported to influence 
PAH absorption, hence bioaccessibility (Ruby et al., 2016).  
 
To date, studies have only focused on the bioaccessibility of a single PAH without 
considering the chemical interaction effects between PAHs in the human digestive system 
and how this may influence their bioaccessibility. Furthermore, there is an absence of 
studies reporting interaction effects between co-contaminated groups such as PAHs and 
metal/loids on bioavailability or bioaccessibility. There are also limited studies on PAH 
bioaccessibility in soils from the Australian continent. In this study, seven contrasting soil 
types were collected from South Australia and Victoria in Australia (Figure 3.1; Chapter 3). 
The soils were spiked with PAHs and metal/loids with the objective to investigate the 
influence of soil properties and compound interactions that reflect PAH bioaccessibility. 
This study provides new insight into effects of ageing and intrinsic soil properties on PAH 
bioaccessibility from the Australian environment. It also helps to understand the interaction 
effects between PAHs and metal/loids in a simulated human digestive system, which can 
be useful in chemical risk assessment.   
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7.2 Materials and methods  
7.2.1 Chemicals and reagents  
Please refer to Chapter 3 (Table 3.1, Table 3.2 and Table 3.3) for the lists of general 
laboratory chemicals, pure standards and culture medium used in cell culture and 
compound extraction, sample clean-up and analysis of PAHs and OH-PAHs.  
 
7.2.2  Stock solutions and calibration standards 
Please refer to Chapter 3; Section 3.5 for details on preparation and storage of stock 
solutions and calibration standards for PAHs and OH-PAHs.  
 
7.2.3 Materials  
Please see the lists of general laboratory materials and kits used in experiments in 
Chapter 3, Section 3.2.  
 
7.2.4 Instrumentation and chromatographic conditions 
Please refer to Chapter 3; Sections 3.3 and 3.4 for details on instrumentation and 
chromatographic conditions. Chapter 3; Table 3.4 lists the GC-QqQ-MS/MS settings for 
PAHs and OH-PAHs and labelled internal standards and Chapter 3; Table 3.5 lists in 
summary the Q-Orbitrap-LC/MS settings for 3OH-B[a]P and corresponding labelled 
internal standard. 
 
7.2.5 Soil sampling and characterisation 
Please refer to Chapter 3; Section 3.6 for details on background soil samples (n = 7). The 
following data on sample nomenclature and physicochemical parameters is for real soil 
samples (i.e. contaminated sites) and soil used in a “juvenile swine” study (Table 7.1 and 
Table 7.2).  
7.2.6       Soil spiking 
Please refer to Chapter 3; Sections 3.6 and 3.7 for preparation and spiking of the soils.  
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Table 7.1. Soil physico-chemical parameters for the Cootamundra gas plant site 
(Sites 1, 2 and 3) and soil from swine study (MTA and N) 
Soil code Site 1 
 
Site 2 
 
Site 3 
 
MTA 
 
N 
 
pH 5.77 6.55 6.85 5.1 7.1 
Clay (%) 5 20 - 21.2 5.7 
Silt (%) 10 17.1 - 16.8 6.7 
Sand (%) 85.8 62.93 - 61.9 87.6 
TC (%) 13.1 0.98 1.3 - - 
TN (%) 0.54 0.13 0.15 - - 
TOC (%) 12.8 0.96 1.3 7.5 1.71 
CEC (cm Kg-1) 6.75 11.23 6.82 6.37 9.44 
Fe oxide (g Kg-1) 11.93 18.9 16 - - 
Al oxide (g Kg-1)  20.98 19.68 23.8 - - 
Mn oxide (g Kg-1) 4.23 2.05 4.22 - - 
Where “-“ indicates not done. Site 1 = Cootamundra sample 1 (NSW); Site 2 = 
Cootamundra sample 2 (NSW); Site 3 = Cootamundra sample 3 (NSW); MTA = Mount 
Tamborine (QLD); N = Dublin (SA) 
 
 
 
7.2.7 Bioaccessibility measurement 
Total concentrations of PAHs spiked in the < 250 µm soil fraction was determined using a 
modified QuEChERS and dispersive solid phase extraction (d-SPE) protocol from 
Association of Analytical Chemists (AOAC) (Anastassiades et al., 2003) and gas 
chromatography with mass spectrometry (GC-QqQ-MS/MS). The Unified BARGE Method 
(UBM), a method simulating the physicochemical (physiological) conditions of human 
gastrointestinal tract is used to test for PAH bioaccessibility. A detailed procedure for UBM 
is published elsewhere (Denys et al., 2012; Cave et al., 2010). In brief, the method used in 
this study is a three stage static in vitro bioaccessibility test. Due to small residence time in 
the saliva (mouth) compartment, the saliva and stomach phase are combined.  
 
The second stage represents the conditions in the small intestine (containing duodenal 
fluids and bile salts). The procedure is modified to extract 0.3 g of soil samples, statistical 
analysis was carried out in a separate study and found no significant differences (p > 0.05) 
between the use of 0.6 g or 0.3 g soil sample (Xia et al., 2016a). The soil extraction in the 
digestive juices is carried out at human body temperature (37 0C) and utilises end-over-
end rotation. The ratio of soil to digestive juices is 1:100. The ratio of the digestive juices is 
1:1.5 (simulated saliva fluid: simulated gastric fluid) and 3:1 (simulated duodenal fluid: 
simulated bile fluid) and the pH in final solution is maintained at 1.2 ± 0.5 for the gastric 
phase extract and 6.3 ± 0.5 for the intestinal phase extract. Soil samples were extracted in 
the gastric phase for 1 h and in the intestinal phase for 4 h. The pH of the gastric and 
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intestinal phase solution is adjusted with the dropwise addition of 37 % HCL when 
necessary. To avoid readsorption of PAHs onto soils, the simulated duodenal and bile 
fluids were immediately added to gastric phase suspension following 1 h of stomach 
phase extraction and mixed thoroughly, subsequently the incubation vessel is replaced for 
incubation in the end-over-end rotation for a further 4 h at 37 oC ± 2 oC. Soil suspensions 
were centrifuged at 3000 x g for 5 min. The extracts were filtered using a 0.45 µm filter and 
transferred to a 50 mL vial. Prior to loading the filtered samples onto solid phase extraction 
(SPE) cartridge, the SPE device is pre-conditioned using 5 mL dichloromethane, 5 mL 
methanol and 2 x 5 mL Milli-Q water and the cartridge was dried under vacuum. Each 
sample was quantitatively added to the SPE cartridge and allowed to pass through at a 
rate of 1 – 2 mL min-1.  
 
Once the samples had passed through, the SPE cartridge was eluted twice with 2 mL Milli-
Q water and dried under vacuum. The C18 SPE column was connected in series to a 
Silica SPE column and eluted twice with 5 mL dichloromethane: hexane (1:1 v/v), the 
eluent is collected in a 50 mL glass tube and volume was reduced to approximately 0.5 mL 
under a gentle stream of high purity nitrogen gas and was quantitatively transferred to a 2 
mL amber screw top vial. Sample volume was made to 1 mL with 20 µL of internal 
standards solution (10 µg mL-1) prior to GC-QqQ-MS/MS analysis. Further clean-up using 
d-SPE was required for gastrointestinal extracts. A conceptual flow chart of PAHs analysis 
in UBM extracts is found in Chapter 3; Figure 3.4. The bioaccessibility of PAHs in soil was 
calculated based on the equation below: 
 
 
 
The UBM procedure has been used to assess contaminant bioaccessibility in soils 
containing both PAHs and metal/loids (Xia, 2016). In this study PAH bioaccessibility in the 
presence or absence of As, Cd and Pb will be assessed using different soil types. The 
total concentrations of As, Cd and Pb in the soils and UBM extracts were analysed using 
the inductively coupled plasma mass spectrometry (Agilent 7500cs ICP-MS, Agilent 
Technologies, Japan), following the US EPA 3051A digestion procedure (Xia et al., 
2016a). Two soil standard reference materials (NIST SRM 2710a and 2711a, National 
Institute of Standards and Technology, Washington, DC), were used as a reference and 
for quality control. The total concentrations of As, Cd and Pb in soils and UBM digests 
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have been reported elsewhere (Xia et al., 2016a; Xia et al., 2016b). As there is no certified 
soil samples for analysis of PAH bioaccessibility. In this study, a soil certified reference 
material used in method validation in Chapter 6 was used for QA/QC. The results of 
certified reference material (industrial soil – BCR® 524) show that the average intestinal 
bioaccessible B[a]P and Pyr were 0.3 ± 0.02 mg Kg-1 and 12.1 ± 0.8 mg Kg-1, respectively 
(n = 6). Benzo[a]pyrene was not found in gastric phase, while Pyr bioaccessibility was 1.5 
± 0.1 mg Kg-1 in the gastric phase. The consistency of results obtained for the reference 
material suggests good reproducibility of UBM.  
 
7.2.8 Statistical analysis 
Statistical analysis was performed using Prism 7 (Graphpad Software Inc., La Jolla, USA). 
Linear regressions were performed to analyse the relationship between bioaccessible 
concentration and total concentration. Goodness of fit (R2) of more than 0.5 was 
considered significant. The Correlation efficiency between different soil properties and 
PAH bioaccessibility was calculated based on Pearson Correlation. For mixture effect, 
data was compared for differences in means using one way ANOVA and Tukey test for 
multiple correlations. Significance difference was set at p < 0.05. The statistics software 
SPSS Statistics 24 from IBM was used to carry out a principal component analysis (PCA) 
to visualise strong patterns in dataset and together with Hierarchical Cluster Analysis 
(HCA) to group more similar data together for interpretation of results.   
 
7.2.9 Quality assurance and quality control (QA/QC) 
Quality control and quality assurance (QA/QC) was incorporated in the procedure by using 
a certified reference material (industrial soil – BCR® 524 from the European Commission 
Institute for Reference Materials and Measurement, Geel, Belgium), spiked sand and soil 
samples. Procedural blanks were included in all sample analysis. Samples were analysed 
in replicate of three. Isotopically labelled deuterated PAHs were used as internal standards 
for identification and quantification of analytes.  
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7.3 Results and discussion  
7.3.1 Quality Control  
The calibration curves of standards were showing good linearity on GC-QqQ-MS/MS 
(supplementary information, Figure S7.1 - S7.4) with correlation coefficients above 0.995. 
Concentrations of standards were established in a range of 1 ng mL-1 to 2000 ng mL-1. To 
achieve lower detection limit, a pre-concentration step was employed after the solid phase 
extraction (SPE) by evaporating the extract to a volume of approximately 0.5 mL using a 
gentle stream of high purity nitrogen gas in a fume hood. An industrial soil CRM (BCR® 
524) was used to assess total PAH extraction using the modified QuEChERS method 
presented in Chapter 6. An acid washed sand (< 250 µm sieved fraction) was included in 
spike recovery samples. Recoveries from C18 and Silica based SPE (in series) were 
satisfactory with values in a range of 78 to 95 % and the RSD were in a range of 5 to 12 
%, an RSD of 30 % resulted with Nap (Table 7.2).  
 
The results from the spike experiments with the SPE indicate that post UBM the C18 and 
Silica sorbent is efficient in the recovery of PAHs and is therefore suitable for the analysis 
of PAHs in the gastrointestinal digests resulting from UBM extraction test. Similar 
recoveries of PAHs are reported for a PBET using Silica based SPE columns and GC-MS 
(Lorenzi et al., 2012). The limit of detection of a given PAH was accepted as the lowest 
concentration that produced a peak signal three times the background noise from the 
chromatograms if PAHs were not found in blank samples. Laboratory background of Phe, 
Pyr and B[a]P was not detected. Trace amounts of Nap was detected in laboratory blank. 
All samples were analysed in triplicates. It is noteworthy, that the use of a vacuum 
manifold makes post UBM extraction of PAHs efficient, however, changes to the flow rate 
(1 – 2 mL min-1) needs to be carefully monitored due to the use of multiple cartridges on 
the manifold.  
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7.3.2 Evaluation of PAH bioaccessibility using UBM 
The total concentrations of individual and the sum of the total PAHs in soil samples was 
determined using a modified QuEChERS approach and a GC-QqQ-MS/MS. The total PAH 
concentrations in soil samples are found in Table 7.3 – Table 7.6. The UBM procedure 
was applied to seven variant soil types spiked with Nap, Phe, Pyr and B[a]P. The 
bioaccessible fractions of Nap, Phe, Pyr and B[a]P obtained using the Unified BARGE 
Method were calculated using the equation in Section 7.2.4 (based on the total content of 
PAHs in soil and the concentration obtained after incubation using the UBM). For the 
seven types of soils studied, overall low bioaccessibilities were obtained for B[a]P (0.2 ± 
0.1 % to 5.1 ± 1.8 %), Nap (0.2 ± 0.1 % to 9 ± 2.6 %), Phe (0.2 ± 0.1 % to 15 ± 0.6 %) and 
Pyr (0.2 ± 0.1 % to 6.3 ± 0.1 %) as reported in Table 7.3 – Table 7.6. Regardless of the 
soil type, the bioaccessibility of Phe was observed to be the highest among the PAHs 
investigated in this study (Table 7.4).  
 
Further, in all soil types the bioaccessibilities of PAHs in the gastric phase was found to be 
significantly lower than the gastrointestinal phase (p < 0.05). Low concentrations of PAHs 
in the gastric phase have been reported in other studies, which also indicate that PAHs 
remained mostly bound to soil particles due to limited solubilisation in the gastric fluids 
(Holman et al., 2002; Van de Wiele et al., 2004). By comparison, higher concentrations of 
PAHs found in the gastrointestinal phase have been related to reagents such as bile salts 
and mucine that are present in the gastrointestinal fluids (Van de Wiele et al., 2004). Bile 
salts and mucine are known to decrease the surface tension due to their surfactant-like 
properties, subsequent decrease in surface tension may favour the mobilisation of PAHs 
from soils (Tang et al., 2006).  
 
Notably, some of the PAHs may be retained inside the bile salts micelles formed during 
the gastrointestinal incubation which may reduce freely available PAHs (Tang et al., 2006). 
While Guney and Zagury (2016) indicate that the comparatively high pH in gastrointestinal 
fluids affects the solubility of soil organic carbon, therefore, influencing PAH 
bioaccessibility via affecting PAH mobilisation attached to soil organic carbon. In published 
literature, bioaccessibility of up to 20 % of total PAHs has been reported for fasted in vitro 
gastrointestinal tests similar to UBM (Tilston et al., 2011; Cave et al., 2010; Tao et al., 
2010; Gron et al., 2007; DIN, 2000).   
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As a conservative measure of bioaccessibility assessment in static systems such as UBM, 
recent studies have investigated the role of sorption sinks using materials such as Tenax 
and silicone cord to improve the mass transfer of PAHs into gastrointestinal solutions, 
these materials prevented readsorption of PAHs to soil and hence bioaccessibility of total 
PAHs increased from 8.25 – 20.8 %  (without Tenax) to 55.7 – 65.9% (using Tenax) and 
up to 81.7 ± 2.7 % using silicone cord (Li et al., 2015; Juhasz et al., 2016). However, the 
same study indicates that addition of a sorption sink like Tenax may create a concentration 
gradient which may be more than the actual gastrointestinal sorption in the physiological 
condition (Li et al., 2015). The UBM protocol is selected for bioaccessibility measurement 
in this study as it has been validated for As, Cd and Pb using inter-laboratory trials and 
been correlated to bioavailability data of a juvenile swine model (Wragg et al., 2011; 
Denys et al., 2012). Further, the developers of the UBM (i.e. The Unified Bioaccessibility 
Research Group of Europe) have used it to assess the oral bioaccessibility of PAHs in 
soils from former industrial sites (Lorenzi et al., 2012).  
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Table 7.2 Recoveries and relative standard deviation of spiked soil and sediment, certified reference material and blank UBM 
matrix. 
Compound  CRM# 
BCR250®  
 C18 + Silica 
SPE 
 UBM 
Gastric 
 UBM 
Gastrointestinal 
 Sand   
 (n = 3)  (n = 3)  (n = 3)  (n = 3)  (n = 3)  
 %Rec %RSD %Rec %RSD %Rec %RSD %Rec %RSD %Rec %RSD 
Nap NA NA 75 ± 8 25 72 ± 10 20 70 ± 8 20 60 ± 12 30 
Phe NA NA 95 ± 5 10 82 ± 5 20 85 ± 4 12 76 ± 7 8 
Pyr 93 ± 5 10 88 ± 7 12 85 ± 8 12 78 ± 12 18 85 ± 4 12 
B[a]P 90 ± 2 4 92 ± 2 8 90 ± 4 10 80 ± 8 15 82 ± 8 5 
# Using the QuEChERS extraction procedure for total PAHs. NA – signifies no official value provided in CRM certificate.  
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Table 7.3 Bioaccessibility of B[a]P in seven different types of spiked soils after UBM extraction 
B[a]P 
bioaccessibility 
 
Soil code 
 
 
Total 
B[a]P 
 
mg kg-1 
7 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
 
Total 
B[a]P 
 
mg kg-1 
30 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
 
Total 
B[a]P 
 
mg kg-1 
90 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
PBA 195 0.6± 0.5 5.1± 1.8 204 0.6±0.1 4.4±0.5 222 0.4±0.2 3.9±0.4 
 44 0.5±0.3 4.4±0.6 41 0.4±0.2 3.7±0.6 46 0.3±0.1 3.2±0.2 
 9 0.4±0.3 4.0±0.9 8 0.4±0.3 3.3±0.8 9 0.3±0.1 3.6±0.7 
DUA 234 0.4±0.3 3.7±1.1 219 0.4±0.3 3.6±1 205 0.4±0.2 3.7±1.1 
 39 0.3±0.1 2.5±0.6 36 0.3±0.1 2.7±0.6 34 0.2±0.2 2.7±0.6 
 11 0.3±0.1 2.6±0.5 10 0.3±0.1 2.9±0.3 9 0.2±0.1 2.9±0.3 
WRA 223 0.3±0.2 2.4±0.6 209 0.3±0.2 2.4±0.6 203 0.2±0.1 2.4±0.6 
 44 0.2±0.1 2.0±0.2 41 0.2±0.1 1.7±0.6 34 0.2±0.1 2.1±0.1 
 9 0.2±0.1 2.1±0.1 9 0.2±0.2 1.6±0.6 6 0.2±0.1 2.1±0.1 
MIA 227 0.2±0.1 1.3±0.5 213 ND 1.3±0.5 198 ND 1.3±0.5 
 39 ND 0.9±0.2 37 ND 1.0±0.2 34 ND 1.0±0.2 
 8 ND 1.0±0.1 8 ND 1.0±0.1 5 ND 1.0±0.1 
TAA 231 0.2±0.1 1.7±1.1 216 ND 1.7±1.1 206 0.2±0.1 1.6±1.1 
 46 ND 0.9±0.2 43 ND 1.0±0.1 33 ND 1.0±0.1 
 10 ND 1.0±0.2 9 ND 1.1±0.1 7 ND 1.1±0.1 
KBA 221 ND 0.7±0.3 207 ND 0.6±0.2 197 ND 0.5±0.1 
 44 ND 0.5±0.1 41 ND 0.5±0.1 30 ND 0.5±0.1 
 7 ND 0.5±0.1 7 ND 0.5±0.1 3 ND 0.5±0.1 
MGA 211 ND 0.2±0.1 197 ND 0.2±0.1 198 ND 0.2±0.1 
 41 ND ND 39 ND ND 34 ND ND 
 7 ND ND 7 ND ND 5 ND ND 
ND – signifies not detected 
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Table 7.4 Bioaccessibility of Phe in seven different types of spiked soils after UBM extraction 
Phe 
bioaccessibility 
 
Soil code 
 
 
Total 
Phe 
 
mg kg-
1 
7 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
 
Total 
Phe 
 
mg kg-
1 
30 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
 
Total 
Phe 
 
mg kg-
1 
90 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
PBA 1089 1.5±0.7 14.2±1.9 1034 1.4±0.5 14.3±2.1 882 1.3±0.3 15±0.6 
 505 1.4±0.6 15.2±0.3 480 1.5±0.7 13.5±3 441 1.1±0.4 13.5±3 
 238 1.4±0.5 12.5±2.8 226 1.4±0.5 13.2±3.6 182 1.1±0.4 12.8±4.2 
DUA 975 1.1±0.5 13.7±2.3 926 1.1±0.5 12.3±2.5 810 1.2±0.5 13.0±2.6 
 485 1.1±0.5 12.0±2.6 461 1.1±0.5 11±3.6 369 0.9±0.1 11.3±3.2 
 263 1.1±0.5 12.0±2.6 250 1.1±0.5 10.3±4.5 225 0.9±0.1 11±3.6 
WRA 1010 0.5±0.3 5.8±1.1 959 0.5±0.3 5.4±0.5 801 0.6±0.4 4.1±1.8 
 499 0.5±0.3 5.1±0.1 474 0.5±0.3 4.4±1.2 378 0.6±0.4 3.7±2.4 
 242 0.5±0.3 4.4±1.2 229 0.5±0.3 4.1±1.8 178 0.6±0.4 3.7±2.4 
MIA 995 0.4±0.2 4.1±0.2 945 0.4±0.2 4.8±1 815 0.5±0.4 3.4±1.3 
 495 0.4±0.2 3.8±0.8 470 0.4±0.2 3.8±0.7 378 0.5±0.4 3.4±1.3 
 249 0.4±0.2 3.9±0.6 237 0.4±0.2 3.8±0.7 168 0.5±0.4 3.1±1.8 
TAA 960 0.3±0.2 3.1±0.1 912 0.3±0.2 3.8±1.1 738 0.5±0.5 2.7±0.6 
 488 0.3±0.2 3.0±0.2 464 0.3±0.2 3.4±0.5 351 0.5±0.5 2.4±1.2 
 238 0.3±0.2 3.1±0.2 226 0.3±0.2 3.1±0.1 194 0.5±0.5 2.4±1.2 
KBA 945 0.2±0.1 2.1±0.3 898 0.2±0.1 2.3±0.2 765 0.4±0.5 1.9±0.4 
 461 0.3±0.1 1.8±0.7 438 0.2±0.1 2.3±0.2 333 0.4±0.5 1.8±0.7 
 229 0.2±0.1 1.8±0.7 217 0.2±0.1 2.3±0.1 159 0.2±0.1 1.8±0.7 
MGA 980 0.3±0.2 1.2±0.1 931 0.2±0.1 1.2±0.1 675 ND 1.4±0.5 
 515 0.2±0.2 1.1±0.1 489 ND 1.1±0.1 333 ND 1.4±0.5 
 236 0.2±0.1 1.2±0.2 224 ND 1.2±0.2 158 ND 1.1±0.2 
ND – signifies not detected 
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Table 7.5 Bioaccessibility of Pyr in seven different types of spiked soils after UBM extraction 
Pyr 
bioaccessibility 
 
Soil code 
 
 
Total 
Pyr 
 
mg kg-
1 
7 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
 
Total 
Pyr 
 
mg kg-
1 
30 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
 
Total 
Pyr 
 
mg kg-
1 
90 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
PBA 931 0.7±0.3 6.3±1.7 857 0.6±0.3 6.4±0.5 784 0.5±0.2 5.4±1.2 
 513 0.5±0.2 5.4±2.2 472 0.5±0.1 5.4±1.2 425 0.4±0.1 5.1±1.8 
 219 0.5±0.1 4.7±2.2 201 0.5±0.1 5.1±1.8 173 0.4±0.1 4.7±2.4 
DUA 942 0.4±0.2 4.7±0.1 867 0.4±0.2 4.7±1.1 792 0.4±0.2 4.1±0.1 
 480 0.3±0.1 4.1±0.6 441 0.4±0.2 3.7±0.6 376 0.3±0.1 3.7±0.6 
 236 0.3±0.1 3.7±1.2 217 0.3±0.1 4.1±0.1 180 0.3±0.1 3.7±0.6 
WRA 969 0.4±0.2 3.4±0.5 891 0.3±0.2 4.1±1.7 768 0.2±0.1 3.4±0.5 
 477 0.3±0.1 3.1±0.1 439 0.3±0.2 2.7±0.6 400 0.2±0.1 3.4±0.5 
 216 0.3±0.1 3.1±0.6 198 0.2±0.1 2.7±0.6 165 0.2±0.1 3.1±0.1 
MIA 929 0.3±0.1 2.4±0.1 855 0.2±0.1 3.1±1.7 702 0.2±0.1 2.1±0.1 
 447 0.2±0.1 2.1±0.1 411 0.2±0.1 2.1±0.1 323 0.2±0.1 2.1±0.1 
 225 0.2±0.1 1.7±0.6 207 0.2±0.1 2.1±0.1 173 0.2±0.1 1.9±0.4 
TAA 943 0.2±0.1 1.4±0.1 868 ND 2.7±2.8 666 ND 1.1±0.1 
 479 ND 1±0.2 440 ND 2.7±0.1 372 ND 1.1±0.1 
 242 ND 1.1±0.3 223 ND 1.1±2.3 162 ND 0.9±0.4 
KBA 918 ND 1.1±0.1 844 ND 2.4±1.7 715 ND 1.1±0.1 
 489 ND 1.0±0.2 450 ND 2.1±1.7 389 ND 1.0±0.3 
 252 0.2±0.1 0.9±0.6 232 ND 2.1±0.1 165 ND 1.0±0.2 
MGA 928 ND 1±0.1 854 ND 0.5±0.1 716 ND 0.5±0.1 
 504 ND 1±0.1 463 ND 0.5±0.1 310 ND 0.5±0.1 
 239 ND 0.6±0.1 220 ND 0.4±0.1 188 ND 0.4±0.1 
ND – signifies not detected 
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Table 7.6 Bioaccessibility of Nap in seven different types of spiked soils after UBM extraction 
Nap 
bioaccessibility 
 
Soil code 
 
 
Total 
Nap 
 
mg kg-
1 
7 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
 
Total 
Nap 
 
mg kg-
1 
30 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
 
Total 
Nap 
 
mg kg-
1 
90 days 
aged 
 
Gastric 
phase  
(%) 
 
 
Gastric + 
intestinal phase  
 
(%) 
 
PBA 462 1.2±0.4 9.0±2.6 482 1.0±0.6 8.7±3.2 462 0.5±0.2 8.0±4.4 
 294 1.2±0.4 8.7±3.2 281 1.0±0.6 8.3±3.8 294 0.4±0.1 7.7±4.9 
 76 1.2±0.4 8.7±3.2 72 1.0±0.7 8.3±3.8 76 0.4±0.1 7.7±4.9 
DUA 496 0.7±0.2 6.7±1.1 474 0.6±0.3 6.1±0.1 496 0.4±0.2 4.7±2.4 
 286 0.5±0.4 4.4±2.9 273 0.5±0.4 5.7±0.6 286 0.3±0.1 4.4±2.9 
 84 0.6±0.3 4.7±1.6 80 0.5±0.4 5.4±1.2 84 0.3±0.1 4.1±2.7 
WRA 462 0.4±0.3 3.2±1.6 442 0.3±0.3 3.4±1.2 462 0.2±0.1 2.9±1.4 
 269 0.4±0.3 2.5±1.5 257 0.3±0.3 3.2±1.5 269 0.2±0.1 2.5±1.5 
 88 0.4±0.3 2.5±1.5 84 0.3±0.3 3.1±1.8 88 0.2±0.1 2.2±1.7 
MIA 508 0.2±0.3 2.6±0.4 486 0.3±0.2 2.3±0.3 508 0.2±0.1 2.3±0.3 
 277 0.2±0.1 2.4±0.5 265 0.2±0.1 2.1±0.1 277 0.2±0.1 2±1 
 69 0.2±0.1 2.1±0.1 66 0.2±0.1 1.7±0.6 69 0.2±0.1 1.8±0.7 
TAA 521 0.2±0.1 2.4±0.5 498 ND 2.1±0.1 521 ND 2±1 
 260 0.2±0.1 1.8±0.5 249 ND 1.7±0.6 260 ND 1.5±0.6 
 105 0.2±0.1 1.5±0.6 100 ND 1.7±0.6 105 ND 1.5±0.6 
KBA 454 0.2±0.1 2.5±0.6 434 ND 2.5±0.6 454 ND 2.2±1.1 
 252 0.3±0.1 2.7±2.1 241 ND 2.1±0.1 252 ND 2.7±2.1 
 67 0.2±0.1 2.4±1.4 64 ND 2.1±0.2 67 ND 2.4±1.4 
MGA 437 0.2±0.1 2.7±1.1 418 ND 2.1±0.1 437 ND 2.4±1.5 
 265 0.3±0.1 2.3±1.3 253 ND 1.8±0.8 265 ND 2.3±1.3 
 64 0.2±0.1 2.±1 61 ND 1.7±0.6 64 ND 2±1 
ND – signifies not detected 
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7.3.3 Relationships between PAH bioaccessibility and total concentrations  
The results from UBM found limited mobilisation of PAHs from soils to gastric or 
gastrointestinal fluids, regardless of the total concentrations in soil. A principal component 
analysis depicting extent of differences between PAHs spiked-soils following an 
exhaustive chemical extraction or a physiologically based extraction from UBM found two 
distinct clusters, indicating that some PAHs remained bound to soils following simulated 
human digestion using UBM (Figure 7.1). Similarly, the hierarchical cluster analysis 
showed two separate groups of extracted PAHs from PAH spiked-soils (Figure 7.2). 
 
In the PAH spiked soil samples, only B[a]P showed a significant linear relationship 
between the total concentration in soils and the bioaccessible concentration in both gastric 
phase (Figure 7.3; R2 = 0.5313, p value = 0.0002) and the gastrointestinal phase (Figure 
7.4; R2 = 0.5497, p = 0.0001). This is further discussed in Section 7.3.4 in relation to 
influence of soil properties and contaminant ageing. Table 7.4 summarises the results of 
increasing soil concentrations of B[a]P and its bioaccessibility in both the gastric and 
intestinal phase for seven different soil types. The results for individual soil type indicates 
that increasing soil concentration did not have a significant effect (p > 0.05) on the 
bioaccessibility of B[a]P. The findings on relationship between bioaccessibility of B[a]P 
following UBM and total concentrations in soils suggest that mass transfer of B[a]P into 
gastric and gastrointestinal fluids maybe dependent on soil properties and solubility of 
B[a]P in the simulated digestive fluids as opposed its total concentration in the soil.  
 
Holman et al. (2002) using an in vitro fasting digestion model found that the release 
percentage of B[a]P from crude oil contaminated soils was low (e.g. 0.1 – 1.4 %) and was 
comparable to the solubility in the gastrointestinal fluids (i.e. 0.5 – 2 %). No significant 
linear relationships were found between bioaccessible Nap, Phe and Pyr and their total 
soil concentrations. Similar to B[a]P, the bioaccessibility of Nap, Phe and Pyr in gastric 
phase was significantly lower than their concentrations in the gastrointestinal phase for 
each soil type. Alternatively, this also suggested that the binding sites in soils were not 
saturated with PAHs (further discussed in Section 7.3.4 in relation to soil properties). 
Taken together, these results indicate that PAH solubility in the digestive fluids may be 
influenced by its hydrophobicity and soil properties. Chun et al. (2002) reports that more 
hydrophobic compounds have greater solubility in digestive fluids as they are held in the 
core of the micelle, whereas less hydrophobic compounds are only solubilized in the 
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interfacial medium, thus limiting their solubility. Van de Wiele et al. (2004) indicates that 
PAHs that remain in solution after centrifugation at 3000 x g consists of free PAHs and 
PAHs taken up in small complexes with bile salts or dissolved organic matter and this is 
the bioaccessible fraction which is available for intestinal absorption. In this study, 
relationships between PAH bioaccessibility and soil properties and ageing are discussed 
in Section 7.3.4. The findings on PAH bioaccessibility were consistent with previous 
studies which report significantly higher concentrations of PAHs in gastrointestinal phase 
compared than gastric phase for protocols using a physiologically based extraction 
techniques that are similar to UBM (Cave et al., 2015; Tang et al., 2006; GrØn et al., 
2007).  
 
 
Figure 7.1 Cross plots of PCA for the 4 PAHs total and bioaccessible concentration; 
 
Phe30G signifies concentration of Phe in gastric phase for Phe spiked-soil aged for 30 
days and labels with e.g. Pyr7T signifies total concentration of Py in Pyr spiked-soil aged 
for 7 days and extracted using exhaustive chemical extraction technique.  
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Figure 7.2 Hierarchical cluster analysis of total and bioaccessible PAHs in soils 
indicating two distinct clusters the labels  
 
Phe30G signifies concentration of Phe in gastric phase for Phe spiked-soil aged for 30 
days and labels with e.g. Pyr7T signifies total concentration of Pyr in Pyr spiked-soil aged 
for 7 days and extracted using exhaustive chemical extraction technique. “G” - gastric 
phase, “GI” – gastric + intestinal phase and “T” – total. The numbers “7” signifies 7 days, 
“30” signifies 30 days and “90” signifies 90 days of ageing.  
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Fig. 7.3 Linear regression analysis between gastric  phase bioaccessible B[a]P and total B[a]P in spiked soils at (A) 7 days and 
(B) 90 days, (n = 21).  
 
Each data is mean ± standard deviation. “G” means gastric phase. R2 represents the goodness of fit, p value represents the significance 
of the relationship.   
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Fig. 7.4 Linear regression analysis between gastrointestinal  phase bioaccessible B[a]P and total B[a]P in spiked soils at (A) 7 
days and (B) 90 days, (n = 21).  
 
Each data is mean ± standard deviation. “GI” means gastric + intestinal phase. R2 represents the goodness of fit, p value represents the 
significant of the relationship.  
  
A B 
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7.3.4 Effect of ageing and soil properties on PAH bioaccessibility using UBM 
The effect of contaminant ageing in soil and influence on bioaccessibility was investigated 
in this chapter. Soils spiked with PAHs were aged over 7 to 90 days. During the ageing 
process PAHs may interact with ligands in soils resulting in changes to its bioaccessibility 
(Zhu et al., 2014; Hundal et al., 2001; Müller et al., 2007). In this study, the 
bioaccessibilities of B[a]P, Nap, Phe and Pyr continued to decrease over the 90 days of 
exposure (Table 7.3 – 7.10). The decline in PAHs bioaccessibility over time varied 
considerably amongst the study soils, decreasing bioaccessibility of PAHs in all soil types 
generally followed a sequence based on increasing TOC content: 
 
PBA > DUA > WRA > MIA > TAA > KBA > MGA 
 
The differences in bioaccessibility of PAHs in these soil reflected varying ageing 
processes in soils and highlighted the importance of soil properties. Correlations between 
the PAH bioaccessibility over 90 days of ageing and key soil properties such as TOC, 
DOC, pH, aluminium oxide and clay content (Table 7.7 – Table 7.10) were carried out to 
determine their influence on the sequestration of PAHs. Statistical analyses using Turkey’s 
multiple correlation analysis for ageing of PAHs at 7 days, 30 days and 90 days found no 
significant differences (p > 0.05) in bioaccessibility between ageing periods for each soil 
type, suggesting steady state was reached within 7 days of ageing. Further decreases in 
the bioaccessibilities beyond the 90 days period can be assumed to be minor in most 
cases. Similarly, Duan et al. (2014) reported that there was no significant effect of ageing 
on the bioaccessibility of B[a]P in 50 days and 90 days aged soils. This may also indicate 
higher saturation of soil active components such as soil organic matter, hence binding 
sites in soils were not saturated with spiked PAHs or As, Cd and Pb.  
 
Soil organic matter and clay minerals are two of most chemically active components of soil 
among other soil properties such as pH and cation exchange capacity (CEC) which will 
affect the sorption–desorption of PAHs (Yu et al., 2014).. It is therefore interesting to note 
that only B[a]P showed a significant relationship between the total concentration and the 
bioaccessible concentration in both gastric phase (Figure 7.3) and the gastrointestinal 
phase (Figure 7.4) up to 90 days of ageing. The results here suggest that the amount of 
dissolved B[a]P in simulated digestive fluids may be strongly influenced by soil property 
such as DOC-associated B[a]P, rather than freely dissolved B[a]P alone. Among several 
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soil properties investigated in this current study, DOC was found to have a significant 
interaction effect on the bioaccessibility of B[a]P (p < 0.05; Table 7.7). Moeckel et al. 
(2014) reported that concentrations of individual PAHs containing five or more aromatic 
rings were strongly correlated to the DOC concentration, implying a significant role of DOC 
in the mobilisation of high molecular weight PAHs.  
 
Soil physicochemical properties including TOC, TC, TN, DOC, pH, clay, FeO and 
aluminium oxide were selected to explore key soil parameters which can affect 
bioaccessibility of PAHs (Chapter 3; Table 3.6). Generally five soil properties, including 
DOC, TOC, clay, pH and Aluminium oxide were controlling the bioaccessibility of PAHs, 
among which DOC and TOC were the most influential (Table 7.7 – Table 7.10). Former 
studies have associated soil organic carbon content, pH, sand and clay for variable PAH 
bioaccessibilities (Moeckel et al., 2014; Cave et al., 2010; GrØn et al., 2007; Oomen et al., 
2004). Based on the goodness of fit (R2), Table 7.7 shows that the affinity of higher 
molecular weight PAHs such as B[a]P to soil organic matter was found to be stronger and 
generally followed the sequence: 
B[a]P > Pyr > Phe > Nap 
 
Moreover, DOC played an important role in controlling bioaccessibility of B[a]P regardless 
of ageing period (R2 = 0.74 – 0.83). In addition, a positive relationship between 
bioaccessibilities of B[a]P and Pyr with pH was observed. Yin et al. (1996) highlighted that 
an increase of solubility of the soil organic matter with increase of solution pH may 
contribute towards enhancement of PAH bioaccessibility in the gastrointestinal phase 
compared with that in the gastric phase. Aluminium oxide as a sorbent is well known for its 
capacity to retains PAHs, in this study aluminium oxide was found to have a negative 
effect on bioaccessibilities of B[a]P and Phe in soils that have been aged over 90 days 
(Table 7.7 and Table 7.8). Results in Table 7.9 show that clay also had a significantly 
strong effect in reducing the bioaccessible Phe, both in fresh spiked soils (7 and 30 days; 
p < 0.05) and up to 90 days of ageing (p < 0.05).  
 
Effect of clay content on desorption of Phe in soils has been reported in a number of 
studies (Müller et al., 2007; White et al., 1999). Müller et al. (2007) reported that capillary 
condensation of Phe into a network of nanosites and microsites of quasicrystals or tactoids 
of clay may limits its accessibility. Such binding to clay may contribute to lower desorption 
of Phe, hence low bioaccessibility. Additionally, due caution must be exercised in the 
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interpretation of soil properties-bioaccessibility relationships based on values of R2 
(goodness of fit) due to the limited soil types (n = 7) used in this study. The inclusion of 
more soil types would reduce incidental correlation between soil properties and strengthen 
the conclusions of the current work.  
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Table 7.7 Relationships (goodness of fit, R2) between B[a]P bioaccessibility and selected soil properties 
Soil properties 
 
 
 7 days  
aged 
 
Gastric 
phase  
 
R2 
 
 
 
 
 
 
P value  
 
 
 
Gastric + 
intestinal 
phase  
R2 
 
 
 
 
 
 
p value 
30 
days 
aged 
 
Gastric 
phase  
R2 
 
 
 
 
 
 
p value 
 
 
 
Gastric + 
intestinal 
phase  
R2 
 
 
 
 
 
 
p value 
90 
days 
aged 
 
Gastric 
phase  
R2 
 
 
 
 
 
 
p value 
 
 
 
Gastric + 
intestinal 
phase  
R2 
 
 
 
 
 
 
p value 
pH  0.4436 0.0010 0.5042 0.0003 0.4544 0.0008 0.4972 0.0004 0.4517 0.0008 0.5519 0.0001 
Clay (%)  0.43 0.0012 0.4121 0.0017 0.4297 0.0013 0.4809 0.0005 0.4295 0.0013 0.4347 0.0011 
Silt (%)  0.2118 0.0358 0.2172 0.0332 0.2178 0.0330 0.2522 0.0203 0.2257 0.0295 0.2373 0.0251 
Sand (%)  0.2928 0.0113 0.292 0.0114 0.2974 0.0106 0.3396 0.0056 0.3035 0.0097 0.3145 0.0082 
TC (%)  0.6579 <0.0001 0.6481 <0.0001 0.6874 <0.0001 0.7348 <0.0001 0.6871 <0.0001 0.6949 <0.0001 
TN (%)  0.5716 <0.0001 0.6008 <0.0001 0.6192 <0.0001 0.6477 <0.0001 0.7228 <0.0001 0.7253 <0.0001 
TOC (%)  0.6938 <0.0001 0.7128 <0.0001 0.7382 <0.0001 0.7791 <0.0001 0.7962 <0.0001 0.8146 <0.0001 
DOC (mg kg-1)  0.766 <0.0001 0.8253 <0.0001 0.7455 <0.0001 0.7745 <0.0001 0.7385 <0.0001 0.8156 <0.0001 
CEC (cm kg-1)  0.3065 0.0092 0.2698 0.0158 0.3114 0.0086 0.3211 0.0074 0.3196 0.0076 0.289 0.0120 
Fe oxide (g Kg-)  0.3121 0.0085 0.3208 0.0074 0.3552 0.0044 0.3468 0.0050 0.4379 0.0011 0.3792 0.0030 
Al oxide (gKg-1)   0.3734 0.0033 0.3783 0.0030 0.4173 0.0016 0.4108 0.0017 0.5006 0.0003 0.4417 0.0010 
Mn oxide ( kg-1)  0.1907 0.0478 0.1689 0.0642 0.1661 0.0667 0.1592 0.0731 0.1486 0.0844 0.1182 0.1269 
Total Fe (g kg-1)  0.3121 0.0085 0.3208 0.0074 0.3552 0.0044 0.3468 0.0050 0.4379 0.0011 0.3792 0.0030 
Total Al(g kg-1)  0.1645 0.0681 0.1644 0.0683 0.1422 0.0919 0.1609 0.0715 0.0953 0.1733 0.1498 0.0830 
Total Mn gKg-1)  0.1401 0.0946 0.1179 0.1275 0.1353 0.1009 0.1295 0.1091 0.1409 0.0935 0.0993 0.1642 
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Table 7.8 Relationships (goodness of fit, R2) between Phe bioaccessibility and selected soil properties 
Soil properties 
 
 
 7 days  
aged 
 
Gastric 
phase  
 
R2 
 
 
 
 
 
 
P value  
 
 
 
Gastric + 
intestinal 
phase  
 
R2 
 
 
 
 
 
 
p value 
30 days 
aged 
 
Gastric 
phase  
 
R2 
 
 
 
 
 
 
p value 
 
 
 
Gastric + 
intestinal 
phase  
R2 
 
 
 
 
 
 
p value 
90 days 
aged 
 
Gastric 
phase  
 
R2 
 
 
 
 
 
 
p value 
 
 
 
Gastric 
+ 
intestinal 
phase  
R2 
 
 
 
 
 
 
p value 
pH  0.4867 0.0004 0.485 0.0005 0.4983 0.0003 0.4559 0.0008 0.4543 0.0008 0.4336 0.0012 
Clay (%)  0.5145 0.0003 0.5309 0.0002 0.5336 0.0002 0.5533 0.0001 0.5363 0.0002 0.5323 0.0002 
Silt (%)  0.2699 0.0158 0.2762 0.0144 0.2818 0.0133 0.2831 0.0130 0.2785 0.0139 0.2641 0.0172 
Sand (%)  0.3637 0.0038 0.3733 0.0033 0.3785 0.0030 0.3851 0.0027 0.3763 0.0031 0.3641 0.0038 
TC (%)  0.6976 <0.0001 0.7673 <0.0001 0.755 <0.0001 0.78 <0.0001 0.8523 <0.0001 0.7321 <0.0001 
TN (%)  0.531 0.0002 0.5961 <0.0001 0.5976 <0.0001 0.5956 <0.0001 0.7252 <0.0001 0.5267 0.0002 
TOC (%)  0.6761 <0.0001 0.7445 <0.0001 0.7422 <0.0001 0.7435 <0.0001 0.8552 <0.0001 0.6798 <0.0001 
DOC (mg kg-1)  0.7476 <0.0001 0.7148 <0.0001 0.7723 <0.0001 0.7223 <0.0001 0.7415 <0.0001 0.6888 <0.0001 
CEC (cm kg-1)  0.3101 0.0087 0.3536 0.0045 0.339 0.0056 0.3766 0.0031 0.412 0.0017 0.3621 0.0039 
Fe oxide (g Kg-)  0.2071 0.0382 0.2622 0.0176 0.2669 0.0165 0.2799 0.0137 0.4377 0.0011 0.215 0.0342 
Al oxide (g Kg-1)   0.2606 0.0180 0.3202 0.0075 0.3248 0.0070 0.3395 0.0056 0.5011 0.0003 0.2713 0.0155 
Mn oxide(g kg-1)  0.175 0.0591 0.1871 0.0502 0.1968 0.0440 0.2329 0.0267 0.2508 0.0208 0.2045 0.0396 
Total Fe (g kg-1)  0.2071 0.0382 0.2622 0.0176 0.2669 0.0165 0.2799 0.0137 0.4377 0.0011 0.215 0.0342 
Total Al  (g kg-1)  0.288 0.0121 0.2802 0.0136 0.2603 0.0181 0.2601 0.0182 0.1735 0.0604 0.3064 0.0092 
Total Mn(g Kg-1)  0.1221 0.1205 0.1492 0.0837 0.149 0.0839 0.1851 0.0516 0.2323 0.0269 0.1563 0.0761 
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Table 7.9 Relationships (goodness of fit, R2) between Pyr bioaccessibility and selected soil properties 
Soil properties 
 
 
 7 days  
aged 
 
Gastric 
phase  
 
R2 
 
 
 
 
 
 
P value  
 
 
 
Gastric + 
intestinal 
phase  
R2 
 
 
 
 
 
 
p value 
30 days 
aged 
 
Gastric 
phase  
 
R2 
 
 
 
 
 
 
p value 
 
 
 
Gastric + 
intestinal 
phase  
R2 
 
 
 
 
 
 
p value 
90 days 
aged 
 
Gastric 
phase  
 
R2 
 
 
 
 
 
 
p value 
 
 
 
Gastric + 
intestinal 
phase  
R2 
 
 
 
 
 
 
p value 
pH  0.5911 <0.0001 0.6641 <0.0001 0.5911 <0.0001 0.3992 0.0021 0.5377 0.0002 0.7009 <0.0001 
Clay (%)  0.3586 0.0041 0.3792 0.0030 0.3076 0.0091 0.3476 0.0049 0.4417 0.0010 0.3341 0.0061 
Silt (%)  0.2469 0.0219 0.254 0.0198 0.1906 0.0479 0.1528 0.0798 0.2567 0.0191 0.2271 0.0290 
Sand (%)  0.2989 0.0103 0.3109 0.0086 0.2405 0.0240 0.2216 0.0313 0.3318 0.0063 0.2765 0.0144 
TC (%)  0.6069 <0.0001 0.6362 <0.0001 0.6059 <0.0001 0.733 <0.0001 0.7514 <0.0001 0.6664 <0.0001 
TN (%)  0.6449 <0.0001 0.6516 <0.0001 0.6447 <0.0001 0.6879 <0.0001 0.676 <0.0001 0.7445 <0.0001 
TOC (%)  0.6897 <0.0001 0.725 <0.0001 0.6997 <0.0001 0.7815 <0.0001 0.7642 <0.0001 0.7953 <0.0001 
DOC  (mg kg-1)  0.7615 <0.0001 0.8286 <0.0001 0.6997 <0.0001 0.7815 <0.0001 0.7849 <0.0001 0.8513 <0.0001 
CEC   (cm kg-1)  0.185 0.0516 0.1884 0.0493 0.2071 0.0382 0.394 0.0023 0.3123 0.0085 0.197 0.0438 
Fe oxide (g Kg-)  0.3517 0.0046 0.298 0.0105 0.3496 0.0048 0.4885 0.0004 0.3587 0.0041 0.3946 0.0023 
Al oxide (g Kg-1)   0.3759 0.0031 0.3314 0.0063 0.3809 0.0029 0.5471 0.0001 0.397 0.0022 0.4245 0.0014 
Mn oxide(gkg-1)  0.2458 0.0223 0.163 0.0695 0.2316 0.0272 0.3046 0.0095 0.3236 0.0071 0.1862 0.0508 
Total Fe  (gkg-1)  0.3517 0.0046 0.298 0.0105 0.3496 0.0048 0.4885 0.0004 0.3587 0.0041 0.3946 0.0023 
Total Al  (g kg-1)  0.1929 0.0464 0.2544 0.0197 0.256 0.0193 0.1932 0.0462 0.3078 0.0090 0.2493 0.0212 
Total Mn (gKg-1)  0.161 0.0714 0.1015 0.1592 0.1505 0.0823 0.2649 0.0170 0.2421 0.0235 0.1252 0.1156 
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Table 7.10 Relationships (goodness of fit, R2) between Nap bioaccessibity and selected soil properties 
Soil properties 
 
 
 7 days  
aged 
 
Gastric 
phase  
 
R2 
 
 
 
 
 
 
P value  
 
 
 
Gastric + 
intestinal 
phase  
R2 
 
 
 
 
 
 
p value 
30 
days 
aged 
 
Gastric 
phase  
R2 
 
 
 
 
 
 
p value 
 
 
 
Gastric + 
intestinal 
phase  
R2 
 
 
 
 
 
 
p value 
90 
days 
aged 
 
Gastric 
phase  
R2 
 
 
 
 
 
 
p value 
 
 
 
Gastric + 
intestinal 
phase 
R2 
 
 
 
 
 
 
p value 
pH  0.3426 0.0053 0.329 0.0066 0.3083 0.0090 0.4058 0.0019 0.4148 0.0016 0.3127 0.0084 
Clay (%)  0.3189 0.0076 0.3558 0.0043 0.3246 0.0070 0.3721 0.0033 0.3449 0.0051 0.3144 0.0082 
Silt (%)  0.1317 0.1059 0.155 0.0775 0.1287 0.1103 0.1576 0.0748 0.1545 0.0780 0.1282 0.1110 
Sand (%)  0.1967 0.0440 0.226 0.0294 0.1957 0.0446 0.2327 0.0268 0.2227 0.0308 0.1925 0.0466 
TC (%)  0.4532 0.0008 0.4885 0.0004 0.21 0.0009 0.5785 <0.0001 0.5053 0.0003 0.4457 0.0009 
TN (%)  0.3297 0.0065 0.3319 0.0063 0.306 0.0093 0.4328 0.0012 0.3954 0.0023 0.3017 0.0099 
TOC (%)  0.4414 0.0010 0.4453 0.0010 0.4196 0.0015 0.5661 <0.0001 0.5143 0.0003 0.4091 0.0018 
DOC  (mg kg-1)  0.6667 <0.0001 0.599 <0.0001 0.6267 <0.0001 0.7029 <0.0001 0.7364 <0.0001 0.5829 <0.0001 
CEC   (cm kg-1)  0.2425 0.0233 0.2656 0.0168 0.2568 0.0191 0.3053 0.0094 0.2431 0.0231 0.2513 0.0206 
Fe oxide (g Kg-)  0.1233 0.1186 0.1171 0.1289 0.1113 0.1394 0.1722 0.0614 0.151 0.0817 0.1037 0.1546 
Al oxide (g Kg-1)   0.1673 0.0656 0.1574 0.0750 0.1545 0.0780 0.2253 0.0297 0.199 0.0427 0.1422 0.0919 
Mn oxide (gkg-1)  0.2048 0.0394 0.2382 0.0248 0.2176 0.0330 0.2004 0.0419 0.1772 0.0574 0.2389 0.0246 
Total Fe (g kg-1)  0.1233 0.1186 0.1171 0.1289 0.1113 0.1394 0.1722 0.0614 0.151 0.0817 0.1037 0.1546 
Total Al  (g kg-1)  0.295 0.0109 0.3386 0.0057 0.3036 0.0096 0.3494 0.0048 0.2929 0.0113 0.3523 0.0046 
Total Mn(g Kg-1)  0.1082 0.1453 0.1383 0.0969 0.1187 0.1261 0.1238 0.1179 0.0944 0.1756 0.1308 0.1072 
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7.3.5 Interaction between PAHs and metal/loids during UBM extraction 
 
Results of interaction between PAHs and metal/loids that were aged up to 90 days in 
different soil types are represented in Figures 7.5 – 7.9. Both gastric and gastrointestinal 
bioaccessibility of B[a]P, Pyr, Phe and Nap in all co-contaminated soils were not 
significantly different from soils spiked with individual PAHs at corresponding ageing times 
(p > 0.05).  
 
In a solution-based binary mixtures study, Chun et al (2002) reports that solubility of Phe 
in the digestive fluids was enhanced in the presence of Nap yet reduced in the presence of 
pyrene. In this current study, a slight increase in the range of 0.1 – 1 % in bioaccessible 
B[a]P was observed in the presence of Nap, Phe or Pyr in soil (Figure 7.5). This suggest 
that compound hydrophobicity may in part influence solubility of PAHs in mixtures (Chun 
et al., 2002). In contrast, when B[a]P was co-present with As, Cd or Pb a decrease in the 
range of 0.2 – 2 %, bioaccessible B[a]P was observed (Figure 7.5). In the simulated 
digestive fluids, bile can dissolve more PAHs from soils by forming bile micelle and 
complex with metal/loids (Tang et al., 2006; Feroci et al., 1995). As the decrease in 
bioaccessibility of B[a]P in binary mixtures with As, Cd or Pb was insignificant (p > 0.05), it 
can be established that B[a]P did not compete against As, Cd or Pb for binding sites of bile 
probably due to adequate concentration of bile (>1000 mg L-1). Xia (2016) investigating 
effects of binary mixtures reported that the occurrence of Pyr or B[a]P in aged soils did not 
show effects on the solubility of As, Cd or Pb in simulated digestive fluids (p > 0.05).  
 
The presence of B[a]P with Nap, Phe or Pyr in binary mixtures had no significant  (p > 
0.05) impact on their bioaccessibility (Figures 7.6 – Figure 7.9) over 90 days of ageing, 
however, in each case a slight increase in bioaccessibility was observed. With Nap its 
bioaccessibility at 7, 30 and 90 days of ageing was slightly higher when co-present with 
B[a]P, Phe or Pyr (Figure 7.6). In contrast, the bioaccessibility of Nap was slightly lower in 
all soils spiked As, Cd and Pb in comparison to soils spiked with Nap only (Figure 7.6). 
Similar interaction activity was generally observed in binary mixtures of Pyr and Phe 
(Figures 7.7 and 7.8). A summary of findings is listed in Table 7.11. An interesting find with 
binary mixtures of Pyr + Phe was that the presence of Phe decreased the bioaccessibility 
of Pyr by 0.6 % (Figure 7.7), while the bioaccessibility of Phe increased by 0.4 % (Figure 
162 
 
7.8). Increase in the bioaccessible Phe in soils through competitive displacement with Pyr 
is documented in the literature (White et al., 1999). 
 
While binary interaction between Pyr+Phe were not significant (p > 0.05), it suggests that 
PAH-soil interaction strongly influences its accessibility. Similar to B[a]P, binary mixture 
combinations of Nap, Phe or Pyr with either As, Cd or Pb resulted in a lower than their 
individual bioaccessibility (Table 7.11) In literature, the sorption of Phe is reported to be 
enhanced in the presence of heavy metal cations (e.g. Pb2+) because rubbery organic 
carbon in soils (including flexible dissolved organic carbon and humic acids) was 
condensed on solid surfaces in the presence of metal cations (Luo et al., 2010). 
Additionally, the cation-π interaction between aromatic pi donors and metal cations in 
aqueous solutions have been documented in literature to enhance sorption of PAHs to 
soils, especially soils with high clay content (White et al., 1999). While, studies on 
adsorption isotherms such as Langmuir isotherms have reported clay and sandy soil as 
efficient adsorbents of PAHs such as Nap and Phe (Balati et al., 2015; Osagie and 
Owabor, 2015). In this study, clay was found to have a strong negative influence on the 
bioaccessibility of Phe (Table 7.8).  
 
Both gastrointestinal and gastric bioaccessibility of B[a]P, Pyr, Phe and Nap in a seven 
compound mixture (i.e. B[a]P+Pyr+Phe+Nap+As+Cd+Pb) spiked soils aged over 90 days 
did not show any significant difference in the bioaccessibility values in comparison to soils 
spiked with individual PAHs at corresponding ageing time (p > 0.05). Results for seven 
compound mixture are found in Figure 7.9. Generally, a decrease in bioaccessibility was 
observed for B[a]P and Pyr. Whereas, Nap and Phe showed slight increase in their 
bioaccessibility. 
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Table 7.11 Summary of observations for mixtures of PAHs and metal/loids 
Mixture Interaction effect on bioaccessibility of PAHs 
 B[a]P Pyr Phe Nap 
B[a]P+Pyr + +   
B[a]P+Phe +  +  
B[a]P+Nap +   + 
B[a]P+As _    
B[a]P+Cd _    
B[a]P+Pb _    
Nap+Pyr  +  + 
Nap+Phe   + + 
Nap+As    _ 
Nap+Cd    _ 
Nap+Pb    _ 
Pyr+Phe  _ +  
Pyr+As    _ 
Pyr+Cd    _ 
Pyr+Pb    _ 
Phe+As    _ 
Phe+Cd    _ 
Phe+Pb    _ 
B[a]P+Pyr+Phe+Nap+As+Cd+Pb _ _ + + 
     
“+” signifies increase in bioaccessibility and “-” signifies decrease in bioaccessibility 
 
It is noteworthy that none of the chemical mixtures in this study had a significant effect on 
the bioaccessibility of PAHs in the gastric and intestinal phase. That is B[a]P, Pyr, Phe and 
Nap bioaccessibility was not significantly impacted by the presence or absence of each 
other or As, Cd and Pb at varying concentrations. A possible reason could be that the 
concentrations of binding sites may be much higher than the solubilised PAHs.   
 
164 
 
 
Figure 7.5 A box and whisker plot of B[a]P BAC (%) at 7, 30 and 90 days of ageing (n = 21)  
 
The whisker at lower end of the box and whisker plot is showing the lowest bioaccessibility of B[a]P and the opposite top end indicates 
highest bioaccessibility of B[a]P. The line in the box is median B[a]P bioaccessibility, lower and top end of the box represents the 25th 
and 75th percentile in 7, 30 and 90 day aged soils. G=gastric phase; GI = combined gastric + intestinal phase. 
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Figure 7.6 A box and whisker plot of Nap BAC (%) at 7, 30 and 90 days of ageing (n = 21)  
 
The whisker at lower end of the box and whisker plot is showing the lowest bioaccessibility of Nap and the opposite top end indicates 
highest bioaccessibility of Nap. The line in the box is median Nap bioaccessibility, lower and top end of the box represents the 25th and 
75th percentile in 7, 30 and 90 day aged soils. G=gastric phase; GI = combined gastric + intestinal phase. 
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Figure 7.7 A box and whisker plot of Pyr BAC (%) at 7, 30 and 90 days of ageing (n = 21)  
 
The whisker at lower end of the box and whisker plot is showing the lowest bioaccessibility of Pyr and the opposite top end indicates 
highest bioaccessibility of Pyr. The line in the box is median Pyr bioaccessibility, lower and top end of the box represents the 25th and 
75th percentile in 7, 30 and 90 day aged soils. G=gastric phase; GI = combined gastric + intestinal phase. 
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Figure 7.8 A box and whisker plot of Nap BAC (%) at 7, 30 and 90 days of ageing (n = 21)  
 
The whisker at lower end of the box and whisker plot is showing the lowest bioaccessibility of Nap and the opposite top end indicates 
highest bioaccessibility of Nap. The line in the box is median Nap bioaccessibility, lower and top end of the box represents the 25th and 
75th percentile in 7, 30 and 90 day aged soils. G=gastric phase; GI = combined gastric + intestinal phase. 
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Figure 7.9 A box and whisker plot of B[a]P, Phe, Pyr and Nap BAC (%) at 7, 30 and 
90 days of ageing (n = 21).  
 
The whisker at lower end of the box and whisker plot is showing the lowest bioaccessibility 
of PAH and the opposite top end indicates highest bioaccessibility of PAH. The line in the 
box is median PAH bioaccessibility, lower and top end of the box represents the 25th and 
75th percentile in 7, 30 and 90 day aged soils. G=gastric phase; GI = combined gastric + 
intestinal phase. 
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7.3.6 Application to real (contaminated) samples 
The field contaminated soils in this study included three soil samples from the vicinity of a 
former manufacturing gas plant site at Cootamundra (NSW) and three soil samples from 
an undisclosed industrial site. The total concentrations of B[a]P in these soils were above 
the soil Health Investigation Levels (HIL A) value of 3 mg Kg-1 (NEPC, 2013). The total 
concentrations of B[a]P in the < 250 µm soil fraction of the field contaminated samples 
were in a range of 3 ± 0.6 mg Kg-1  to 103 ± 15.6 mg Kg-1 (Tables 7.12 and Table 7.13). 
The concentrations of the spiked and aged samples for B[a]P were 3 ± 0.5 mg Kg-1 to 234 
± 6 mg Kg-1, the field samples were therefore appropriate for comparison. Site 1 soil from 
the Cootamundra site had particularly high total organic carbon content, therefore it was 
no surprise that the bioaccessible B[a]P was low at  3.2 ± 1 %.   
 
No B[a]P was found in the gastric phase suggesting it was not or near zero bioaccessible 
if gastric phase was used for BAC determination. Sites 2 and 3 from Cootamundra had 
very low total organic carbon content (i.e. TOC = 0.96 and 1.3 %) and the bioaccessible 
B[a]P up to 18 ± 2.1 % was found (Table 7.11). The bioaccessibility of B[a]P was 
particularly low in soils from the undisclosed industrial sites and were found in the range 
0.2 ± 0.1 % to 1.3 ± 0.1 % (Table 7.12). A recent study investigating bioaccessibility of 16 
US EPA priority PAHs in soils originating from former manufacturing gas plant sites using 
PBET with silicon cord (sorption sink) found total bioaccessible concentrations of 16 US 
EPA PAHs in a range of 3.8 % to 15.3 % (Juhasz et al., 2016).  
 
Low bioaccessibilities of PAHs at such contaminated sites could be attributed to pyrogenic 
inputs. Jonkers and Koelmans (2002) and Cornelissen et al. (2005) highlighted that 
desorption of PAHs originating from pyrogenic sources may be reduced due to occlusion 
and or entrapment of PAHs in the soot matrix resulting from the co-production processes. 
Juhasz et al. (2016) reported PAH desorption in soils from pyrogenic sources can also be 
influenced by the effects of coke, lampblack and other chars that result from the 
incomplete combustion of total organic carbon. However, sum of 16 US EPA PAHs 
bioaccessible concentrations of up to 60 % have been found in a few studies using fasted 
PBET (Juhasz et al., 2016; Tang et al., 2006). Juhasz et al. (2016) highlighted the reason 
for high bioaccessibility of PAHs is because these soils were impacted with creosote. Tang 
et al. (2006) provided very basic information for soil properties for the soil sample with the 
highest bioaccessibility of 60 %, except that the organic carbon content was 1.99 %.  
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The bioaccessibility of B[a]P (3.2 ± 1 % to 18 ± 2.1 %) in soils from the Cootamundra sites 
(former manufacturing gasworks site) were similar to that reported in the literature for other 
former manufacturing gas plant sites (Juhasz et al., 2016; GrØn et al., 2007; Van de Wiele 
et al., 2004). The low bioaccessibility of B[a]P in both the Cootamundra Site 1 and the 
undisclosed industrial sites, indicates that B[a]P-soil interaction is strong as B[a]P is very 
immobile and tightly bound to soil ligands. The presence of black carbon in soils from 
former manufacturing gasworks sites has been linked to significant sequestration of B[a]P 
in soils (Jonkers and Koelmans, 2002; Pignatello and Xing, 1996).  
 
Table 7.12. Total concentrations of PAHs in soil samples from the Cootamundra site 
Compound Site 1   Site2  Site 3  
 (n=3)  (n=3)  (n=3)  
 Total  
(mg Kg-1) 
BAC (%) 
GI phase 
Total  
(mg Kg-1) 
BAC (%) 
GI phase 
Total  
(mg Kg-1) 
BAC (%) 
GI phase 
B[a]P 60±4.8 3.2±1 59±12 11.5±3.5 3±0.6 18±2.1 
Nap 3±0.6 10±4.5 2±0.6 30±8.2 1±0.4 42±6.4 
Phe1 54.4±8.2 12.5±1.4 22.7±4.5 10.7±1.6 6.8±2.7 7.2±1.8 
Pyr2 112.4±13.5 4.5±1.8 23.5±3.6 7.6±2.7 8.9±1.2 8.1±2.5 
Where “-“indicates not done. Site 1= Cootamundra sample 1 (NSW); Site 2 = 
Cootamundra sample 2 (NSW); Site 3 = Cootamundra sample 3 (NSW); MTA = Mount 
Tamborine (QLD); N = Dublin (SA).  
 
 
 
Table 7.13 Total concentrations of PAHs in soil samples from undisclosed industrial 
sites 
Compound PB8   PB18  PB24  
 (n=3)  (n=3)  (n=3)  
 Total  
(mg Kg-1) 
BAC (%) 
GI phase 
Total  
(mg Kg-1) 
BAC (%) 
GI phase 
Total  
(mg Kg-1) 
BAC (%) 
GI phase 
B[a]P 25.5±6.2 1.3±0.1 54.8±8.7 0.6±0.2 103±15.6 0.2±0.1 
Nap 0.5±0.1 10.3±1.2 0.88±0.2 5.4±1 0.45±0.1 12±1.1 
Phe 2.3±0.4 16.5±1.6 3.5±1.1 4±0.8 6.8±1.2 8±2.4 
Pyr1 13.3±1.5 4±0.2 13±1.8 8±0.5 75.3±12 6±1.8 
1In sample PB24 the gastric phase bioaccessibility of Pyr was 0.7 %. None of the other 
compounds were detected in gastric phase of PB8, PB18 and PB24.   
 
Both low and high bioaccessibilities of Pyr, Phe and Nap were found in real contaminated 
soil samples (Table 7.12 and Table 7.13). High bioaccessibility of Nap (42 ± 6.4 %) in Site 
3 soil can be attributed to low TOC content (Table 7.1). The bioaccessibility of Phe in real 
samples were in the range of 2.3 ± 0.4 % to 16.5 ± 1.6 %. The bioaccessibility of Pyr in 
real samples were in the range of 4 ± 0.2 % to 13 ± 1.8 %. The low bioaccessibility of 
B[a]P in real soil samples and highly variable bioaccessibilities of other PAHs in these 
soils suggests a more complex matrices (i.e. tarry materials) and mechanism of 
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partitioning to soil organic content and desorption. James et al. (2016) explains that soil 
sorption of organic compounds follows either adsorption to amorphous organic matter or 
adsorption to carbonaceous geosorbents (i.e. black carbon, unburnt coal and coke). 
Cornelissen et al. (2005) suggests that adsorption to amorphous organic matter follows a 
linear, non-competitive binding with fast desorption kinetics, whereas adsorption to 
carbonaceous geosorbents follows non-linear competitive binding with slow desorption 
kinetics. In this study, low molecular weight PAHs such as Nap and Phe had 
comparatively higher bioaccessibilities in real soil samples than B[a]P and Pyr. The real 
soils samples in part are from former manufacturing gasworks sites where operational 
processes would impact surface soil with more carbonaceous geosorbents such as coke 
or black carbon. Such carbon source could explain the differences between PAH 
bioaccessibilities and suggest competitive binding aspects of carbonaceous geosorbents.    
 
Relative bioaccessibility of B[a]P in soils used in a “juvenile swine” study 
The relative bioaccessibility of B[a]P in soils used previously in a juvenile swine study was 
determined using UBM and soil fraction size of <250 µm. The total concentrations of B[a]P 
in the two soil samples were found above HIL A for B[a]P (Table 7.14). In this study, the 
relative bioaccessibility of B[a]P in two soils used in a juvenile swine study were compared 
to relative bioavailability of B[a]P. For soil MTA (Mount Tamborine, QLD), the relative 
bioaccessibility of B[a]P was 53.3 ± 10.7 % and was found not to be significantly different 
(p value = 0.21) from the relative bioavailability value of 62.7 % reported in the juvenile 
swine study (Duan, 2014). For soil N (Dublin, SA), the relative bioaccessibility of B[a]P 
was found to be 120 ± 5.3 %, which was higher and significantly different (p = 0.02) from 
the relative bioavailability value of 108 %. Based on the statistical difference, for soil N the 
bioaccessibility of B[a]P using UBM overestimated the in vivo bioavailability of B[a]P in the 
juvenile swine model. Due to the use of only two soil samples from juvenile swine study, 
the relationships between in vitro and in vivo assays although seem acceptable but will 
require further validation using a wider range of environmental soils. 
 
Table 7.14 Total concentrations of B[a]P in soil samples MTA and N 
Compound MTA  N  
 (n=3)  (n=3)  
 Total (mg Kg-1) Relative 
BAC (%) 
GI phase 
Total (mg Kg-1) Relative 
BAC (%) 
GI phase 
B[a]P 5 ± 0.5 53.3 ± 10.7 4.4 ± 1.2 120 ± 5.3 
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7.4 Conclusion 
This study has identified significantly strong relationships between soil physicochemical 
properties and its influence on the bioaccessibility of PAH compounds Nap, Phe, Pyr and 
B[a]P. The UBM results suggest that the most significant interactions between PAHs and 
soil components controlling its bioaccessibility was completed by the first 7 days of ageing 
condition of this study. Soil properties such as DOC and solution pH had prominent effect 
on mobilisation of PAHs from soils to simulated digestive fluids over a period of 90 days of 
ageing. Soil TOC had a major effect on reducing bioaccessibility of Nap, Phe, Pyr and 
B[a]P in all seven soil types. Clay content was found to negatively influence the 
bioaccessibility of Phe, but increase in soil pH was found to increase the bioaccessible 
B[a]P and Pyr in both the gastric and intestinal solutions. Aluminium oxide was found to 
reduce the bioaccessibility of Phe and B[a]P in the gastric phase in the 90 day aged soils. 
This is more apparent in the absence of high concentration of competing ligands like bile 
salts as found in the gastrointestinal fluids. Increasing total soil concentrations had no 
statistically significant effect on PAH bioaccessibility in the gastric or intestinal phase. For 
mixture effects, the bioaccessibility of B[a]P in the presence of As, Cd or Pb decreased by 
0.2 %, 1.8 % and 2 %, respectively. Similar observations were seen with Pyr, Phe and 
Nap in combination with As, Cd or Pb, with decrease in bioaccessibilities in the range of 
0.1 – 1.8 %. The results from field contaminated soils presents a much complex matrix 
and may require testing with a wider range of soil properties to elucidate interaction 
effects. The relative bioaccessibility in two soil samples from a “juvenile swine” study were 
close to relative bioavailability values, the relationships between in vitro and in vivo assays 
although seem acceptable will require further validation using a wider range of 
environmental soils.  
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Chapter 8 Uptake of UBM-extracted PAHs in human liver cells in the presence or 
absence of As, Cd and Pb 
 
Abstract 
A major route of exposure to polycyclic aromatic hydrocarbons (PAHs) is via the incidental 
ingestion of soil particles. Soil-bound PAHs may become available for uptake after 
mobilization from soil particles into gastrointestinal fluids. In this chapter, PAH spiked and 
aged soils or field contaminated soils were digested using UBM followed by exposure to 
HepG2 cells to quantify uptake and metabolism (as a surrogate measure of bioavailability). 
The PAHs investigated included B[a]P, Pyr, Phe and Nap. Interactions of B[a]P, Pyr, Phe 
and Nap demonstrated that freely available PAHs may influence their respective uptake 
into cells. The average % uptake of B[a]P, Pyr, Phe and Nap in HepG2 cells were 1.6 %, 
4.2 %, 1.2 % and 0.05 %, respectively. Concomitantly, the type of PAHs may influence the 
uptake and metabolism in mixtures and possibly their resultant toxic effects. The 
interaction between UBM-extracted (B[a]P+Pyr), (B[a]P+Nap) and (B[a]P+Phe) increased 
percentage uptake of B[a]P in HepG2 cells by 0.3 %, 0.9 % and 0.4 %, respectively. While 
binary mixtures of B[a]P with As, Cd and Pb increased percentage uptake of B[a]P in 
HepG2 cells by 0.3 %. In contrast, the percentage uptake of UBM-extracted B[a]P in 
HepG2 cells decreased by 0.2 % in the mixture (B[a]P+Pyr+Phe+Nap+As+Cd+Pb). Using 
UBM-extracted solutions, interaction effects on uptake of PAHs in HepG2 cells suggests 
additive and less than additive.   
 
Keywords: Benzo[a]pyrene, HepG2, metabolism, uptake, chemical risk assessment 
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8.1 Introduction 
Bioavailability (BA) is defined as the amount of contaminant that is absorbed into the body 
following skin contact, ingestion or inhalation (Ng et al., 2010). Currently, environmental 
regulatory guidelines for site contamination assessment in Australia, National Environment 
Protection Measures (NEPM) and overseas are often set assuming the contaminant is 
100% bioavailable (Ng et al., 2010; National Environment Protection Council, 2013). 
However, it has been shown repeatedly that many hydrophobic soil contaminants, 
including PAHs are less than 100 % bioavailable and that its bioaccessibility tends to 
decrease in aged soils (Reeves et al., 2001; Pignatello and Xing, 1996). The process of 
ageing of PAHs in soil has been a subject of investigation in a number of studies (Reeves 
et al., 2001; Alexander, 2000). Soil properties, including the type and amount of organic 
matter are often associated to interactions between soil and PAHs (Piatt and Brusseau, 
1998).  
 
Incidental ingestion of contaminated soil is a major route of exposure to PAHs in humans, 
children being the highest risk group due to their hand-to-mouth activity which exposes 
them to soil or dust particles (Duggan et al., 1985; Wilson et al., 2001). While Norris et al. 
(1998) reports that the absorption of soil particles in the gastrointestinal tract of higher 
animals is thought to be negligible. It is noteworthy that during digestion the constituents in 
the gastrointestinal fluids could mobilise portions of the contaminants sorbed onto the soil 
particles, which ultimately could be bioavailable to cells (Weber and Lanno, 2001; Oomen 
et al., 2001; Dulfer et al., 1996). The “gold standard” in animal testing to determine the 
bioavailability of contaminants is the use of a “juvenile swine” due to its anatomical 
similarity to infants. However, considering the 3R principle in animal testing, alternative 
approaches including cell based in vitro methods are given attention as they are 
comparatively inexpensive, avoids unethical issues of animal testing for large-scale 
screening and are more reproducible. Further, cell based in vitro systems take into 
consideration metabolic processes and mass balance of compounds, which could be 
useful in determining more toxicologically relevant concentrations causing cellular 
response (Madureira et al., 2014; Kramer et al., 2012). Additionally, a number of studies 
have used in vitro methods designed to mimic gastrointestinal digestion and measure the 
amount of PAHs that mobilised from soils into digestive fluids (Juhasz et al., 2016; Li et al., 
2015; Cave et al., 2010) as a means of estimating relative bioaccessibility (a surrogate for 
prediction of bioavailability). Most of these in vitro models have been used successfully for 
the prediction of the bioavailability of inorganic compounds (metal/loids). Denys et al. 
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(2012) evaluated the relative bioavailability of As, Cd and Pb using a juvenile swine model 
and demonstrated that the stomach phase of the in vitro test (Unified BARGE Method) 
correlated with the bioavailability values from the in vivo model. However, similar data with 
a range of PAHs is not available. Further, there are limited studies that have used in vitro 
methods that mimic gastrointestinal digestion together with a cell based bioassay to 
investigate uptake into cells. Oomen et al. (2001) using an in vitro gastrointestinal model 
found that 54 % of polychlorinated biphenyls (PCBs) were mobilised from spiked soils into 
digestive fluids, however, the uptake of PCBs into cultured human enterocytes (Caco-2 
cells) was less than 10 % of the mobilised PCBs. While Reeves et al. (2001) investigating 
the impacts of ageing on in vivo and in vitro measurements of soil-bound PAHs availability 
indicated that, at high application rates, soil contact time may not play as significant a role 
in determining availability as simple dispersion and sorption on soil. 
 
The aims of this chapter were to quantify the interaction effects of ageing and soil 
properties on the mobilisation and uptake of PAHs bound to spiked or field-contaminated 
soils, and to quantify interaction between chemical mixtures of B[a]P, Pyr, Phe, Nap, As, 
Cd or Pb on uptake of PAHs in human liver cells. Two in vitro models were used to 
achieve these aims.  The UBM simulated human digestive fluids and HepG2 cell bioassay 
was used as a surrogate for the liver, which is the key organ for metabolism.  
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8.2 Materials and methods  
8.2.1 Chemicals and reagents  
Please refer to the detailed lists of general laboratory chemicals, pure standards and 
culture medium used in cell culture and compound extraction, sample clean-up and 
analysis of PAHs and OH-PAHs found in Chapter 3 (see Table 3.1, Table 3.2 and Table 
3.3).   
8.2.2 Dosing of PAH-UBM extracts into human liver cells  
The HepG2 cells were cultured using DMEM and complemented with 10 % FBS, the 
protocol for cell culture, dosage and collection is found in Chapter 3 of general materials 
and methodology in Section 3.8. The PAHs in contaminated soils were extracted using 
Unified BARGE Method (UBM) and solubilised in simulated human digestive fluids as 
described in Chapter 7. The UBM gastrointestinal-phase solutions containing PAHs 
extracted from contaminated soils (Chapters 7) were utilised for uptake study in this 
chapter. The extracts were introduced into DMEM (maintained at 37 0C) with gentle 
shaking before dosing cells for a 24 h exposure.   
8.2.3 Extraction and measurement of PAHs and OH-PAHs in the culture medium  
Please refer to Chapter 5, Section 5.2.3 for the protocol on extraction and measurement of 
PAHs and OH-PAHs in the culture medium. 
8.2.4 Extraction and measurement of PAHs and OH-PAHs in human liver cells 
Please refer to Chapter 5, Section 5.2.4 for the protocol on extraction and measurement of 
PAHs and OH-PAHs in human liver cells. 
8.2.5 Extraction and measurement of PAHs and OH-PAHs in the flask plastic 
Please refer to Chapter 5, Section 5.2.5 for the protocol on extraction and measurement of 
PAHs and OH-PAHs in flask plastic.  
8.2.6 Quality Control  
Background concentrations of PAHs and OH-PAHs were checked using blank samples, 
media and culturing flask. Spike recoveries and blanks were included in each batch 
analysis. Isotopically labelled standards were used as internal standards to identify 
compounds and were also included in matrix matched standards. All samples were 
analysed with a minimum of three replicates.    
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8.2.7 Statistical analysis 
Statistical analysis was performed using Prism 7 (Graphpad Software Inc., La Jolla, USA). 
Statistical differences among treatments were determined by a two-tailed Student t test, 
with a significance level set at more than 95 %. For mixture effect, data was compared for 
differences in means using one way ANOVA and Tukey test for multiple correlations. 
Significance difference was set at p < 0.05. 
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8.3 Results and discussion 
8.3.1 Mass balance and uptake of PAHs in the HepG2 in vitro system 
The GC-QqQ-MS/MS and Q-Orbitrap-LC/MS data were used to calculate the mass 
balance of PAHs. All four PAHs and their biotransformation products were measured in 
different compartments of the in vitro system (i.e. medium, HepG2 cells and plastic) at a 
24 h exposure time (Table S8.1, supplementary information). HepG2 cells have been 
widely used in cytotoxicity assessments due to the scare availability of fresh human liver 
samples. Despite their similarity in genotypic features of normal human liver cells, HepG2 
cells lack similar metabolic capacity to primary hepatocytes (Gerets, 2012). The amount of 
PAHs in the different compartments is expressed as percentage of initial measured 
concentration. The analysis revealed that up to 97 % of the PAHs were found to be 
present in the culture medium and up to 5 % was measured in the HepG2 cells, whereas 
up to 1 % was bound to flask plastic. The near complete recovery of PAHs can be 
explained through loss of metabolism (i.e. metabolites not quantified) and some volatility 
issues (i.e. trace concentrations of Nap in treated samples) resulting from a 24 h 
incubation. Concentrations of PAHs in culture media and flask plastic were measured in 
control experiments in the absence of cells. At 24 h of exposure and in the absence of 
HepG2 cells, the amount of PAHs bound to flask plastic were up to 2 %. The decrease in 
the amount of B[a]P bound to flask plastic over exposure time and diffusing into the culture 
medium has been demonstrated in a previous study (Madureira et al., 2014). All 
experiments were conducted in replicates (n = 3).  
 
The analysis revealed that majority of the PAHs remained in the culture medium, this 
presumably is due to the high affinity of PAHs to serum components. Serum component in 
culture medium has been reported to play an important role in determining the availability 
of B[a]P in mammalian cells (Madureira et al., 2014). Similarly, Hestermann et al. (1999) 
demonstrated that majority of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD, used in 
activation of the aryl hydrocarbon receptor or AhR) is found in the medium and that small 
changes in serum concentrations could have significant effects on compound uptake into 
cells.     
 
To investigate the uptake of PAHs into HepG2 cells, the internal cell concentrations were 
measured after 24 h exposure to UBM-DMEM solution (i.e. PAHs solubilised into 
gastrointestinal fluids and added to the DMEM cell culture medium). The internal 
concentrations of B[a]P and its transformation products were quantitatively measured in 
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HepG2 cells. Cells were exposed to 0.2 ± 0.1 µM to 3.9 ± 0.5 µM concentration of B[a]P 
for 24 h. The cell numbers determined after 24 h of exposure were used to normalise 
B[a]P concentrations. Cellular uptake of B[a]P in HepG2 cells over 24 h was in a range of 
6 ± 2 ng/106 cells to 150 ± 12 ng/106 cells (Figure 8.1). The metabolite 3-OH-B[a]P 
resulting from biotransformation of B[a]P in HepG2 cells was also quantified after 24 h 
exposure. Concentrations of 3-OH-B[a]P were normalised based on cell number  (Figure 
8.1). The results indicate that as the exposure concentration of B[a]P in the UBM-DMEM 
solution increased, the internal cell concentrations of B[a]P and 3-OH B[a]P increased as 
well (R2 = 0.93 and 0.83, Figure 8.1). The % uptake of B[a]P (i.e. B[a]P+3-OH B[a]P) in 
HepG2 cells (expressed as percentage of initial measured concentration) was found in the 
range of 1.3 ± 0.1 % to 2 ± 0.3 % (Table 8.1).  Notably, the % uptake of B[a]P in HepG2 
cells decreased by 0.5 % from exposure to UBM-DMEM solution compared to B[a]P 
exposure using pure chemical solutions (Chapter 5). As B[a]P is highly hydrophobic in 
nature (Log Kow = 6.13), the findings in this chapter suggests a further sequestration of 
B[a]P in UBM-DMEM solution though binding to competing ligands such as lipoproteins 
from cell culture medium, serum and UBM (i.e. intestinal digestive fluids).  
 
In previous studies, Busbee et al. (1990) using rat hepatocytes found that uptake of B[a]P 
was potentiated by high density lipoproteins (HDL) and impeded by low density 
lipoproteins (LDL). Plant et al. (1985) using delivery vehicles, which were HDL, LDL and 
very low density lipoproteins (VLDL) reported that B[a]P uptake by human fibroblast cells 
was a simple partitioning phenomenon, controlled by the relative lipid volumes of 
extracellular donor lipoproteins and of cells, and does not involve lipoprotein endocytosis 
as an obligatory step. Further, the fetal bovine serum (FBS) used in this study contains 
both HLD and LDL with LDL being the major class of lipoprotein (Forte et al., 1981) and 
the VLDL is the major lipoprotein in the intestinal digestive fluids (Iqbal and Hussain, 
2009). Together, these explain the results in this chapter, which demonstrates that only a 
fraction of UBM-extracted B[a]P exposed become available to cells, while major amounts 
remain sequestered in the culture media. It is noteworthy, exposure in the absence of FBS 
may increase the sensitivity of cell bioassay. Hestermann et al. (2000) emphasised that 
using serum-free medium allows the greatest sensitivity in response to inducing 
compounds. However, the ability of cells to grow in serum-free medium and in the 
presence of B[a]P was not determined in this study and may be useful for comparison in 
future studies. Exposure experiments in this current study included serum which contain 
additional protein and lipid contents to help sustain cell growth. This also presents an 
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exposure scenario where proteins and lipids from food or soil containing PAHs may 
interact and affect the bioavailability of PAHs. It is also noteworthy, most serum 
replacements still contain a high protein or lipid content (Hestermann et al., 2000).  
181 
 
                          
           
Figure 8.1 Total PAHs uptake into HepG2 cells over 24 h of exposure, values are shown as mean ± SD, n = 3  
 
A is showing the total uptake of B[a]P (B[a]P + 3-OH B[a]P) from exposure to UBM-extracts of seven soil types. B is showing the total Pyr 
uptake (Pyr + 1-OH Pyr) in HepG2 cells; C is showing total uptake of Phe (Phe + 4-OHPhe) in HepG2 cells and D is showing total uptake 
of Nap (Nap + 1-OH Nap) in HepG2 cells. The “X” axis is showing the exposure concentrations of PAHs in the UBM-DMEM solution.  
 
 
A   B 
 C   D 
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The uptake and metabolism of Nap, Phe and Pyr in HepG2 cells exposed for 24 h is 
shown in Figure 8.1. HepG2 cells were exposed to Pyr at concentrations of 1.7 ± 0.2 µM to 
27.7 ± 2.5 µM. This resulted in cellular uptake of Pyr at 24 h in the range of 160 ± 10 
ng/106 cells to 2100 ± 10 ng/106 cells. As seen with B[a]P, the intracellular concentrations 
of Pyr and its metabolite 1-OH Pyr also increased with increasing concentrations of Pyr in 
UBM-DMEM solution (R2 = 0.94 and 0.83; Figure 8.1). The % uptake of Pyr (Pyr+1-OH 
Pyr) in HepG2 cells at 24 h were in the 3.9 ± 1.1 to 4.9 ± 0.1 % range. When comparing 
the % uptake of Pyr in pure chemical solutions (Chapter 5) to the results in this chapter, it 
was found that there was a 1 % increase in the % uptake of Pyr in HepG2 cells from 
exposure to UBM-DMEM solutions.  
 
Phenanthrene cellular uptake showed similar behaviour with the intracellular 
concentrations found in the range of 129 ± 5 ng/106 cells to 1350 ± 25 ng/106 cells (R2 = 
0.89; Figure 8.1). Its metabolite, 4-OH Phe also increased in a concentration-dependent 
exposure (R2 = 0.84; Figure 8.1). The % uptake of Phe (Phe+4-OH Phe) in HepG2 cells 
was in the range of 0.9 ± 0.2 % to 1.5 ± 0.1 %.  Further, exposure to Phe in UBM-DMEM 
solution resulted in a 0.3 % increase in % uptake of Phe in HepG2 cells compared to data 
from pure chemical solution study (Chapter 5). It can be proposed that Pyr and Phe may 
additionally be transported in combination with small bile acids or lipoproteins into HepG2 
cells via passive diffusion or membrane carriers. Which could explain increase in 
intracellular concentrations following exposure to UBM-DMEM solution, which introduces 
additional lipoproteins and contains small bile acids from UBM-extracts (intestinal 
digestion fluids).  
 
The uptake of Nap in HepG2 cells was found to be low and in the range of 4 ± 0.5 ng/106 
cells to 18 ± 2 ng/106 cells. As a result, 1-OH-Nap was only detectable at low 
concentrations (Figure 8.1). Most of the Nap was found in UBM-DMEM solution or bound 
to the flask plastic (Table S8.1, supplementary information), minor loss also resulted due 
to volatility issues. Further, Nap is the least hydrophobic PAH (Log Kow = 3.30) and was 
mostly solubilised in UBM-DMEM solution. Hence, the % uptake of Nap in HepG2 cells 
was found in the range of 0.03 ± 0.01 % to 0.06 ± 0.01 %. Additionally, the % uptake of 
Nap in HepG2 cells increased by 0.01 % from exposure to UBM-DMEM solution compared 
to Nap exposure using pure chemical solutions (Chapter 5).  
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Table 8.1 Percentage (%) uptake) of single PAHs in HepG2 cells at different treatment concentrations in UBM-DMEM 
Compound Concentration (µM) % Uptake Compound Concentration (µM) % Uptake 
B[a]P 0.2 ± 0.1  
0.4 ± 0.2 
1.3 ± 0.2 
1.4 ± 0.1 
Pyr 3.7 ± 0.2 
4.4 ± 0.2 
4.4 ± 0.1 
4.5 ± 0.1 
 0.6 ± 0.2 1.4 ± 0.1  4.8 ± 0.4 4.0 ± 0.1 
 1.0 ± 0.1  1.6 ± 0.3  6.2 ± 0.5  4.1 ± 0.1 
 1.1 ± 0.2  1.6 ± 0.1  11.1 ± 0.5 4.4 ± 0.2 
 1.2 ± 0.2 1.6 ± 0.2   12.3 ± 0.5 4.8 ± 0.2  
 1.6 ± 0.2 1.5 ± 0.2  12.5 ± 0.4 2.9 ± 0.5 
 1.9 ± 0.3 1.6 ± 0.2  15.3 ± 0.4 4.9 ± 0.2 
 2.0 ± 0.5  2.0 ± 0.3  15.5 ± 0.4  4.1 ± 0.1 
 2.1 ± 0.1 1.8 ± 0.2  17.2 ± 0.5 3.8 ± 0.2 
 3.0 ± 0.2  1.8 ± 0.2  19.2 ± 0.5  4.5 ± 0.2 
 3.1 ± 0.1  1.6 ± 0.2  20 ± 1.0  4.5 ± 0.2 
 3.6 ± 0.2 1.5 ± 0.1  25.9 ± 1.0 3.6 ± 0.2 
 3.9 ± 0.3  1.4 ± 0.1  27.7 ± 0.5 3.6 ± 0.2 
      
Phe 7.8 ± 0.5  
10.6 ± 0.2 
1.4 ± 0.2 
1.5 ± 0.1 
Nap 5.8 ± 0.5  
7.0 ± 1.0 
0.05 ± 0.01 
0.06 ± 0.01 
 0.6 ± 0.2 1.4 ± 0.1  7.5 ± 0.5 0.05 ± 0.01 
 11 ± 0.2  1.1 ± 0.2  7.8 ± 1.1  0.05 ± 0.01 
 15.9 ± 0.5  1.2 ± 0.2  8.3 ± 1.1  0.05 ± 0.01 
 18.5 ± 0.5 1.1 ± 0.2   8.8 ± 0.5 0.06 ± 0.01 
 14.8 ± 1.0 1.5 ± 0.2  8.9 ± 1.1 0.05 ± 0.02 
 24.2 ± 0.5 1.1 ± 0.1  9.8 ± 1.2 0.03 ± 0.01 
 21.8 ± 1.1  1.1 ± 0.1  10.0 ± 1.0  0.04 ± 0.01 
 17.5 ± 0.5 1.4 ± 0.1  15.5 ± 1.1 0.05 ± 0.02 
 27.6 ± 1.1 1.0 ± 0.1  19.2 ± 1.1  0.04 ± 0.01 
 31.3 ± 0.5  1.0 ± 0.1  22.1 ± 1.1 0.04 ± 0.01 
 70.6 ± 0.5 0.9 ± 0.1  24.5 ± 0.5 0.06 ± 0.01 
 82.5 ± 0.5  0.9 ± 0.1  27.8 ± 1.0 0.04 ± 0.01 
Uptake (%) of PAHs into HepG2 cells over 24 h of exposure, values are shown as mean ± SD, n = 3. 
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Moreover, the results in this chapter suggest that a major route of PAH uptake in HepG2 
cells is passive diffusion. In a previous study, Vasiluk et al. (2007) observed similar uptake 
values for liver and metabolically inert Caco-2 cells and suggested that major route of 
B[a]P uptake in Caco-2 cells is passive diffusion. Barhoumi et al. (2000) using laser 
cytometry technique demonstrated that B[a]P uptake into rat liver cell line (Clone 9; CRL 
1439) was rapid and partitioning of B[a]P into the plasma membrane and membranes of 
intracellular organelles occurred within minutes of exposure. Further, Kocan et al. (1983) 
using human fibroblast cells observed remarkably high intracellular concentrations of 
B[a]P and accumulation within vesicles as crystal when cells were exposed to 
concentrations at or above 10 µg mL-1 (~40 µM) of B[a]P using DMSO or acetone as a 
vehicle and in the absence of serum. This suggests that concentration-dependent uptake 
of PAHs in cells may only be linear up to certain exposure concentrations and additional 
transport mechanisms for PAH uptake in cells may also influence its bioavailability. In this 
current study, a concentration-dependent uptake of B[a]P, Pyr, Phe and Nap was 
observed within the limited exposure concentrations of the UBM-DMEM solutions (Figure 
8.1).   
 
It is generally believed that hydrophobicity might play a role in bioavailability of PAHs. 
Gilbert et al. (2014) has reported diffusive transport is particularly relevant for the transport 
of highly hydrophobic chemicals (log Kow > 5). In this study, Pyr uptake in HepG2 was 
higher in comparison to Phe in terms of cell internal concentration, even when both were 
treated at similar concentrations. Presumably the octanol-water partition coefficient may 
be influential in limiting uptake of PAHs in HepG2 cells. This could also explain low uptake 
of Nap in HepG2 cells compared to other PAHs in this study. The dosing concentrations of 
Pyr, Phe and Nap were higher than B[a]P in the UBM-DMEM solution and competition for 
freely available compounds by cells and lipoproteins could explain increase in internal cell 
concentrations (but not the % uptake – see Table 8.1), however, this was efficiently 
counteracted with cell metabolism (Figure 8.1). Furthermore, the linear relationship 
between internal cell concentrations and UBM-extracted PAHs in Figure 8.1 can be 
attributed to extracellular PAH concentrations being lower than toxic concentrations (i.e. 
B[a]P LC20 = 5 µM, for Pyr, Phe and Nap up to 82.5 µM did not exhibit toxicity).  
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8.3.2 Uptake of UBM-extracted PAHs in HepG2 cells in the presence or absence of 
As, Cd and Pb 
 
Based on the findings of the concentration-dependent response of HepG2 cells to single 
PAH compounds, further investigations were directed at elucidating the effects of mixtures 
of B[a]P, Pyr, Phe and Nap in the presence or absence of As, Cd and Pb on their 
individual uptake in HepG2 cells. Similar to the pure chemical solution study in Chapter 5, 
the effects of chemical mixtures in UBM-soil extracts were evaluated to see if interaction 
with other PAHs and metal/loids can influence uptake of PAHs into HepG2 cells.  
 
Recent studies using HepG2 bioassay have demonstrated the effects of PAH and 
metal/loid mixtures on end points such as micronucleus formation, oxidative stress and 
cytotoxicity (Peng et al., 2015, Muthusamy et al., 2016a; Muthusamy et al., 2016b). A 
much larger chemical mixtures study was which was partially funded by the U.S. EPA 
using human cells (i.e. primary human hepatocyte cultures and HepG2 cells) and focused 
on determining the effects of mixtures of PAHs and metal/loids on induction of CYP1A1 
(Vakharia and Kaminsky, 2001; Vakharia et al., 2000).  
 
However, to date the effects of mixtures of PAHs and metal/loids on PAH uptake and 
metabolism in HepG2 is largely unknown. In this chapter effects of binary and seven-
compound chemical mixtures of B[a]P, Pyr, Phe, Nap, As, Cd and Pb on % uptake of 
PAHs in HepG2 cells was investigated using UBM-DMEM solutions (i.e. UBM-soil extracts 
added to DMEM) at concentrations similar to exposure from individual PAH compounds. In 
binary mixtures of (B[a]P+Pyr), (B[a]P+Nap) and (B[a]P+Phe), the % uptake of B[a]P in 
HepG2 cells increased by 0.3 %, 0.9 % and 0.4 %, respectively (Figure 8.2). It is 
noteworthy that the interaction from Phe (p value = 0.047) and Nap (p value < 0.01) 
causing an increase in % uptake of B[a]P in HepG2 cells was statistically significant. The 
% uptake of B[a]P in HepG2 cell also increased in the presence of Pyr, and however, the 
difference in % uptake between single compound B[a]P and (B[a]P+Pyr) was not 
significant (p = 0.30).  The binary mixture results for B[a]P suggests that interaction 
between freely available PAHs may influence their respective uptake into cells. In a 
previous study, Chun et al. (2002) observed that solubility of Phe in the digestive fluids 
was enhanced in the presence of Nap yet reduced in the presence of Pyr and therefore 
proposed that compound hydrophobicity may in part influence solubility of PAHs in 
mixtures. This may explain the results for increase in % uptake of B[a]P in binary 
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combinations of (B[a]P+Nap) and (B[a]P+Phe), where most significant increase in % 
uptake was in combination with Nap (p value < 0.01). Naphthalene has the lowest octanol-
water partition coefficient (Kow) of any PAHs at Kow = 3.30 and therefore B[a]P with a Kow = 
6.04 was more soluble in the cell membrane. Kocan et al. (1983) reported that due to 
hydrophobic nature of B[a]P, it easily binds to proteins, nucleic acid and dissolves in cell 
membranes. It is also noteworthy that a decrease in 3-OH B[a]P was observed in binary 
mixtures of B[a]P with Pyr, Phe and Nap. Although not significant (p > 0.05), it indicates 
competition for the same metabolising enzymes. Hence it can be proposed that HepG2 
cell metabolism may have an influential role in uptake of PAHs.  
In binary mixtures of B[a]P with As, Cd and Pb, the % uptake of B[a]P in HepG2 cells 
increased by 0.3 % (Figure 8.2). Although the % uptake of B[a]P in these combinations 
were not significant (p > 0.05), it indicates accumulation of B[a]P in HepG2 cells may be 
due to suppressed metabolism. It is well known that As, Cd and Pb inhibit CYP1A1 and 
CYP1B1 that is required for PAH metabolism (Vakharia et al., 2000). Furthermore, similar 
to findings with pure compounds in solutions (Chapter 5), an overall decrease in the 
concentration of 3-OH B[a]P was noted with B[a]P binary combinations and no metabolite 
was detected below 1.2 µM treatment. Notably, a study partially funded by the U.S. EPA 
reported that mixtures of PAHs (including As, Cd and Pb) did not induce PAH bioactivation 
by CYP 1A1 to the full potential of the individual PAH compounds (Vakharia and 
Kaminsky, 2001). Taken together, this may explain the findings regarding increased % 
uptake of B[a]P binary mixtures with As, Cd and Pb.  
More recent studies investigating interaction effects between B[a]P and As, Cd and Pb 
found additive effects in mixtures of (B[a]P+Cd) on formation of micronucleus in HepG2 
cells at 1 µM (Cheng et al., 2015), additive effect in mixtures of (B[a]P+Cd) on cell 
cytotoxicity at 13.7 µM and synergistic effects in mixtures of (B[a]P+As) and (B[a]P+Pb) on 
cell cytotoxicity at 109.5 µM and 132.7 µM, respectively (Muthusamy et al., 2016b).  The 
current study suggests additivity in binary mixtures of B[a]P (Figure 8.2) with As, Cd and 
Pb on % uptake of B[a]P in HepG2 cells at concentrations of 1 µM (B[a]P+Cd) and 50 µM 
(B[a]P+As, B[a]P+Pb). Additionally, due to their distinct physicochemical properties (i.e. 
As, Cd and Pb are hydrophilic and B[a]P is highly hydrophobic), As, Cd and Pb are not 
likely to interfere in the uptake of B[a]P by competition.  
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Figure 8.2 Uptake (%) of PAHs into HepG2 cells over 24 h of exposure, values are shown as mean ± SD, n = 3.  
Where A is showing % uptake of B[a]P (B[a]P+3-OH B[a]P) in single compound exposure and in binary mixtures. The degree of significance is indicated by asterisks “*”. (B[a]P+Phe) 
(p value = 0.04) and (B[a]P+Nap) (p value > 0.05). B is showing % uptake of Pyr (Pyr+1-OH Pyr); C is showing % uptake of Phe (Phe+4-OH Phe) and D is showing % uptake of Nap 
(Nap+1-OH Nap)  in single exposure and binary mixtures. The bottom and top of box represents 25th and 75th quartile of % uptake, the line in the box is the median % uptake of PAH. 
The top whisker is the highest % uptake and bottom whisker is the lowest % uptake. Between the two whiskers is the spread of % uptake of PAHs in HepG2 cells.  
   A B 
 C  D 
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In this study, no significant interaction uptake was observed for binary mixtures of Pyr and 
Phe (Figure 8.2). Notably, the % uptake of Nap into HepG2 cells significantly (p = 0.042) 
decreased in the presence of Pyr in UBM-DMEM solutions. Concentrations of Pyr and Nap 
in UBM-extracted soils were comparable (Chapter 7), however, when added to the DMEM 
cell culture medium the freely dissolved Pyr which is more hydrophobic in nature is 
preferably taken up cell membrane. The % uptake of B[a]P, Phe and Nap were not 
significantly affected by the presence of Pyr, As, Cd and Pb in a seven compound mixture 
(Figure 8.3). However, a significant (p = 0.043) increase in the % uptake of Pyr in HepG2 
cells was observed when it co-occurred with B[a]P, Phe, Nap, As, Cd and Pb. Competition 
by all four PAHs for the same sites on the metabolising enzymes and inhibition of CYP1A1 
by As, Cd and Pb could influence PAH accumulation within cells.  
 
Additionally, both B[a]P and Phe are known to have “bay region” in their chemical 
structures which may induce further metabolic activation by CYPs and epoxide hydrolase, 
therefore influencing their biotransformation (Shimada and Fujii-Kuriyama, 2004). Pyrene 
is known to be without a “bay region” in its chemical structure, therefore, in the presence of 
B[a]P and Phe and competition for enzymes, Pyr is accumulated within HepG2 cells. 
Notably, there was no change in the concentration of 1-OH Pyr metabolite. Together, the 
results indicate that the type of PAHs (i.e. based on their physicochemical properties and 
structure) may influence uptake and metabolism in mixtures and possibly toxic effects.  
 
Overall the data in this chapter suggests that the HepG2 in vitro bioassay can be useful in 
chemical risk assessment of UBM-extracted PAHs as demonstrated by quantifiable 
changes in PAH uptake in cells and biotransformation based on exposure concentration. 
On this basis, effects of PAH-metal/loids binary and seven-compound mixtures on % 
uptake of UBM-extracted PAHs in HepG2 cells were investigated. It is also noteworthy, 
effects on % uptake of B[a]P, Pyr, Phe and Nap in HepG2 cells from individual dose, 
binary mixtures and seven compound mixtures were limited to the exposure 
concentrations used in this study. The use of more replicate samples and exposure 
concentrations will reduce variations in % uptake that may result from variations in cell 
response or uncertainties in measurement.  
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Figure 8.3 Uptake (%) of PAHs into HepG2 cells over 24 h of exposure, values are shown as mean ± SD, n = 3.  
Where A is showing % uptake of B[a]P (B[a]P+3-OH B[a]P) in single compound exposure and in 7 compound mixtures. The degree of significance is indicated by 
asterisks “*”.B is showing % uptake of Pyr (Pyr+1-OH Pyr); (Pyr+B[a]P+Phe+Nap+As+Cd+Pb) p value = 0.04); C is showing % uptake of Nap (Nap+1-OH Nap) and 
D is showing % uptake of Phe (Phe+4-OH Phe) in single exposure and 7 compound mixtures. The bottom and top of box represents 25th and 75th quartile of % 
uptake, the line in the box is the median % uptake of PAH. The top whisker is the highest % uptake and bottom whisker is the lowest % uptake. Between the two 
whiskers is the spread of % uptake of PAHs in HepG2 cells.  
   C   D 
A   B 
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8.3.3 Effect of ageing and soil properties on PAH uptake into HepG2 cells 
 
A number of studies have suggested that PAHs become less available in the soil over time 
and, therefore, probably exert less toxic effect (Reeves et al., 2001; Alexander, 2000). 
There are few studies in literature that have investigated bioavailability of organic 
contaminants including PAHs by use of in vitro gastrointestinal digestion of spiked soils in 
combination with Caco-2 cells (Oomen et al., 2001; Vasiluk et al., 2007). In this Chapter 
the availability of individual PAHs and mixtures of PAHs with As, Cd and Pb on 7 day aged 
soils and soils aged up to 90 days were investigated using UBM and HepG2 cells in vitro 
methods. The UBM measured the bioaccessibility of PAHs, the PAHs that solubilised in 
simulated digestive fluids were introduced to the HegG2 cell bioassay to measure PAH 
uptake and metabolism (i.e. together as a surrogate measure of bioavailability).  
 
The % uptake of B[a]P (B[a]P+3-OH B[a]P) in HepG2 cells following exposure to UBM-
extracts from seven soil types aged up to 90 days is shown in Figure 8.4. In Chapter 7 no 
significant interaction was found in the mobilisation of B[a]P from aged soils into UBM-
extracts as steady state in soils was reached within 7 days of exposure. In this chapter, 
UBM-extracted soils aged up to 90 days had no significant interaction effect on the % 
uptake of B[a]P in HepG2 cells (Figure 8.4). Further, the bioaccessibility of B[a]P was 
significantly influenced by different soil properties such as TOC, DOC, clay, aluminium 
oxide and soil pH and therefore different amounts of B[a]P were mobilised into UBM 
extracts from the seven contrasting soil types (Chapter 7).  
 
The bioaccessibility of B[a]P from seven soil types was in the range of 0.2 ± 0.1 % to 5.1 ± 
1.8 %. In this chapter, the % uptake of B[a]P from exposure to UBM-extracts from seven 
soil types was in the range of 1.3 ± 0.2 % to 2.0 ± 0.5 %. The concentrations of B[a]P 
mobilised into simulated digestive fluids was highest in soil PBA (5.1 ± 1.8 %) and lowest 
in soil MGA (0.2 ± 0.1 %). The cell internal concentrations of B[a]P from exposure to UBM-
DMEM extracts of PBA and MGA were 150 ± 12 ng/106 cells and 6 ± 2 ng/106 cells, 
respectively. Based on soil property, comparatively higher concentrations of B[a]P in cells 
was associated to soil with low TOC content (i.e. PBA). Vasiluk et al. (2007) using Caco-2 
cells reported the amount of B[a]P mobilised from gastrointestinal extract-DMEM into cells 
was significantly greater with low organic matter soils. Notably, intracellular concentrations 
of B[a]P increased in relation to changes in the concentration of B[a]P in the UBM-DMEM 
solution. However, as illustrated in Figure 8.4, the % uptake of B[a]P in HepG2 cells were 
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not significantly different between the seven soil types and ageing period. Therefore, there 
is some uncertainty in extrapolating interaction effects from UBM extraction to cell uptake.  
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Figure 8.4 Uptake (%) of PAHs into HepG2 cells over 24 h of exposure, values are shown as mean ± SD, n = 3. Where A is % uptake of 
B[a]P (B[a]P+3-OH B[a]P) in HepG2 cells from exposure to 7 soil types that have been aged up to 90 days; B is showing the % uptake of Pyr (Pyr+1-OH Pyr) in HepG2 cells; C is 
showing % uptake of Phe (Phe+4-OH Phe) in HepG2 cells; D is showing % uptake of Nap (Nap+1-OH Nap) in HepG2 cells. Details for soil codes can be found in Chapter 3.   
A B 
C    D 
193 
 
Taken together, the results indicate that the HepG2 in vitro system provides enough 
sensitivity to detect matrix effects on amount of B[a]P in cells, but more importantly it 
supports the notion that the free concentration of B[a]P as opposed to the nominal 
concentration is available for uptake into cells. The results may find use in determining 
internal concentrations at which toxicity occurs.   
 
The % uptake of Pyr (Pyr+1-OH Pyr), Phe (Phe+4-OH Phe) and Nap (Nap+1-OH Nap) in 
HepG2 cells following exposure to UBM-extracts from seven soil types aged up to 90 days 
is shown in Figure 8.4. Similar to B[a]P, these three PAHs had reached a steady state in 
soil following their exposure and therefore no significant interaction effects were found 
between their bioaccessibility and ageing of Pyr, Phe and Nap in soils up to 90 days 
(Chapter 7). Figure 8.4 shows that there was no significant interaction between ageing of 
Pyr in soils and % uptake of Pyr into HepG2 cells. Additionally, % uptake of Pyr were not 
significantly different between the seven soil types (p > 0.05).  
 
In case of Phe, there was a significant (p value = 0.02) difference between % uptake of 
Phe from exposure to UBM-extracts of soil PBA and MGA. The bioaccessibility of Phe in 
soil PBA was 14.2 ± 1.9 % and in soil MGA was 1.2 ± 0.1 % (Chapter 7). The internal cell 
concentrations of Phe from exposure to PBA soil extracts was 1350 ± 25 ng/106 cells and 
from MGA soil extracts was 129 ± 5 ng/106 cells. The amount of Phe mobilised from soil 
PBA into UBM-extracts and then taken up by HepG2 cells was more than 10 fold higher 
than soil MGA. These data clearly show the utility of HepG2 in vitro model in detecting 
significant differences in % uptake of PAHs such as Phe mobilised from different soil 
matrices. No significant differences were found between the mobilisation of Nap from 
seven soil types into UBM-extracts and uptake into HepG2 cells. 
 
Results of the current study are unique to the soils and limited to the UBM-extracted 
concentrations employed. Additional soil types and more replicate analysis will help further 
investigate the role that soil parameters play in determining availability of PAHs during 
digestion and uptake in cells.  
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8.3.4 Application to real (contaminated) samples 
 
The field contaminated soils in this study included three soil samples from the vicinity of a 
former manufacturing gas plant site at Cootamundra (NSW) and three soil samples from 
an undisclosed industrial site. The total concentrations of B[a]P in field contaminated 
samples were above the soil Health Investigation Levels (HIL-A) value of 3 mg kg-1 
(NEPC, 2013). The concentrations of B[a]P in the < 250 µm soil fraction of the real soil 
samples were in a range of 3 ± 0.6 mg Kg-1  to 103 ± 15.6 mg Kg-1 (Chapter 7; Tables 7.12 
and Table 7.13). Additionally, two soil samples spiked with B[a]P only and used previously 
in a juvenile swine study (Duan, 2014) were included in this chapter to determine uptake of 
B[a]P in these samples. The total concentrations of B[a]P in the two soil samples were 
found above HIL-A for B[a]P and were in the range of 4.4 ± 1.2 mg Kg-1  to 5 ± 0.5 mg Kg-1 
(Chapter 7; Table 7.14). All field contaminated samples and two samples used in the in 
vivo study were UBM extracted and added to DMEM then exposed to HepG2 cell for 24 h. 
Table 8.2 shows the % uptake of PAHs into HepG2 cells. 
 
 The % uptake of B[a]P (B[a]P+3-OH B[a]P) in HepG2 cells from exposure to UBM-
extracts of Site 1, 2 and 3 soils were 1.3 ± 0.1 %, 1.4 ± 0.2 % and 1.2 ± 0.1 %, respectively 
(Table 8.2). The bioaccessibility of B[a]P in soils from Site 1, 2 and 3 were 3.2 ± 1 %, 11.5 
± 3.5 % and 18 ± 2.1 %, respectively. Additionally, the total organic carbon (TOC) content 
in Site 1, 2 and 3 soils were 12.8 %, 0.95 % and 1.3 %, respectively. While the 
bioaccessible concentrations of B[a]P were significantly different between soils with low 
and high TOC content (p < 0.05), exposure to low and high TOC soil UBM-extracts 
resulted in no significant % uptake of B[a]P in HepG2 cells (p > 0.05). The results here 
indicate the need for caution in extrapolating interactions from one process (e.g. UBM - 
digestive system) to another (i.e. HepG2 - liver accumulation). Notably, no B[a]P was 
detected in cells exposed to UBM-extracts of soils from undisclosed industrial sites and 
soil MTA used in the in vivo study (Table 8.2). This can be attributed to very low 
concentrations of B[a]P that mobilised from these soils into UBM fluids, subsequently very 
low concentrations were available for uptake into the HepG2 cells (Table 8.2). However, in 
UBM-extract of soil N, the % uptake of B[a]P in HepG2 cells was 1.1 ± 0.1 %. Based on % 
uptake data of pure B[a]P, the relative uptake of B[a]P in HepG2 cell is 52.3 ± 1 %. In this 
current study the relative bioaccessibility of B[a]P for soil N was found to be 120 ± 5.3 % 
(Chapter 7). It is noteworthy, that soil N is a very sandy soil and in vivo bioavailability of 
B[a]P in this soil using the juvenile swine model was found to be 108 % (Duan, 2014). For 
195 
 
this soil type, the bioaccessibility of B[a]P using UBM was similar to in vivo bioavailability 
of B[a]P in the juvenile swine model, however it overestimated the relative % uptake 
(surrogate bioavailability) of B[a]P in HepG2 cells. The use of a wide range of 
environmental soils will be useful in further validation of the in vitro and in vivo assays.  
 
Table 8.2 Percentage (%) uptake (surrogate bioavailability) of PAHs in HepG2 cells 
from exposure to UBM extracts of field soil samples and soil used in a “Juvenile 
Swine” study 
Compound Soil code UBM-DMEM   (µM) % Uptake 
 
B[a]P Site 1 0.72 ± 0.2 1.3 ± 0.1  
Nap  0.21 ± 0.1 ND 
Phe  2.8 ± 1.1 1.1 ± 0.1 
Pyr  2.2 ± 0.1 3.1 ± 0.2 
    
B[a]P Site 2 2.1 ± 0.5 1.4 ± 0.2 
Nap  0.47 ± 0.2 ND 
Phe  1.4 ± 1.1 0.9 ± 0.1 
Pyr  0.84 ± 0.2 ND 
    
B[a]P Site 3 0.21 ± 0.1 1.2 ± 0.1 
Nap  0.33 ± 0.2 ND 
Phe  0.28 ± 0.1 ND 
Pyr  0.34 ± 0.2 ND 
    
B[a]P PB 8 0.14 ± 0.2 ND 
Nap  0.04 ± 0.01 ND 
Phe  0.21 ± 0.1 ND 
Pyr  0.25 ± 0.1 ND 
    
B[a]P PB 18 0.12 ± 0.2 ND 
Nap  0.04 ± 0.01 ND 
Phe  0.08 ± 0.02 ND 
Pyr  0.5 ± 0.1 ND 
    
B[a]P PB 24 0.11 ± 0.1 ND 
Nap   0.04 ± 0.01 ND 
Phe  0.31 ± 0.1 ND 
Pyr  2.1 ± 1.1 2.8 ± 0.1 
    
B[a]P MTA 0.04 ± 0.01 ND 
    
 N 0.11 ± 0.1 1.1 ± 0.1 
    
Uptake (%) of PAHs into HepG2 cells over 24 h of exposure, values are shown as mean ± 
SD, n = 3. Where Site 1= Cootamundra sample 1 (NSW); Site 2 = Cootamundra sample 2 
(NSW); Site 3 = Cootamundra sample 3 (NSW); MTA = Mount Tamborine (QLD); N = 
Dublin (SA). ND = not detected in cell extracts; PB 8 = undisclosed site 1, PB 18 = 
undisclosed site 2 and PB 24 = undisclosed site 3.  
196 
 
The findings from real soil samples also relate to the importance of conducting risk 
assessment of contaminated soils on a site specific basis. Furthermore, Pyr, Phe and Nap 
were co-present with B[a]P in real soil samples and interaction effects between 
compounds for binding sites in UBM-DMEM solution and cell membrane is reflected in 
decrease in the % uptake of B[a]P, Phe and Pyr and Nap by 0.7 %, 1.8 %, 0.4 % and 0.04 
%, when compared to their individual % uptake in HepG2 from exposure to UBM-extracted 
spiked soil samples. 
 
8.4 Conclusion 
The results of this chapter provide the first outcomes in relation to PAH uptake and 
metabolism in HepG2 cells when exposed to UBM-extracted PAHs from soils spiked and 
aged up to 90 days and using field contaminated soils. The % uptake of pure B[a]P in 
HepG2 cells was 0.4 % higher than % uptake of UBM-extracted B[a]P in HepG2 cells. 
Interaction effects of B[a]P, Pyr, Phe and Nap on their respective uptake in HepG2 cells 
demonstrate that Phe and Nap can significantly increase the uptake of B[a]P whereas Pry, 
As, Cd and Pb only slightly increased uptake of B[a]P. The findings suggest that 
interactions between freely available PAHs may influence their respective uptake into 
cells. Based on quantification of metabolites towards determining % uptake of PAHs in 
HepG2 cells, it can be proposed that metabolism of PAHs in cells may have an influential 
role in the uptake of PAHs. Further, findings from the seven compound mixtures indicate 
that the type of PAHs may influence uptake and metabolism in mixtures and possibly toxic 
effects. Ageing of PAHs between 7 and 90 days in soil had no significant interaction 
effects on uptake into cells. Although cells were found to be sensitive to soil matrix effects, 
based on % uptake data the mobilisation of PAHs into cells was independent of the UBM-
DMEM concentrations. In future work, a wider range of soil types and concentrations 
above HIL A could be useful to assess the in vitro hepatic cell system, especially using 
soils that could be correlated with an in vivo animal model such as the “juvenile swine”. 
The availability of a soil certified reference material for assessment of bioaccessibility or 
bioavailability would greatly contribute to research and development in this area.  
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Chapter 9 General discussion, conclusions and recommendations 
9.1 General discussion 
A human health risk assessment is the process to estimate the nature and probability of 
adverse health effects in humans who may be exposed to chemicals in contaminated 
environmental media, now or in the future (US EPA, 2016). Therefore, addressing 
uncertainties in human health risk assessment is a critical issue when evaluating the 
effects of contaminants on public health (Dong et al., 2015). Remediation of contaminated 
soils to avoid human exposure to chemicals that could have negative health effects is 
recognised by governments both in Australia and overseas as a public health issue. The 
environmental regulatory guidelines for site contamination assessment in Australia is 
designated as National Environment Protection Measures (NEPM), which is set often 
assuming the contaminant is 100 % bioavailable in the absence of site specific data (Ng et 
al., 2010; NEPC, 2013). Contaminated soils contain a toxic cocktail of chemicals and 
based on current regulatory guidelines, the risk assessment is established on individual 
chemical data. Additivity of doses or effects is generally applied for risk assessment of 
chemical mixtures. However, this approach may over or under estimate the actual risk 
from exposure to contaminated soils. Consequently, such a conservative approach based 
on the absence of site-specific data could lead to unnecessary or expensive remediation 
options (Ng et al., 2013). Assessment of contaminant bioavailability may help to refine 
quantitative aspects of exposure in human health risk assessment. 
Both PAHs and metal/loids are major classes of ubiquitous environmental pollutants that 
are often co-present in contaminated soils at elevated concentrations through 
anthropogenic activities. For example, soils in Australia from within the vicinity of former 
manufacturing gasworks sites have been found to be co-contaminated with PAHs and 
metal/loids (Thavamani et al., 2011). From a remediation point of view, the removal of 
PAHs from soils at such contaminated sites is complex due to the presence of other 
organic and inorganic contaminants. Hence, the inclusion of bioavailability values is a key 
parameter which can be utilised for minimising the uncertainty associated with exposure in 
risk assessment (Ng et al., 2013).  
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Two of the key objectives in this PhD study were to provide information on the application 
of bioaccessibility and bioavailability of both organic and inorganic contaminants in order 
to better inform human health risk assessment of mixtures. This study investigated PAHs 
as chemicals of concern (COC) in spiked and aged soils and soils from sites co-
contaminated with metal/loids (i.e. As, Cd and Pb). Considering the 3R principle in animal 
ethics, alternative in vitro methods were used for screening a range of contaminated soils 
types that included 7 variants of spiked soils and several contaminated soils obtained from 
industrial sites. The Unified BARGE Method (UBM) developed by the Bioaccessibility 
Research Group of Europe (BARGE) simulated human gastrointestinal digestion and was 
used to measure the amount of PAHs that mobilised from soils into digestive fluids. While 
HepG2 cells (surrogate liver) based in vitro system took into consideration uptake and 
metabolism of PAHs (together as surrogate bioavailability). Taken together, the UBM-
HepG2 in vitro system demonstrated its use in addressing the key research questions of 
this PhD:  
 Do metal/loids (As, Cd and Pb) and PAH mixtures lead to an increase or decrease 
in the bioaccessibility of naphthalene (Nap), phenanthrene (Phe), pyrene (Pyr) and 
benzo[a]pyrene (B[a]P) in a simulated human digestive system? 
 Is there an increase or decrease in uptake of Nap, Phe, Pyr and B[a]P into HepG2 
cells from PAH mixtures in the presence or absence of As, Cd and Pb? 
 Do ageing of soil-contamination and soil properties impact on PAH bioaccessibility 
and uptake? 
To begin answering these questions, there was a need to develop a suitable analytical 
method fit for the purpose of screening large number of samples associated to in vitro 
analyses and with the flexibility to accommodate both parent PAHs and its metabolites. 
The simplicity and cost effectiveness of the QuEChERS approach was found to be useful 
in screening large batches of samples. Further, modifications to the QuEChERS approach 
enabled the use of smaller samples sizes without compromising sensitivity, the developed 
method may prove useful in risk assessment studies. The modified QuEChERS method 
was used together with both Gas Chromatography and Liquid Chromatography techniques 
coupled with Mass Spectrometry, which allowed co-analysis of PAHs and its mono-
hydroxilated metabolites (OH-PAHs) that varied widely in their physicochemical properties 
and log Kow ranges from 2.7 – 6.13.  
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In Chapter 4, a specific and sensitive procedure based on the QuEChERS approach was 
validated for the simultaneous analysis of PAHs and OH-PAHs in human liver cells 
(HepG2) using GC-QqQ-MS/MS and Q-Orbitrap-LC/MS. A number of parameters were 
investigated to optimise the performance of the modified QuEChERS based extraction 
protocol. These included; sample size, enzymatic hydrolysis, volume of the extraction 
solvents, use of QuEChERS extraction salts, compound derivatisation and extraction time. 
Following optimisation of the method conditions, the procedure was validated to measure 
its performance capability. Some of the key performance characteristics including good 
selectivity, sensitivity and acceptable recovery of the analytes showed that the method 
developed in Chapter 4 was accurate and can be applied for the analysis of PAHs and 
OH-PAHs in HepG2 cells or similar biological samples.  
The mean recoveries of PAHs in the spiked samples (n = 10) were between 70 – 120 % 
with the relative standard deviation (RSD) in a range of 2 – 20 %. Further, the LODs 
depending on the compound were in a range of 0.1 – 2 ng g-1. To our knowledge, this is 
the first analytical report in which a modified QuEChERS approach with GC-QqQ-MS/MS 
and Q-Orbitrap-LC/MS is applied to the simultaneous determination of PAHs and OH-
PAHs in HepG2 cells. Additionally, the suitability of the method for the determination of 
PAHs and OH-PAHs in HepG2 cells after exposure to PAHs was established. The 
QuEChERS based method can be applied as a new tool in risk assessment studies that 
uses in vitro bioassays to quantify PAH uptake and metabolism. The ability of the 
QuEChERS approach to accommodate extraction of a range of chemicals may be 
particularly useful in chemical mixtures study. 
Chapter 6 presents the first analytical protocol in which a QuEChERS based method was 
used in the analysis of PAHs and OH-PAHs in soil. Method optimisation and validation 
protocols were applied similar to Chapter 4. The recoveries of all compounds of interest in 
soil matrix were in the range of 76 % to 120 %, with relative standard deviation (RSD) in a 
range of 1 – 18 %. The LODs depending on the analyte were in a range of 0.2 – 10 ng g-1. 
The method was then applied to a soil certified reference material where a good 
agreement with certified and experimental results was found. Replicate analysis of the soil 
certified reference material indicated good accuracy and repeatability of the method. The 
application of the method for the determination of PAHs and OH-PAHs with field 
contaminated soils was tested through the analysis of three soils samples from a former 
manufacturing gasworks site. A range of PAHs were found in soils, however, the 
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concentration of B[a]P was found at or above the acceptable health investigation level for 
residential use (HIL-A), which is 3 mg Kg-1 (NEPC, 2013). The results in Chapter 6 
demonstrated that the method could be applied to different kinds of soils, and therefore it 
can be applied as a useful new tool in risk assessment studies investigating chemical 
bioavailability of PAHs and their metabolites. 
 
The key results in Chapters 5, 7 and 8 address the research questions of this PhD and are 
discussed in four key sections below:  
 
9.1.1 Bioaccessibility of B[a]P, Pyr, Phe and Nap in a simulated human digestion 
system using spiked and aged soils and field contaminated soils 
 
In this study, seven soil types were spiked with B[a]P, Pyr, Phe and Nap and aged at 7, 30 
and 90 days to assess their bioaccessibilities using UBM. No significant differences (p > 
0.05) were found between the bioaccessibilities of B[a]P, Pyr, Phe and Nap in ageing 
period and indicated that a steady bioaccessibility was reached in soils after 7 days of 
ageing. Therefore, taking average of bioaccessibility data obtained from seven types of 
soils (Chapter 7), bioaccessibility of B[a]P, Pyr, Phe and Nap was 0.1, 0.6, 0.6 and 0.2 % 
in the gastric phase, and 1.7, 2.6, 5.7 and 2.7 % in the intestinal phase, respectively. It is 
noted that there was a significant lower bioaccessibility (p < 0.05) of B[a]P, Pyr, Phe and 
Nap in the gastric phase in comparison to that of intestinal phase. Phe bioaccessibility was 
the highest amongst all PAHs, followed by Nap and Pyr. The bioaccessibility of B[a]P was 
the lowest. Overall, the PAH bioaccessibility data indicates that PAHs remained bound to 
soil particles and had limited solubilisation in the simulated digestive fluids.  
 
The differences in the comparatively higher concentrations of PAHs solubilised in the 
intestinal phase is due to the presence of bile salts and mucine in simulated 
gastrointestinal fluids. These ligands are known for their surfactant-like properties and aid 
in decreasing the surface tension, which favours the mobilisation of PAHs from soil into 
gastrointestinal fluids. The higher pH (5.5 – 6.8) in the gastrointestinal fluids also affects 
the solubility of soil organic carbon, therefore, increasing the mobilisation of PAHs 
attached to soil organic carbon into gastrointestinal fluids. Notably, increasing total soil 
concentrations had no statistically significant effect on PAH bioaccessibility in the gastric 
or intestinal phase (p > 0.05). This may be due to limited solubilisation of PAHs using UBM 
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and excess of binding ligands in the simulated digestive fluids. Alternatively, this also 
suggested that the binding sites in soils were not saturated with PAHs. The results in the 
spiked-soil study suggest that desorption of PAHs from soils was related to its 
hydrophobicity and solubility in the digestive fluids as opposed to its total concentration in 
soil. These are further discussed in Section 9.1.4 in relation to soil properties.  
 
Bioaccessibility data of spiked soils were also compared with data of real environmental 
samples reported in the literature and field contaminated soils used in this study. The 
concentrations of individual PAHs in field contaminated soils in this study were found to be 
within the range of spiked soils (Chapter 7), therefore, useful for comparison. The 
concentrations of B[a]P in soils from the former manufacturing gasworks site at 
Cootamundra (NSW, Australia), soils from undisclosed industrial sites and soils used in a 
juvenile swine study (Duan, 2014) were above the health investigation level for residential 
use (HIL A), which is 3 mg Kg-1 (NEPC, 2013). As B[a]P is the model compound for PAHs, 
the use of these soils in bioaccessibility and bioavailability assessment was appropriate. 
The concentrations of Pyr, Phe and Nap in all real soil samples were below the total PAHs 
guideline value for assessment of contaminated sites, which is 300 mg Kg-1 (NEPC, 2013). 
The bioaccessibility of B[a]P in soil samples from Cootamundra were found in the range of 
3 ± 0.6 % to 18 ± 2.1 %. Differences in bioaccessibility of B[a]P was attributed to varying 
TOC content. At Site 1 the TOC content was 12.8 % and had the lowest bioaccessibility 
value of 3 ± 0.6 %. Sites 2 and 3 had TOC content of 0.96 % and 1.3 %, respectively and 
their BAC were 11.5 ± 3.5 % and 18 ± 2.1 %. The highest bioaccessibility of B[a]P was at 
Site 3, which was 18 ± 2.1 % (Chapter 7).  
 
In comparison to spiked soils, the bioaccessibilities of B[a]P in soils from undisclosed 
industrial sites were particularly low and were found in the range of 0.2 ± 0.2 % to 1.3 ± 0.1 
%. Bioaccessibilities of Pyr, Phe and Nap in all field contaminated soil were also highly 
variable and together with the results for B[a]P, the bioaccessibility data for field 
contaminated soils suggest a more complex matrices (i.e. tarry materials) and mechanism 
of partitioning to soil organic content and desorption. As field contaminated soils were 
collected from within the vicinity of former manufacturing gasworks sites and other 
industrial sites, the operational processes at such sites may have impacted surface soils 
with carbonaceous geosorbents such as coke or black carbon. Even though soils in this 
study were not tested for presence of black carbon, presence of such carbon source in 
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these samples could explain the differences between bioaccessibilities of PAHs and 
suggest competitive binding aspects of carbonaceous geosorbents.  
 
In order to validate the use of in vitro assays as a surrogate measure of contaminant 
bioavailability, the relationship between in vivo bioavailability and in vitro bioaccessibility 
needs to be established (Ng et al., 2010). In this study, the relative bioaccessibility of 
B[a]P in two soils used in a juvenile swine study were compared to relative bioavailability 
of B[a]P. For soil MTA, the relative bioaccessibility of B[a]P was 53.3 ± 10.7 % and was 
found not to be significantly different (p value = 0.21) from the relative bioavailability value 
of 62.7 % reported in the juvenile swine study (Duan, 2014). For soil N the relative 
bioaccessibility for B[a]P was found to be 120 ± 5.3 % and was significantly different (p = 
0.02) from the relative bioavailability value of 108 %. For this soil type, the bioaccessibility 
of B[a]P using UBM overestimated the in vivo bioavailability of B[a]P in the juvenile swine 
model. However, for risk assessment purposes these two values can be considered 
similar considering other uncertainties which may be involved. Soil N was a sandy soil with 
low TOC content of 1.71 % and soil MTA had a TOC content of 7.5 %.  Hence, the 
difference in bioaccessible B[a]P was attributed to the binding effect of TOC. Due to the 
use of only two soil samples from juvenile swine study, the relationships between in vitro 
and in vivo assays although seem acceptable but will require further validation using a 
wider range of environmental soils.  
 
9.1.2 Interaction effects between B[a]P, Pyr, Phe and Nap on their respective 
bioaccessibilities and uptake in HepG2 cells 
 
Seven contrasting soil types were spiked with mixtures of B[a]P, Pyr, Phe, Nap, As, Cd 
and Pb. Bioaccessibilities of PAHs were determined for ageing time of 7, 30 and 90 days 
similar to the single pure compound study. Both gastric and gastrointestinal 
bioaccessibilities of B[a]P, Pyr, Phe and Nap in all co-contaminated soils were not 
significantly different (p > 0.05) from that in soils spiked with individual PAHs at 
corresponding ageing times. In this current study, a slight increase in the range of 0.1 – 1 
% in bioaccessible B[a]P was observed in the presence of Nap, Phe or Pyr in soil. The 
increase was highest in the presence of Nap, followed by Phe and Pyr. The results 
suggest that compound hydrophobicity may in part influence solubility of B[a]P in mixtures 
of PAHs.  
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In other binary mixtures, the presence of B[a]P with Nap, Phe or Pyr had no significant  (p 
> 0.05) effect on their individual bioaccessibilities over 90 days of ageing. However, an 
interesting find with binary mixtures of (Pyr+Phe) was that the presence of Phe decreased 
the bioaccessibility of Pyr by 0.6 %, while the bioaccessibility of Phe increased by 0.4 %. 
White et al. (1999) reported increase in the bioaccessibility of Phe in soils through 
competitive displacement with Pyr. While binary interaction between Pyr and Phe were not 
significant (p > 0.05), it suggests that PAH-soil interaction strongly influences its 
accessibility. Similarly, both bioaccessibilities of individual PAHs in the gastrointestinal and 
gastric phase in soils spiked with seven compound mixture (i.e. 
B[a]P+Pyr+Phe+Nap+As+Cd+Pb) and aged over 90 days were not significantly different to 
the bioaccessibility values in soils spiked with individual PAHs at corresponding ageing 
time (p > 0.05). Excess concentrations of binding sites and low concentrations of 
solubilised PAHs in the digestive fluids may explain lack of significant interaction effects 
between PAH compounds.  
 
After PAHs are solubilised in the simulated human digestion (i.e. UBM), the uptake of PAH 
and its metabolism (surrogate bioavailability) were investigated using the HepG2 cell 
based in vitro system, a surrogate for human liver, which is the key organ for detoxifying 
contaminants. Initially, individual PAHs in pure solutions in cell culture medium (e.g. 
DMEM) were exposed to HepG2 cells as a function of time over 24 h and then in a 
concentration-dependant manner at 24 h (Chapter 5). The UBM-extracted PAHs were 
exposed to HepG2 cells for 24 h to investigate any differences in uptake and metabolism 
of PAHs due to the presence of a complex matrix (e.g. UBM-DMEM solution). Both single 
compound PAHs, including B[a]P, Pyr, Phe and Nap and their mixtures with each other 
and As, Cd and Pb were exposed to HepG2 cells in pure solutions or from UBM-extracts. 
The interaction effects of As, Cd and Pb are discussed in Section 9.1.3.  
 
When B[a]P was exposed to HepG2 cells as a single compound using pure solutions, its 
uptake (i.e B[a]P+3-OH B[a]P) into HepG2 cells as a function of time was in the range of 
0.5 – 2.2 %. Concentration-dependent exposure to B[a]P was carried out at 24 h as 3-OH 
B[a]P metabolite concentrations were easily quantifiable at 24 h time point and because 
most toxicological investigations are carried out at 24 h. Three different concentrations of 1 
µM, 2.5 µM  and 5 µM B[a]P in pure solutions were exposed to HepG2 at 24 h and 
resulted in uptake of 1.7 – 2.5 %. In comparison, the uptake of Pyr (Pyr+1-OH Pyr) in time-
dependent exposure was 0.3 – 4.9 % and concentration-dependent exposure was 2.7 – 
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3.8 %. Similarly, the uptake of Phe (Phe+4-OH Phe) in time-dependent exposure was 0.2 
– 1.4 % and concentration-dependent exposure was 0.92 – 1.03 %. Whereas for Nap 
(Nap+1-OH Nap), the uptake in HepG2 cells in the time-dependant exposure was 0.02 – 
0.04 % and concentration-dependant exposure was 0.04 %. Overall, low uptake of PAHs 
were found in HepG2 cells and most of the PAHs remained sequestered in the cell culture 
medium. The increasing concentrations of PAH metabolites over 24 h of exposure 
indicated metabolic capacity of HepG2 cells to detoxify PAHs. Notably, metabolic 
activation in HepG2 cells is caused by a much lower concentration of PAHs than that 
added to the exposure medium.  
 
Taking internal cell concentrations into account will help refine chemical risk assessment 
of exposure to PAHs. Furthermore, the uptake data from pure solutions suggests that 
hydrophobicity might play a role in the bioavailability of PAHs in HepG2. Both B[a]P and 
Pyre are more hydrophobic in nature (higher Log Kow values) than Phe and Nap, their rate 
of uptake and biotransformation in HepG2 cells was found to be higher than Nap and Phe. 
Another key finding from the pure solution study was that uptake of PAHs into HepG2 cells 
was independent of the external exposure concentration, which pointed towards passive 
diffusion as the dominant uptake route.  
 
Interaction uptake of PAHs in binary, ternary and seven compound mixtures in pure 
solutions were also investigated in comparison to single compound uptake in HepG2. The 
uptake of Phe and Nap in HepG2 cells decreased significantly in the presence of Pyr (p < 
0.05) in their binary mixtures. Similarly, the uptake of Phe and Nap in HepG2 cells 
decreased significantly (p < 0.05) in ternary mixtures in the presence of B[a]P, Pyr or both. 
The only significant decrease in uptake of B[a]P into HepG2 cells was found in ternary 
mixtures in the presence of Pyr and Nap (p = 0.043). Further, a significant decrease in the 
uptake of Phe was observed in the seven compound mixtures (p = 0.001). Interaction 
study on uptake of PAHs in HepG2 cells generally showed less than additive effects 
among binary, ternary and seven compound mixtures of B[a]P, Pyr, Phe and Nap. 
Notably, studies using both hepatocytes and HepG2 cells reported that mixtures of PAHs 
(including As, Cd and Pb) did not induce PAH bioactivation to the full potential of the 
individual PAH compounds (Vakharia and Kaminsky, 2001; Vakharia et al., 2000).  
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Based on the pure solution study (Chapter 5) and bioaccessibility study (Chapter 7), the 
HepG2 cells were exposed to UBM-extracted PAHs to investigate uptake from PAHs 
solubilised in human digestive system. The uptake of B[a]P, Pyr, Phe and Nap from 
exposure to UBM-extracted soils were in the range of 1.3 – 2 %, 3.9 – 4.9 %, 0.9 – 1.5 % 
and 0.04 %, respectively. Again, the bulk of the UBM-extracted PAHs remained 
sequestered in the cell culture medium (i.e. UBM-DMEM). Interaction uptake of PAHs in 
binary and seven compound mixtures in UBM-extracts were also investigated in 
comparison to single compound uptake in HepG2 cells. A significant increase in the % 
uptake of B[a]P in HepG2 cells was observed in the presence of Nap (p < 0.01) and Phe 
(p = 0.043) in binary mixtures. Similarly, a significant increase (p = 0.043) in the % uptake 
of Pyr in HepG2 cells was observed in the seven compound mixture. In contrast, a 
significant decrease in the % uptake of Nap in HepG2 cells was observed in the presence 
of Pyr (p = 0.042). The results indicates that freely available and more hydrophobic PAHs 
such as B[a]P and Pyr are more passively available to HepG2 cells and reflect on their 
affinity to lipoproteins and cell membrane.  
 
The increased % uptake in HepG2 cells suggest additional transport mechanism of PAHs 
in addition to passive diffusion in HepG2 cells. It can be proposed that UBM-extracted 
PAHs such as B[a]P and Pyr may additionally be transported in combination with small 
bile acids into HepG2 cells via passive diffusion or membrane carriers. Moreover, the % 
uptake data from UBM-extracted real soil samples showed a decrease in % uptake of 
B[a]P, Pyr, Phe and Nap by 0.7 %, 1.8 %, 0.4 % and 0.04 %, respectively when compared 
to their individual PAH % uptake in HepG2 cells from exposure to UBM-extracted spiked 
soil samples. As all PAHs were co-present in real soil samples the results suggest 
competitive interaction for binding sites in UBM-DMEM solution and cell membrane. 
Generally, interaction study on uptake of PAHs in HepG2 cells following exposure to UBM-
extracted PAHs suggests additive or less than additive effects among binary and seven 
compound mixtures of B[a]P, Pyr, Phe and Nap.  
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 9.1.3 Interaction effects of As, Cd or Pb on the bioaccessibility of B[a]P, Pyr, Phe 
and Nap and their uptake in HepG2 cells 
 
The effect on bioaccessibilities of PAHs in the presence of As, Cd and Pb in soils spiked 
and aged up to 90 days was also investigated in this study. The bioaccessibility of B[a]P in 
the presence of As, Cd or Pb decreased by 0.2 %, 1.8 % and 2%, respectively. Similar 
observations were seen with Pyr, Phe and Nap in combination with As, Cd or Pb, with 
decrease in bioaccessibilities in the range of 0.1 – 1.8 %. In literature, the cation-π 
interaction between aromatic pi donors and metal cations have been reported to enhance 
sorption of PAHs to soils, especially soils with high clay content (White et al., 1999). It can 
be established that PAHs did not compete against As, Cd or Pb for binding sites of bile, 
the concentration of bile (>1000 mg L-1) is much higher than solubilised PAHs. Similarly, 
the presence of As, Cd and Pb had no significant effects on the bioaccessibilities of PAHs 
in soils spiked and aged up to 90 days with seven compounds (e.g. 
B[a]P+Pyr+Phe+Nap+As+Cd+Pb).  
 
Effects of As, Cd and Pb on the % uptake of B[a]P, Pyr, Phe and Nap were tested by 
dosing HepG2 cells with pure solutions and UBM extraction solutions from spiked and 
aged soils. Uptake data from pure solutions demonstrate that the % uptake of B[a]P, Pyr 
and Nap was not affected by As, Cd or Pb. Whilst the uptake of Phe in HepG2 cells  was 
found to decrease significantly in the seven compound mixture (p < 0.01) which had As, 
Cd and Pb. This was mainly from exposure at higher concentration and may indicate 
damage to cell membrane. In comparison, the % uptake data from UBM extraction 
solutions showed that % uptake of B[a]P, Pyr, Phe and Nap was not affected by As, Cd or 
Pb. The results suggest that due to their distinct physicochemical properties (i.e. As, Cd 
and Pb are hydrophilic and PAH hydrophobic) the inorganic compounds most likely do not 
significantly interfere in the uptake of PAHs in HepG2 cells by competition. Generally the 
interaction study on uptake of PAHs in HepG2 cells in mixtures with As, Cd and Pb 
suggests less than additive effects among binary, ternary and seven compound mixtures 
of B[a]P, Pyr, Phe and Nap. 
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9.1.4 Effects of ageing and soil properties on the bioaccessibility of B[a]P, Pyr, Phe 
and Nap and their uptake in HepG2 cells 
 
Bioaccessibility of B[a]P, Pyr, Phe and Nap measured in soils aged for 7 days, 30 days 
and 90 days (Chapter 7) were similar to each other for individual soil types. The results 
suggest that the most significant interactions between PAHs and soil components 
controlling its bioaccessibility was completed by the first 7 days of ageing condition of this 
study. This may also indicate that the binding sites in soils were not saturated with PAHs 
or As, Cd and Pb. This suggest higher saturation of soil active components such as soil 
organic matter. Yu et al (2014) identified soil organic matter and clay minerals as the two 
most chemically active components of soil among other soil properties such as pH and 
cation exchange capacity (CEC) which will affect the sorption–desorption of PAHs. In this 
current study, both TOC and DOC had strong influence on the bioaccessibilities of B[a]P, 
Pyr, Phe and Nap. Whereas soil clay content and aluminium oxide had a strong linear 
relationship in decreasing the bioaccessibility of Phe (R2 = 0.50 – 0.53). According to 
Raber et al (1998), the mobility of PAHs and metal/loids can be enhanced by DOC based 
on the soil type and compositional differences with respect to hydrophobic and hydrophilic 
components of the dissolved organic matter. This study employed limited soil types, 
however, effects of key soil properties such as TOC and clay provided an apparently 
strong retention and limited the mobilisation of B[a]P, Pyr, Phe and Nap into UBM 
digestive fluids.  
 
Three key soil parameters, including TOC, clay and aluminium oxide were most influential 
in decreasing bioaccessibility of B[a]P, Pyr, Phe and Nap in the spiked and aged soil 
samples (R2 = 0.5 – 0.86). Decreasing bioaccessibility of PAHs in all soil types generally 
followed a sequence based on increasing TOC content. Whereas the DOC (R2 = 0.74 – 
0.83) was found to be the key soil parameter in increasing the bioaccessibility of B[a]P, 
Pyr, Phe and Nap in spiked and aged soil samples (Chapter 7). These relationships were 
based on the values of R2 and considering limited soil types used in this study, it is 
suggested that interpretation of soil parameter-bioaccessibility relationships be taken with 
caution.  
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In field contaminated soil samples, low molecular weight PAHs such as Nap and Phe had 
comparatively higher bioaccessibilities than B[a]P and Pyr, even though B[a]P and Pyr 
were found in higher concentrations in these soils (Chapter 7). This indicated that high 
molecular weight PAHs such as B[a]P are highly sequestered in impacted soils. Surface 
soils from field contaminated samples are expected to have been impacted from 
operational processes with carbonaceous geosorbents such as coke or black carbon over 
a long period of operation. Such carbon source could explain the differences between 
PAH bioaccessibilities and suggest competitive binding aspects of carbonaceous 
geosorbents.   
 
The uptake data for B[a]P, Pyr, Phe and Nap from exposure to UBM-extracted soils aged 
up to 90 days indicates highest uptake of Pyr, followed by B[a]P, Phe and Nap in HepG2 
cells (Chapter 8). Notably, different ageing periods of 7, 30 and 90 days had no significant 
effect on the uptake of B[a]P, Pyr, Phe and Nap in HepG2 cells suggesting a steady state 
was reached in within 7 days of spiking. The effects of soil properties on the uptake of 
B[a]P, Pyr Phe and Nap in HepG2 cells was also investigated. Even though increase in 
intracellular concentrations of B[a]P and Phe could be associated to UBM-DMEM 
concentrations, the uptake of individual PAHs were independent of the UBM-DMEM 
concentrations. For example, there was no significant difference (p > 0.05) in the uptake of 
B[a]P in HepG2 cells from UBM-extracts of Sites 1, 2 and 3 (1.2 ± 0.1 % to 1.4 ± 0.2 %) in 
the field contaminated soils regardless of UBM-DMEM concentration (0.21 ± 0.1 µM to 2.1 
± 0.5 µM) and widely varying soil TOC values (i.e. 0.96 % to 12.8 %). Due to very low 
concentrations of Nap in UBM-DMEM, it was not detected in HepG2 cells. Whereas, Phe 
uptake in HepG2 cells was limited to Sites 1 and 2 UBM-extracted soils. The results 
indicate that PAH in contaminated soils impacted by anthropogenic activities may not 
necessarily be readily available. The findings here relate to the importance of conducting 
risk assessment of contaminated soils on a site specific basis.  
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9.2 Conclusions 
 
Two QuEChERS based analytical methods have been developed and validated for the 
simultaneous analysis of PAHs and OH-PAHs in HepG2 cells and soils. Both methods are 
the first analytical reports with applications in chemical mixtures study and as a useful new 
tool in risk assessment studies investigating chemical bioavailability of PAHs and their 
metabolites.  
 
The bioaccessibilities of B[a]P, Pyr, Phe and Nap were investigated in seven types of soils 
that were aged for 7, 30 and 90 days using the UBM. Differences in the bioaccessibilities 
of B[a]P, Pyr, Phe and Nap for different ageing periods was found to be insignificant, 
indicating PAHs reacted rapidly with soil components within 7 days of exposure to reach a 
steady bioaccessibility (p > 0.05). The bioaccessibility of PAHs in both the gastric and 
gastrointestinal phase generally followed the sequence: Phe > Nap > Pyr > B[a]P. The 
amount of B[a]P, Pyr, Phe and Nap solubilised in the gastrointestinal phase was 
significantly higher compared to the gastric phase (p < 0.05). In general, the PAH 
bioaccessibility data indicates that PAHs remained bound to soil particles and had limited 
solubilisation in the simulated digestive fluids. 
 
Key soil properties that decreased bioaccessibilities of B[a]P, Pyr, Phe and Nap included; 
TOC > Clay > aluminium oxide. Whereas, DOC was the key soil property that increased 
the mobilisation of PAHs from soils to simulated digestive fluids. Further, DOC correlated 
strongly with bioaccessibilities of B[a]P, Pyr, Phe and Nap in gastrointestinal fluids. Higher 
solution pH is known to dissolve more organic carbon and hence increase bioaccessibility 
of DOC-associated PAHs. In field contaminated soil samples, high molecular weight PAHs 
such as B[a]P was highly sequestered in some impacted soils and together with high 
variability in bioaccessibilities of all PAHs, the results indicate a more complex mechanism 
of sorption-desorption to soil organic carbon. Generally, bioaccessibility data suggests that 
desorption of PAHs from soils was related to its hydrophobicity and solubility in the 
digestive fluids as opposed to its total concentration in soil. However, it is noteworthy that 
due to limited number of soil types used in this current study, interpretations of the soil 
properties-bioaccessibilities relationship should be taken with care.  
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Interactions among B[a]P, Pyr, Phe and Nap in soil and solutions indicated that compound 
hydrophobicity may in part influence solubility and sorption-desorption of individual 
compounds in mixtures of PAHs. However, the excess concentrations of binding sites and 
low concentrations of solubilised PAHs in the digestive fluids may explain lack of 
significant interaction effects between mixtures of PAH compounds and As, Cd and Pb in 
digestive fluids.  
 
HepG2 cells were found to be reliable cell based bioassay to investigate uptake, 
metabolism and interaction of B[a]P, Pyr, Phe and Nap on hepatic level. Generally, PAHs 
remained sequestered in the cell culture medium and uptake of individual PAHs in HepG2 
cells was found to be independent of the external exposure concentration, which pointed 
towards passive diffusion as the dominant uptake route. Notably, freely available and more 
hydrophobic PAHs such as B[a]P and Pyr are more passively available to HepG2 cells 
and reflect on their affinity to lipoproteins and cell membrane. Hence, hydrophobicity of 
PAH may influence its uptake in HepG2 cells. Furthermore, metabolic activation in HepG2 
cells was found to result from a much lower concentrations of PAHs than that added to the 
exposure medium. Both uptake and metabolism of PAHs in HepG2 cells may influence 
bioavailability of PAHs. 
 
When using pure solutions, the interaction study on uptake of PAHs in HepG2 cells 
generally resulted in less than additive effects among binary, ternary and seven compound 
mixtures of B[a]P, Pyr, Phe and Nap. Similarly, interaction study on uptake of PAHs in 
HepG2 cells in mixtures with As, Cd and Pb showed less than additive effects among 
binary, ternary and seven compound mixtures of B[a]P, Pyr, Phe and Nap. Using UBM-
extracted solutions, interaction effects on uptake of PAHs in HepG2 cells was found to be 
both additive and less than additive. Which suggests additional transport mechanism of 
PAHs in addition to passive diffusion of freely available PAHs in HepG2 cells. Hence, 
more hydrophobic PAHs such as B[a]P and Pyr may additionally be transported in 
combination with small bile acids into HepG2 cells via passive diffusion or membrane 
carriers.  
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Results of bioaccessibility, uptake and metabolism (surrogate bioavailability) of B[a]P, Pyr, 
Phe and Nap as individual compounds or mixtures in the presence or absence of As, Cd 
and Pb provide significant new understanding towards interaction effects of these 
compounds in the context of human health risk assessment. For assessment of soils 
contaminated with PAHs and metal/loids, it clarifies situations where additive effects can 
be expected rather than assuming additivity as a general rule in risk assessment of 
chemical mixtures.  
 
9.3 Future work 
 
Future work may include but not limit to the following: 
 
1. Future work should include more soil types to reduce uncertainties in soil properties-
bioaccessibility correlation. 
 
2. Testing a further range of soil properties, including type of organic carbon (e.g. 
carbonaceous or amorphous organic carbons) and dissolved organic carbon (e.g. fulvic 
and humic acids) to elucidate DOC-associated PAH bioaccessibility. 
 
3. Current study used Health Investigation Levels A as a guideline value in developing 
spiking concentrations of PAHs in soils, in future the use of sorption capacities and 
Langmuir adsorption model is suggested to account for soil loadings and estimation of 
active sites. 
 
4. The development and use of a certified reference material for assessment of 
bioavailability or bioaccessibility will advance research and improve knowledge in this field. 
 
5. There is a need to conduct in vivo – in vitro validation of PAH bioaccessibility 
assessment using the UBM method, such experiments in the future would need to use a 
wide range of soil types and spiking concentrations which are higher than spiking at Health 
Investigation Level A for B[a]P and other PAHs, including Pyr, Phe and Nap; and more 
importantly in a wider range of real environmentally contaminated soils.  
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6. HepG2 cell bioassay can be made more sensitive by reducing the serum concentration 
in the exposure medium. This will need to be investigated against the results in the current 
study.  
 
7. In future HepG2 cell system as an in vitro model would need validation against an 
animal model which has bioavailability data for PAHs in liver.  
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Appendices 
Appendix 1: Chapter 3 Supplementary material 
Schematic flow chart of Unified BARGE Method and fluid ingredients 
 
       
 
Figure S3.1 Schematic diagram of Unified BARGE Method 
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Table S3 Composition of the digestive solutions used in Unified BARGE Method 
Saliva Gastric phase Intestinal phase Bile 
Inorganic solution (500 mL) 
KCL 896 mg 
 
NaCl 2752 mg 
 
NaCl 7012 mg 
 
NaCl 5259 mg 
NaH2PO4 888 mg NaH2PO4 266 mg NaHCO3 5607 mg NaHCO3 5785 mg 
KSCN 200 mg KCl 824 mg KH2PO4 80 mg KCl 376 mg 
Na2S04 570 mg CaCl2 400 mg Mg Cl2 50 mg  
NaCl 298 mg NH4Cl 306 mg 180 µL HCL 37 % 180 µL HCL 37 % 
1.8 mL NaOH 1.0 M 8.3 mL HCL 37 %   
    
Organic solution (500 mL)    
Urea 200 mg Glucose 650 mg Urea 100 mg Urea 250 mg 
 Glucuronic acid 20 mg   
 Urea 85 mg   
 Glucosamine hydrochloride 330 mg   
Added compounds    
Amylase 145 mg Bovine albumin 1g CaCl2 200 mg CaCl2 222 mg 
Mucin 50 mg Mucin 3g Bovine albumin 1 g Bovine albumin 1.8 g 
Uric acid 15 mg Pepsin 1g Pancreatin 3 g Porcine bile 6g  
  Lipase 500 mg  
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Figure S3.2 BCR-524 INDUSTRIAL SOIL (PAH's) 
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Appendix 2: Chapter 5 Supplementary material 
Distribution and mass balance of pure compound PAHs in the HepG2 in vitro system   
 
Table S5.1 Distribution of B[a]P in the culture medium, flask plastic and HepG2 cells 
over 24 h. Distribution is measured as percentage of initial measured concentration.  
Time (h) Concentration (µM) Compartment % B[a]P 
0 5 Plastic 3 
  Medium 96 
  Cell  0.5 
    
3 5 Plastic 2.5 
  Medium 95 
  Cell 1.8 
    
6 5 Plastic 2 
  Medium 95 
  Cell 1.9 
    
12 5 Plastic 2 
  Medium 95 
  Cell 1.8 
    
24 5 Plastic 1.5 
  Medium 94 
  Cell 2.2 
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Table S5.2 Distribution of Pyr in the culture medium, flask plastic and HepG2 cells 
over 24 h. Distribution is measured as percentage of initial measured concentration. 
Time (h) Concentration (µM) Compartment % Pyr 
0 20 Plastic 4 
  Medium 95 
  Cell  0.3 
    
3 20 Plastic 4 
  Medium 94.5 
  Cell 1.8 
    
6 20 Plastic 3 
  Medium 91.5 
  Cell 4.5 
    
12 20 Plastic 2 
  Medium 92 
  Cell 4.6 
    
24 20 Plastic 2 
  Medium 90 
  Cell 4.9 
    
 
Table S5.3 Distribution of Phe in the culture medium, flask plastic and HepG2 cells 
over 24 h. Distribution is measured as percentage of initial measured concentration. 
Time (h) Concentration (µM) Compartment % Phe 
0 20 Plastic 4 
  Medium 94.7 
  Cell  0.2 
    
3 20 Plastic 4 
  Medium 94 
  Cell 0.4 
    
6 20 Plastic 3 
  Medium 93 
  Cell 1.3 
    
12 20 Plastic 2.5 
  Medium 92.5 
  Cell 1.3 
    
24 20 Plastic 2 
  Medium 92 
  Cell 1.4 
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Table S5.4 Distribution of Nap in the culture medium, flask plastic and HepG2 cells 
over 24 h. Distribution is measured as percentage of initial measured concentration. 
Time (h) Concentration (µM) Compartment % Nap 
0 20 Plastic 4 
  Medium 95.2 
  Cell  0.02 
    
3 20 Plastic 4 
  Medium 95 
  Cell 0.04 
    
6 20 Plastic 3.5 
  Medium 94.5 
  Cell 0.04 
    
12 20 Plastic 3.1 
  Medium 95 
  Cell 0.04 
    
24 20 Plastic 2 
  Medium 93 
  Cell 0.04 
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Appendix 3: Chapter 6 Supplementary material 
 
Table S6.1 Recovery data obtained with GC-QqQ-MS/MS and Q-Orbitrap-LC/MS methods for analysis of PAHs and OH-PAHs in 
variant soils with and without the use of mini ceramic homogenisers 
 
Compounda 
 
 
PBA 
Rec (%) 
 
 
 
RSD (%) 
 
 
DUA 
Rec (%) 
 
 
 
RSD 
(%) 
 
 
WRA 
Rec (%) 
 
 
 
RSD (%) 
Soil type 
 
MIA 
Rec (%) 
 
 
 
RSD (%) 
 
 
TAA 
Rec (%) 
 
 
 
RSD (%) 
 
 
KBA 
Rec (%) 
 
 
 
RSD (%) 
 
 
MGA 
Rec (%) 
 
 
 
RSD (%) 
PAHs               
               
Nap 82 (80) 6 (8) 88 (80) 7 (10) 76 (72) 4 (5) 77 (70) 5 (3) 76 (70) 6 (7) 75 (77) 9 (7) 75 (72) 5 (5) 
Phe 101 (95) 8 (10) 120 (107) 6 (8) 77 (78) 7 (10) 80 (78) 7 (8) 78 (80) 4 (3) 75 (70) 12 (10) 75 (74) 8 (10) 
Pyr 92 (89) 4 (5) 94 (87) 11 (15) 82 (80) 7 (10) 86 (79) 8 (10) 85 (79) 9 (8) 80 (78) 10 (11) 77 (72) 6 (5) 
B[a]P 90 (85) 5 (6) 97 (90) 2 (5) 80 (78) 6 (8) 90 (88) 5 (8) 85 (80) 5 (9) 80 (75) 7 (9) 78 (75) 7 (3) 
               
OH-PAHs               
               
1-OH Nap 77 (72) 10 (10) 82 (82) 5 (6) 82 (80) 18 (15) 80 (76) 10 (11) 80 (76) 6 (7) 77 (70) 12 (10) 77 (70) 12 (9) 
2-OH Nap 78 (72) 7 (10) 88 (80) 5 (5) 75 (77) 6 (8) 77 (79) 6 (8) 76 (72) 5 (7) 75 (72) 16 (12) 75 (70) 16 (12) 
1-OH Phe 75 (70) 12 (10) 79 (72) 8 (10) 80 (77) 9 (8) 83 (79) 9 (8) 82 (80) 8 (8) 77 (70) 6 (8) 75 (72) 9 (9) 
2-OH Phe 79 (71) 8 (11) 80 (82) 9 (8) 77 (72) 10 (7) 77 (75) 9 (7) 75 (72) 10 (12) 75 (70) 11 (10) 76 (72) 9 (9) 
3-OH Phe 82 (80) 12 (12) 78 (77) 11 (10) 77 (72) 10 (12) 80 (81) 11 (10) 79 (71) 6 (8) 77 (72) 7 (5) 76 (70) 11 (15) 
4-OH Phe 88 (80) 15 (15) 90 (92) 7 (5) 80 (80) 7 (8) 80 (80) 9 (11) 80 (80) 7 (6) 80 (82) 8 (8) 80 (82) 11 (10) 
1-OH Pyr 75 (72) 12 (15) 80 (79) 4 (4) 76 (76) 7 (8) 82 (77) 7 (12) 78 (76) 7 (5) 77 (80) 11 (10) 76 (77) 4 (4) 
3-OH B[a]P 80 (80) 10 (12) 80 (75) 2 (2) 75 (70) 6 (7) 75 (70) 6 (6)) 75 (78) 6 (6) 75 (70) 10 (10) 77 (72) 10 (5) 
               
a Nap, Naphthalene; Phe, Phenanthrene; Pyr, Pyrene; B[a]P, Benzo[a]pyrene; 1-OH Nap, 1-hydroxynaphthalene; 2-OH Nap, 2-
hydroxynaphthalene; 1-OH Phe, 1-hydroxyphenanthrene; 2-OH Phe, 2-hydroxyphenanthrene; 3-OH Phe, 3-hydroxyphenanthrene; 4-OH 
Phe, 4-hydroxyphenanthrene; 1-OH Pyr; 1-hydroxypyrene; 3-OH B[a]P, 3-hydroxybenzo[a]pyrene. The recovery (%) and relative 
standard deviation (% RSD) is based on replicate analysis (n = 3). Values in ( ) represent extraction without the use of mini ceramic 
homogenisers. 
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Appendix 4: Chapter 7 Supplementary material 
Calibration curves for PAHs and OH-PAHs 
 
 
Figure S7.1 Calibration curve for B[a]P 
 
 
 
Figure S7.2 Calibration curve for Phe 
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Figure S7.3 Calibration curve for Nap 
 
 
 
 
Figure S7.4 Calibration curve for Pyr 
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Figure S7.5 Calibration curve for 1-OH Nap  
 
 
 
 
 
Figure S7.5 Calibration curve for 2-OH Nap 
 
 
Figure S7.6 Calibration curve for 1-OH Phe 
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Figure S7.7 Calibration curve for 2-OH Phe  
 
 
 
Figure S7.8 Calibration curve for 3-OH Phe 
 
 
Figure S7.9 Calibration curve for 4-OH Phe 
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Figure S7.10 Calibration curve for 1-OH Pyr 
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Appendix 5: Chapter 8 Supplementary materials 
Distribution and mass balance of UBM-extracted PAHs in the HepG2 in vitro system   
 
Table S8.1 Distribution of B[a]P in the culture medium, flask plastic and HepG2 cells 
over 24 h. Distribution is measured as percentage of initial measured concentration. 
Time (h) Concentration (µM) Compartment % B[a]P 
  Plastic 0.5 
24 5 Medium 97 
  Cell  1.6 
    
 
Table S8.2 Distribution of Pyr in the culture medium, flask plastic and HepG2 cells 
over 24 h. Distribution is measured as percentage of initial measured concentration. 
Time (h) Concentration (µM) Compartment % Pyr 
  Plastic 0.5 
24 20 Medium 93 
  Cell  4.3 
    
 
Table S8.3 Distribution of Phe in the culture medium, flask plastic and HepG2 cells 
over 24 h. Distribution is measured as percentage of initial measured concentration. 
Time (h) Concentration (µM) Compartment % Phe 
  Plastic 0.8 
24 20 Medium 95 
  Cell  1.2 
    
 
Table S8.4 Distribution of Nap in the culture medium, flask plastic and HepG2 cells 
over 24 h. Distribution is measured as percentage of initial measured concentration. 
Time (h) Concentration (µM) Compartment % Nap 
  Plastic 1 
24 20 Medium 97 
  Cell  0.05 
    
 
 
  
 
 
